
<html lang="en"     class="pb-page"  data-request-id="d46216df-525c-4fd1-bb46-cf324fae2e3e"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;article:article:10.1021/acs.jmedchem.7b01250;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2017.60.issue-24;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Highly Selective and Potent α4β2 nAChR Antagonist Inhibits Nicotine Self-Administration and Reinstatement in Rats" /></meta><meta name="dc.Creator" content="Jinhua  Wu" /></meta><meta name="dc.Creator" content="Andrea  Cippitelli" /></meta><meta name="dc.Creator" content="Yaohong  Zhang" /></meta><meta name="dc.Creator" content="Ginamarie  Debevec" /></meta><meta name="dc.Creator" content="Jennifer  Schoch" /></meta><meta name="dc.Creator" content="Akihiko  Ozawa" /></meta><meta name="dc.Creator" content="Yongping  Yu" /></meta><meta name="dc.Creator" content="Huan  Liu" /></meta><meta name="dc.Creator" content="Wenteng  Chen" /></meta><meta name="dc.Creator" content="Richard A.  Houghten" /></meta><meta name="dc.Creator" content="Gregory S.  Welmaker" /></meta><meta name="dc.Creator" content="Marc A.  Giulianotti" /></meta><meta name="dc.Creator" content="Lawrence  Toll" /></meta><meta name="dc.Description" content="The α4β2 nAChR is the most predominant subtype in the brain and is a well-known culprit for nicotine addiction. Previously we presented a series of α4β2 nAChR selective compounds that were discover..." /></meta><meta name="Description" content="The α4β2 nAChR is the most predominant subtype in the brain and is a well-known culprit for nicotine addiction. Previously we presented a series of α4β2 nAChR selective compounds that were discover..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="December 13, 2017" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.7b01250" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2017 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b01250" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.7b01250" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b01250" /></link>
        
    
    

<title>Highly Selective and Potent α4β2 nAChR Antagonist Inhibits Nicotine Self-Administration and Reinstatement in Rats | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b01250" /></meta><meta property="og:title" content="Highly Selective and Potent α4β2 nAChR Antagonist Inhibits Nicotine Self-Administration and Reinstatement in Rats" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01250/20171221/images/large/jm-2017-01250w_0011.jpeg" /></meta><meta property="og:description" content="The α4β2 nAChR is the most predominant subtype in the brain and is a well-known culprit for nicotine addiction. Previously we presented a series of α4β2 nAChR selective compounds that were discovered from a mixture-based positional-scanning combinatorial library. Here we report further optimization  identified highly potent and selective α4β2 nAChR antagonists 5 (AP-202) and 13 (AP-211). Both compounds are devoid of in vitro agonist activity and are potent inhibitors of epibatidine-induced changes in membrane potential in cells containing α4β2 nAChR, with IC50 values of approximately 10 nM, but are weak agonists in cells containing α3β4 nAChR. In vivo studies show that 5 can significantly reduce operant nicotine self-administration and nicotine relapse-like behavior in rats at doses of 0.3 and 1 mg/kg. The pharmacokinetic data also indicate that 5, via sc administration, is rapidly absorbed into the blood, reaching maximal concentration within 10 min with a half-life of less than 1 h." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.7b01250"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b01250">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.7b01250&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.7b01250&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.7b01250&amp;href=/doi/10.1021/acs.jmedchem.7b01250" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2017</span><span class="cit-fg-volume">, 60</span><span class="cit-fg-issue">, 24</span><span class="cit-fg-pageRange">, 10092-10104</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/60/24" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.7b01290" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.7b01331" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Highly Selective and Potent α4β2 nAChR Antagonist Inhibits Nicotine Self-Administration and Reinstatement in Rats</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jinhua++Wu">Jinhua Wu</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol "><sup>#</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0003-3733-5616" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Andrea++Cippitelli">Andrea Cippitelli</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol "><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yaohong++Zhang">Yaohong Zhang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span><span class="author-xref-symbol "><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ginamarie++Debevec">Ginamarie Debevec</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jennifer++Schoch">Jennifer Schoch</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Akihiko++Ozawa">Akihiko Ozawa</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yongping++Yu">Yongping Yu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Huan++Liu">Huan Liu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wenteng++Chen">Wenteng Chen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Richard+A.++Houghten">Richard A. Houghten</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gregory+S.++Welmaker">Gregory S. Welmaker</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Marc+A.++Giulianotti">Marc A. Giulianotti</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lawrence++Toll">Lawrence Toll</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Torrey Pines Institute for Molecular Studies, 11350 SW Village Parkway, Port St. Lucie, Florida 34987, United States</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Assuage Pharmaceuticals, Inc, 11350 SW Village Parkway, Port St. Lucie, Florida 34987, United States</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Institute of Materia Medica, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, P. R. China</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">⊥</span> <span class="aff-text">School of Chemistry and Chemical Engineering, Zhejiang Key Laboratory of Alternative Technologies for Fine Chemicals Process, Shaoxing University, Shaoxing 312000, Zhejiang, P. R. China</span></div><div class="corresp-info"><strong>*</strong>J.W.: phone, (772) 345-4716; e-mail, <a href="/cdn-cgi/l/email-protection#eb819c9eab9f9b828698c584998c"><span class="__cf_email__" data-cfemail="2d475a586d595d44405e03425f4a">[email protected]</span></a></div><div class="corresp-info"><strong>*</strong>M.A.G.: e-mail, <a href="/cdn-cgi/l/email-protection#fa979d938f96939b94958e8e93ba8e8a939789d495889d"><span class="__cf_email__" data-cfemail="fa979d938f96939b94958e8e93ba8e8a939789d495889d">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b01250&amp;href=/doi/10.1021%2Facs.jmedchem.7b01250" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2017</span></span><span class="cit-volume">, 60</span><span class="cit-issue">, 24</span><span class="cit-pageRange">, 10092–10104</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">November 27, 2017</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>1 September 2017</li><li><span class="item_label"><b>Published</b> online</span>13 December 2017</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 28 December 2017</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.7b01250" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01250</a></div><div class="article_header-article-copyright"><strong>Copyright © 2017 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D10092%26pageCount%3D13%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DJinhua%2BWu%252C%2BAndrea%2BCippitelli%252C%2BYaohong%2BZhang%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D60%26issueNum%3D24%26contentID%3Dacs.jmedchem.7b01250%26title%3DHighly%2BSelective%2Band%2BPotent%2B%25CE%25B14%25CE%25B22%2BnAChR%2BAntagonist%2BInhibits%2BNicotine%2BSelf-Administration%2Band%2BReinstatement%2Bin%2BRats%26numPages%3D13%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D10104%26publicationDate%3DDecember%2B2017">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.7b01250"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1229</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">6</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.7b01250" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Highly Selective and Potent α4β2 nAChR Antagonist Inhibits Nicotine Self-Administration and Reinstatement in Rats&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Jinhua&quot;,&quot;last_name&quot;:&quot;Wu&quot;},{&quot;first_name&quot;:&quot;Andrea&quot;,&quot;last_name&quot;:&quot;Cippitelli&quot;},{&quot;first_name&quot;:&quot;Yaohong&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Ginamarie&quot;,&quot;last_name&quot;:&quot;Debevec&quot;},{&quot;first_name&quot;:&quot;Jennifer&quot;,&quot;last_name&quot;:&quot;Schoch&quot;},{&quot;first_name&quot;:&quot;Akihiko&quot;,&quot;last_name&quot;:&quot;Ozawa&quot;},{&quot;first_name&quot;:&quot;Yongping&quot;,&quot;last_name&quot;:&quot;Yu&quot;},{&quot;first_name&quot;:&quot;Huan&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Wenteng&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Richard&quot;,&quot;last_name&quot;:&quot;A. Houghten&quot;},{&quot;first_name&quot;:&quot;Gregory&quot;,&quot;last_name&quot;:&quot;S. Welmaker&quot;},{&quot;first_name&quot;:&quot;Marc&quot;,&quot;last_name&quot;:&quot;A. Giulianotti&quot;},{&quot;first_name&quot;:&quot;Lawrence&quot;,&quot;last_name&quot;:&quot;Toll&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2017&quot;,&quot;month&quot;:&quot;12&quot;,&quot;day&quot;:&quot;13&quot;,&quot;issue&quot;:&quot;24&quot;,&quot;volume&quot;:&quot;60&quot;,&quot;pages&quot;:&quot;10092-10104&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.7b01250&quot;},&quot;abstract&quot;:&quot;The α4β2 nAChR is the most predominant subtype in the brain and is a well-known culprit for nicotine addiction. Previously we presented a series of α4β2 nAChR selective compounds that were discovered from a mixture-based positional-scanning combinatorial library. Here we report further optimization identified highly potent and selective α4β2 nAChR antagonists 5 (AP-202) and 13 (AP-211). Both compounds are devoid of in vitro agonist activity and are potent inhibitors of epibatidine-induced changes in membrane potential in cells containing α4β2 nAChR, with IC50 values of approximately 10 nM, but are weak agonists in cells containing α3β4 nAChR. In vivo studies show that 5 can significantly reduce operant nicotine self-administration and nicotine relapse-like behavior in rats at doses of 0.3 and 1 mg/kg. The pharmacokinetic data also indicate that 5, via sc administration, is rapidly absorbed into the blood, reaching maximal concentration within 10 min with a half-life of less than 1 h.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01250&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01250" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01250&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01250" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01250&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01250" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b01250&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01250&amp;href=/doi/10.1021/acs.jmedchem.7b01250" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.7b01250" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.7b01250" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (1 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01250&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.7b01250%26sid%3Dliteratum%253Aachs%26pmid%3D29178785%26genre%3Darticle%26aulast%3DWu%26date%3D2017%26atitle%3DHighly%2BSelective%2Band%2BPotent%2B%25CE%25B14%25CE%25B22%2BnAChR%2BAntagonist%2BInhibits%2BNicotine%2BSelf-Administration%2Band%2BReinstatement%2Bin%2BRats%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D60%26issue%3D24%26spage%3D10092%26epage%3D10104%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291171" title="Antagonists">Antagonists</a>,</li><li><a href="/action/doSearch?ConceptID=292589" title="Agonists">Agonists</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291184" title="Nicotine">Nicotine</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/60/24" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/jmcmar.2017.60.issue-24/20171228/jmcmar.2017.60.issue-24.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01250/20171221/images/medium/jm-2017-01250w_0011.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01250/20171221/images/large/jm-2017-01250w_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01250&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The α4β2 nAChR is the most predominant subtype in the brain and is a well-known culprit for nicotine addiction. Previously we presented a series of α4β2 nAChR selective compounds that were discovered from a mixture-based positional-scanning combinatorial library. Here we report further optimization  identified highly potent and selective α4β2 nAChR antagonists <b>5</b> (AP-202) and <b>13</b> (AP-211). Both compounds are devoid of in vitro agonist activity and are potent inhibitors of epibatidine-induced changes in membrane potential in cells containing α4β2 nAChR, with IC<sub>50</sub> values of approximately 10 nM, but are weak agonists in cells containing α3β4 nAChR. In vivo studies show that <b>5</b> can significantly reduce operant nicotine self-administration and nicotine relapse-like behavior in rats at doses of 0.3 and 1 mg/kg. The pharmacokinetic data also indicate that <b>5</b>, via sc administration, is rapidly absorbed into the blood, reaching maximal concentration within 10 min with a half-life of less than 1 h.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_42831" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_42831" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Worldwide, 6 million people, including 480 000 in the United State, die premature deaths from smoking-induced disease each year.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Despite decades of public health efforts, 17.8% of U.S. adults continue to smoke, with direct medical costs averaging $170 billion/year and lost productivity costs averaging $156 billion/year.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> Moreover, although 70% of smokers say they want to quit, smoking’s powerful dependence results in at least a 90% failure.<a onclick="showRef(event, 'ref1 ref3'); return false;" href="javascript:void(0);" class="ref ref1 ref3">(1, 3)</a></div><div class="NLM_p">Current FDA-approved pharmacotherapies to facilitate smoking cessation include nicotine replacement therapy (patches, gums, inhalers, and nasal sprays), the antidepressant bupropion, and varenicline. Unfortunately, cessation rates in most clinical trials of these therapies still average only from 10% to 20% for nicotine replacement therapy, from 15% to 25% for bupropion, and from 23% to 40% for varenicline.<a onclick="showRef(event, 'ref4 ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref4 ref5 ref6">(4-6)</a> Although varenicline is the most successful treatment currently in clinical use, some users have become plagued by significant psychological problems including depression and thoughts of suicide.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Additional nicotine pharmacotherapies are in clinical trials, including the nonselective nicotinic acetylcholine receptor (nAChR) antagonist mecamylamine, the opioid antagonist naltrexone, and nicotine monoclonal antibody therapy. Clearly new medications are a high priority.</div><div class="NLM_p">Nicotine addiction, like addiction to other psychomotor stimulants, is thought to be due to the activation of the dopaminergic mesocorticolimbic pathway.<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8, 9)</a> The nicotinic receptor subtype most prevalent in this region is the α4β2 nAChR, although there is a significant level of the α6 subunit.<a onclick="showRef(event, 'ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref10 ref11">(10, 11)</a> A great deal of evidence suggests that the α4β2 receptor is involved in nicotine dependence. In particular, β2-knockout mice do not self-administer nicotine,<a onclick="showRef(event, 'ref8 ref12'); return false;" href="javascript:void(0);" class="ref ref8 ref12">(8, 12)</a> the selective antagonists dihydro-β-erythroidine (DHβE) and 2-fluoro-3-(4-nitrophenyl)deschloroepibatidine (4-nitro-PFEB) block nicotine self-administration,<a onclick="showRef(event, 'ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref13 ref14">(13, 14)</a> and the α4β2 nAChR partial agonist varenicline is clinically used as a smoking cessation medication.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> More recently, the importance of other nAChR subunits in nicotine self-administration has been demonstrated, particularly α6 and α5 in the ventral tegmental area (VTA) and α5 and β4 in the habenular–interpeduncular pathway.<a onclick="showRef(event, 'ref15 ref16 ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref15 ref16 ref17 ref18">(15-18)</a> Nevertheless, as demonstrated with varenicline, modulation of α4β2 nAChR clearly has promise as a mechanism to modulate smoking.</div><div class="NLM_p">The Torrey Pines Institute for Molecular Studies (TPIMS) has a collection of small molecule libraries arranged in systematically formatted mixtures.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Computational analysis of the TPIMS small molecule libraries demonstrates that the collection covers novel areas of chemical space as well as structural features not available in other compound collections.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> The TPIMS collection contains over 5 million individual small molecules; however, due to the formatting of these as mixtures, one can identify active individual compounds with moderate throughput capabilities (typically, fewer than 300–500 samples need to be tested). Utilizing the TPIMS small molecule library collection, compounds were screened for binding affinity at α4β2 nAChR and α3β4 nAChR. Initially, a “scaffold-ranking library” was tested. This library was made up of 37 mixtures, each mixture containing on average 135 000 structurally analogous compounds (identical scaffolds). One mixture, the one containing the bis-cyclic guanidines (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>), showed significant inhibition of [<sup>3</sup>H]epibatidine binding. After screening the positional scanning library associated with this mixture, we identified a series of individual analogs of these compounds, some of which demonstrated low micromolar (μM) affinity at α4β2 nAChR. Several of these analogs show >10-fold selectivity at α4β2 over α3β4 nAChR. All of these steps are discussed in detail in our recent publication.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> From the compounds identified by library screening, traditional medicinal chemistry was initiated. Herein we discuss high affinity compounds that were identified as selective α4β2 nAChR pure antagonists and provide details of one compound in particular [<b>5</b> (AP-202)] that showed significant activity in decreasing nicotine taking and seeking behaviors.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01250/20171221/images/medium/jm-2017-01250w_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01250/20171221/images/large/jm-2017-01250w_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Bis-cyclic guanidine scaffold contains compounds with moderate affinity for α4β2 nAChR.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01250/20171221/images/large/jm-2017-01250w_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01250&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83648" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83648" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2-1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> SAR Studies</h3><div class="NLM_p">By utilization of 16 R1 and 21 R2 functionalities, over 140 different analogs with core A were made (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>; note that not all combinations of R groups were made). The compounds were initially tested for ability to inhibit [<sup>3</sup>H]epibatidine binding at a single concentration (10 μM) at both α4β2 and α3β4 nAChR, and representative data are shown in <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a> [8 R1 groups (<i>x</i>-axis) and 21 R2 groups (<i>y</i>-axis)]. Each dot in <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a> represents a compound tested. The dots are color coded by α3β4 affinity [using a color gradient: red (0%, no binding) to green (100%, binding affinity)] and sized by α4β2 affinity (larger is higher affinity). A larger green dot binds to both targets at 10 μM, a large red dot indicates binding only to α4β2 at 10 μM, and a small green dot indicates binding only to α3β4 at 10 μM. Many of the compounds that do not exhibit α4β2 selectivity at 10 μM (large green dots) are selective for α4β2 upon dose response. R group functionalities play a critical role in both affinity and selectivity. Increasing the size at the R1 position significantly reduces the affinity of the compound (this trend was seen for an additional 8 R1 groups tested, data not shown). For the R2 position, specific substituted aromatic functionalities provide the highest affinity compounds. Also, attachment position to the pyridyl ring (i.e., R2-2 to R2-3) or the length of the carbon chain (i.e. R2-2 to R2-9) had a significant effect on affinity. Of note, some of the compounds containing an aliphatic group at the R2 position maintained α4β2 affinity, albeit at reduced levels, while exhibiting no α3β4 affinity at 10 μM (R2-20).</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01250/20171221/images/medium/jm-2017-01250w_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01250/20171221/images/large/jm-2017-01250w_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. SAR of different analogs with core A utilizing the different R group functionalities shown. The compounds were tested for ability to inhibit [<sup>3</sup>H]epibatidine binding at a single concentration (10 μM) at both α4β2 and α3β4 nAChR. Each dot represents a compound tested. The dots are color coded by α3β4 affinity [using a color gradient: red (0%, no binding) to green (100%, binding affinity)] and sized by α4β2 affinity (larger is higher affinity). A larger green dot binds to both targets at 10 μM, a large red dot indicates binding only to α4β2 at 10 μM, and a small green dot indicates binding only to α3β4 at 10 μM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01250/20171221/images/large/jm-2017-01250w_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01250&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">On the basis of these data, compounds were selected for <i>K</i><sub>i</sub> determination. <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a> contains the data reported in nanomolar (nM) from a series of compounds in which 2-(pyridine-3-yl)ethyl (R2-2 from <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>) is fixed in the R2 position. The compounds in this series all show selectivity toward α4β2 with a shift in affinity favoring the small R1 substitutions (hydrogen, methyl, and hydroxymethyl) as previously noted in <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>. We next determined the <i>K</i><sub>i</sub> values for a series of analogs where the R1 position was fixed with one of the small R1 functionalities and R2 was adjusted (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). Using either 2-(pyridine-3-yl)ethyl or 2-(6-chloropyridin-3-yl)ethyl at the R2 position produced potent and α4β2 nAChR-selective compounds (<b>24</b>, 11 nM with an 11-fold selectivity, and <b>13</b> (AP-211), 13 nM with a 74-fold selectivity). Utilization of a non-pyridyl aromatic group at R2 either eliminates or slightly inverts the desired selectivity (i.e., compounds <b>1</b>, <b>3</b>, <b>17</b>, and <b>21</b>), and shortening the R2 linker carbon chain significantly reduces the affinity against both targets (<b>15</b> vs <b>8</b> and <b>14</b> vs <b>5</b>). Compounds with highest affinity and selectivity for α4β2 over α3β4 nAChR were <b>5</b> and <b>13.</b></div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Binding Affinity and Selectivity over α4β2 and α3β4 nAChR of a Series of Compounds Where 2-(Pyridine-3-yl)ethyl (R2-2 from <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>) Is Fixed in the R2 Position<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01250/20171221/images/medium/jm-2017-01250w_0009.gif" alt="" id="GRAPHIC-d409e531-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center">α3β4</th><th class="colsep0 rowsep0" align="center">α4β2</th><th class="colsep0 rowsep0" align="center" char=".">selectivity</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left"><i>S</i>-benzyl</td><td class="colsep0 rowsep0" align="left">12348 ± 1861</td><td class="colsep0 rowsep0" align="left">771 ± 334</td><td class="colsep0 rowsep0" align="char" char=".">16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left"><i>S</i>-methyl</td><td class="colsep0 rowsep0" align="left">1026 ± 254</td><td class="colsep0 rowsep0" align="left">18 ± 3</td><td class="colsep0 rowsep0" align="char" char=".">57</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left"><i>S</i>-isobutyl</td><td class="colsep0 rowsep0" align="left">18683 ± 2058</td><td class="colsep0 rowsep0" align="left">4964 ± 103</td><td class="colsep0 rowsep0" align="char" char=".">4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left"><i>S</i>-2-butyl</td><td class="colsep0 rowsep0" align="left">18107 ± 1529</td><td class="colsep0 rowsep0" align="left">863 ± 13</td><td class="colsep0 rowsep0" align="char" char=".">21</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">hydrogen</td><td class="colsep0 rowsep0" align="left">644 ± 17</td><td class="colsep0 rowsep0" align="left">58 ± 3</td><td class="colsep0 rowsep0" align="char" char=".">11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left"><i>S</i>-isopropyl</td><td class="colsep0 rowsep0" align="left">24487 ± 622</td><td class="colsep0 rowsep0" align="left">577 ± 25</td><td class="colsep0 rowsep0" align="char" char=".">42</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left"><i>S</i>-3-propylguanidine</td><td class="colsep0 rowsep0" align="left">24043 ± 1073</td><td class="colsep0 rowsep0" align="left">1531 ± 30</td><td class="colsep0 rowsep0" align="char" char=".">16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left"><i>S</i>-4-hydroxylbenzyl</td><td class="colsep0 rowsep0" align="left">27420 ± 4396</td><td class="colsep0 rowsep0" align="left">1606 ± 41</td><td class="colsep0 rowsep0" align="char" char=".">17</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left"><i>S</i>-2-(methylthio)ethyl</td><td class="colsep0 rowsep0" align="left">35590 ± 173</td><td class="colsep0 rowsep0" align="left">448 ± 14</td><td class="colsep0 rowsep0" align="char" char=".">79</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left"><i>R</i>-hydroxymethyl</td><td class="colsep0 rowsep0" align="left">964 ± 193</td><td class="colsep0 rowsep0" align="left">13 ± 1</td><td class="colsep0 rowsep0" align="char" char=".">74</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">All experiments are performed in duplicate or triplicate and repeated 2–3 times. Data are presented as the mean ± SEM.</p></div></div></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Binding Affinity and Selectivity over α4β2 and α3β4 nAChR of a Series of Compounds Having Three Small R1 Functionalities with an Adjusted R2 Group<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01250/20171221/images/medium/jm-2017-01250w_0010.gif" alt="" id="GRAPHIC-d409e779-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R1</th><th class="colsep0 rowsep0" align="center">R2</th><th class="colsep0 rowsep0" align="center">α3β4</th><th class="colsep0 rowsep0" align="center">α4β2</th><th class="colsep0 rowsep0" align="center">selectivity</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">hydrogen</td><td class="colsep0 rowsep0" align="left">2-(3,4-dichlorophenyl)ethyl</td><td class="colsep0 rowsep0" align="left">711 ± 18</td><td class="colsep0 rowsep0" align="left">1296 ± 44</td><td class="colsep0 rowsep0" align="left">0.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">hydrogen</td><td class="colsep0 rowsep0" align="left">pyridine-4-ylmethyl</td><td class="colsep0 rowsep0" align="left">50107 ± 1806</td><td class="colsep0 rowsep0" align="left">652 ± 166</td><td class="colsep0 rowsep0" align="left">77</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">hydrogen</td><td class="colsep0 rowsep0" align="left">phenylethyl</td><td class="colsep0 rowsep0" align="left">325 ± 40</td><td class="colsep0 rowsep0" align="left">361 ± 1</td><td class="colsep0 rowsep0" align="left">0.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left"><i>S</i>-methyl</td><td class="colsep0 rowsep0" align="left">2-(pyridine-3-yl)ethyl</td><td class="colsep0 rowsep0" align="left">1026 ± 254</td><td class="colsep0 rowsep0" align="left">18 ± 3</td><td class="colsep0 rowsep0" align="left">57</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">hydrogen</td><td class="colsep0 rowsep0" align="left">2-(pyridine-3-yl)ethyl</td><td class="colsep0 rowsep0" align="left">644 ± 17</td><td class="colsep0 rowsep0" align="left">58 ± 3</td><td class="colsep0 rowsep0" align="left">11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left"><i>R</i>-hydroxymethyl</td><td class="colsep0 rowsep0" align="left">2-(pyridine-3-yl)ethyl</td><td class="colsep0 rowsep0" align="left">964 ± 193</td><td class="colsep0 rowsep0" align="left">13 ± 1</td><td class="colsep0 rowsep0" align="left">74</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left"><i>S</i>-methyl</td><td class="colsep0 rowsep0" align="left">pyridine-3-ylmethyl</td><td class="colsep0 rowsep0" align="left">36547 ± 729</td><td class="colsep0 rowsep0" align="left">1358 ± 9</td><td class="colsep0 rowsep0" align="left">27</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">hydrogen</td><td class="colsep0 rowsep0" align="left">pyridine-3-ylmethyl</td><td class="colsep0 rowsep0" align="left">98927 ± 1106</td><td class="colsep0 rowsep0" align="left">3750 ± 81</td><td class="colsep0 rowsep0" align="left">26</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left"><i>S</i>-methyl</td><td class="colsep0 rowsep0" align="left">phenylethyl</td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" align="left">2250 ± 20</td><td class="colsep0 rowsep0" align="left">N/A</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left"><i>R</i>-hydroxymethyl</td><td class="colsep0 rowsep0" align="left">2-(3,4-dichlorophenyl)ethyl</td><td class="colsep0 rowsep0" align="left">321 ± 33</td><td class="colsep0 rowsep0" align="left">1045 ± 91</td><td class="colsep0 rowsep0" align="left">0.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">hydrogen</td><td class="colsep0 rowsep0" align="left">3-fluorophenylethyl</td><td class="colsep0 rowsep0" align="left">633 ± 6</td><td class="colsep0 rowsep0" align="left">221 ± 17</td><td class="colsep0 rowsep0" align="left">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left"><i>S</i>-methyl</td><td class="colsep0 rowsep0" align="left">3-fluorophenylethyl</td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" align="left">474 ± 12</td><td class="colsep0 rowsep0" align="left">N/A</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left"><i>R</i>-hydroxymethyl</td><td class="colsep0 rowsep0" align="left">3-fluorophenylethyl</td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" align="left">704 ± 36</td><td class="colsep0 rowsep0" align="left">N/A</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left">hydrogen</td><td class="colsep0 rowsep0" align="left">3-bromophenylethyl</td><td class="colsep0 rowsep0" align="left">314 ± 26</td><td class="colsep0 rowsep0" align="left">601 ± 42</td><td class="colsep0 rowsep0" align="left">0.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="left"><i>S</i>-methyl</td><td class="colsep0 rowsep0" align="left">3-bromophenylethyl</td><td class="colsep0 rowsep0" align="left">628 ± 61</td><td class="colsep0 rowsep0" align="left">361 ± 30</td><td class="colsep0 rowsep0" align="left">1.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="left"><i>R</i>-hydroxymethyl</td><td class="colsep0 rowsep0" align="left">3-bromophenylethyl</td><td class="colsep0 rowsep0" align="left">1090 ± 123</td><td class="colsep0 rowsep0" align="left">640 ± 72</td><td class="colsep0 rowsep0" align="left">1.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="left"><i>S</i>-methyl</td><td class="colsep0 rowsep0" align="left">2-(6-chloropyridin-3-yl)ethyl</td><td class="colsep0 rowsep0" align="left">125 ± 6</td><td class="colsep0 rowsep0" align="left">11 ± 1</td><td class="colsep0 rowsep0" align="left">11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="left">hydrogen</td><td class="colsep0 rowsep0" align="left">2-(6-chloropyridin-3-yl)ethyl</td><td class="colsep0 rowsep0" align="left">471 ± 16</td><td class="colsep0 rowsep0" align="left">80 ± 5</td><td class="colsep0 rowsep0" align="left">6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="left"><i>R</i>-hydroxymethyl</td><td class="colsep0 rowsep0" align="left">2-(6-chloropyridin-3-yl)ethyl</td><td class="colsep0 rowsep0" align="left">281 ± 19</td><td class="colsep0 rowsep0" align="left">20 ± 2</td><td class="colsep0 rowsep0" align="left">14</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">All experiments are performed in duplicate or triplicate and repeated 2–3 times. Data are presented as the mean ± SEM.</p></div></div></div><div class="NLM_p"><b>5</b> and <b>13</b> were tested for binding affinity to α4β2, α3β4, α4β4, α3β2, and α3β4α5 nAChR in membranes from cells transfected with these receptors. As seen in <a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>, <b>5</b> and <b>13</b> have higher affinity for β2-containing nAChR over β4-containing receptor, with 14-fold or greater selectivity for α4β2 over α3β4, α4β4, and α3β4α5 nAChR.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. <i>K</i><sub>i</sub> (nM) Values for 5 and 13 at Various nAChR Subtypes<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">α4β2</th><th class="colsep0 rowsep0" align="center">α3β4</th><th class="colsep0 rowsep0" align="center">α4β4</th><th class="colsep0 rowsep0" align="center">α3β2</th><th class="colsep0 rowsep0" align="center">α3β4α5</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">18.0 ± 2.68</td><td class="colsep0 rowsep0" align="left">1026 ± 254</td><td class="colsep0 rowsep0" align="left">716 ± 200</td><td class="colsep0 rowsep0" align="left">167 ± 20.4</td><td class="colsep0 rowsep0" align="left">1619 ± 93.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">13.06 ± 0.55</td><td class="colsep0 rowsep0" align="left">964 ± 193</td><td class="colsep0 rowsep0" align="left">184 ± 28.7</td><td class="colsep0 rowsep0" align="left">85.4 ± 9.64</td><td class="colsep0 rowsep0" align="left">957 ± 70.6</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">All experiments are performed in triplicate and repeated 3–4 times. Data are presented as the mean ± SEM.</p></div></div></div><div class="NLM_p"><a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a> shows the in vitro activity for <b>5</b> and <b>13</b>. Compounds were tested for their ability to induce a change in membrane potential or Ca<sup>2+</sup> flux in HEK cells transfected with rat α4β2 nAChR and α3β4 nAChR, respectively. Both <b>5</b> and <b>13</b> are devoid of agonist activity in this in vitro model (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>A), and both are very potent inhibitors of epibatidine-induced changes in membrane potential in cells containing α4β2 nAChR, with IC<sub>50</sub> values of approximately 10 nM (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>B). In cells containing α3β4 nAChR, these compounds have weak agonist activity with EC<sub>50</sub> values of 3509 nM and 2538 nM (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>C) and also weakly desensitize the receptor with IC<sub>50</sub> values of 6730 nM and 2717 nM, respectively (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>D). Neither of these compounds have ability to activate α7 nAChR or block acetylcholine induced changes in membrane potential in cells transfected with α7 nAChR (data not shown). Therefore, these compounds are high affinity and selective α4β2 nAChR antagonists.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01250/20171221/images/medium/jm-2017-01250w_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01250/20171221/images/large/jm-2017-01250w_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Activity of <b>5</b> and <b>13</b> on α4β2 nAChR and α3β4 nAChR in HEK cells. (A) Both <b>5</b> and <b>13</b> alone have no agonistic activity on α4β2 nAChR. (B) <b>5</b> and <b>13</b> potently inhibit epibatidine-induced α4β2 nAChR activation in a dose-dependent manner. (C) Both <b>5</b> and <b>13</b> alone only stimulate α3β4 nAChR at high dose. (D) <b>5</b> and <b>13</b> partially block epibatidine-induced α3β4 nAChR activation only at high dose. All experiments are performed in triplicate and repeated at least twice. Data are presented as mean ± SEM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01250/20171221/images/large/jm-2017-01250w_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01250&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Our lead compounds <b>5</b> and <b>13</b> possess many properties that are in the desirable range for orally available central nervous system (CNS)-active drugs and are compared to the mean values for marketed CNS drugs<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> shown in <a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Properties of Compounds <b>5</b> and <b>13</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd property</th><th class="colsep0 rowsep0" align="center"><b>5</b></th><th class="colsep0 rowsep0" align="center"><b>13</b></th><th class="colsep0 rowsep0" align="center">mean value of marketed CNS drugs</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">molecular weight</td><td class="colsep0 rowsep0" align="left">204</td><td class="colsep0 rowsep0" align="left">220</td><td class="colsep0 rowsep0" align="left">310</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">total no. of O and N</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">4.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ClogP</td><td class="colsep0 rowsep0" align="left">0.2</td><td class="colsep0 rowsep0" align="left">–0.8</td><td class="colsep0 rowsep0" align="left">2.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">tPSA</td><td class="colsep0 rowsep0" align="left">51</td><td class="colsep0 rowsep0" align="left">72</td><td class="colsep0 rowsep0" align="left">60–70 (<90)</td></tr></tbody></table></div></div></div><div id="sec2-2" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> In Vivo Activity</h3><div class="NLM_p"><b>5</b> was tested for its ability to block nicotine self-administration in 2 h operant sessions. Response rate at the end of the experiment was 25.4 ± 4.4 infusions for the vehicle group; 21.4 ± 4.4 for the <b>5</b>, 0.3 mg/kg group; and 22.1 ± 4.8 for the <b>5</b>, 1.0 mg/kg group. Initial one-way analysis of variance (ANOVA) conducted on the cumulative infusions obtained in 2 h sessions revealed no effect of <b>5</b> treatment (<i>F</i><sub>(2,12)</sub> = 2.7, NS) (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>A). However, by analysis of the infusions obtained in 30 min intervals, the experiment led to different results with <b>5</b> showing effectiveness in significantly attenuating nicotine self-administration. In fact, two-way ANOVA revealed significant interaction “time point × treatment” (<i>F</i><sub>(6,36)</sub> = 4.1, <i>p</i> < 0.01). Post hoc analysis indicated that <b>5</b> treatment decreased nicotine self-administration during the first 30 min but not during the remaining 90 min period of the session, thus suggesting short-term activity of the antagonist (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>B). Additionally, both doses examined of <b>5</b>, 0.3 and 1.0 mg/kg, were effective (<i>p</i> < 0.01, <i>p</i> < 0.001, respectively). These data are consistent with other α4β2 nAChR antagonists, which also block nicotine self-administration.<a onclick="showRef(event, 'ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref13 ref14">(13, 14)</a></div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01250/20171221/images/medium/jm-2017-01250w_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01250/20171221/images/large/jm-2017-01250w_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Effect of <b>5</b> on operant nicotine self-administration under a FR-3 reinforcement schedule. (A) Subcutaneous administration of <b>5</b> failed to alter the cumulative number of nicotine lever presses across a 120 min session. (B) <b>5</b> successfully decreased nicotine self-administration across the first 30 min (0.3 and 1 mg/kg) while leaving lever pressing unaltered across the remaining portion of the session. Results are described as mean (±SEM) cumulative number and 30 min fractions of nicotine infusions, respectively: (∗∗) <i>p</i> < 0.01, (∗∗∗) <i>p</i> < 0.001 difference from vehicle (<b>5,</b> 0 mg/kg). For detailed statistics, see “<a class="ref internalNav" href="#sec2" aria-label="Results">Results</a>”.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01250/20171221/images/large/jm-2017-01250w_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01250&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Subsequently, <b>5</b> was tested for its ability to reduce nicotine-seeking behavior. As shown in <a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>A, ANOVA analysis performed on the nicotine-associated lever indicated a main effect of 0.15 mg/kg nicotine priming in inducing nicotine-seeking behavior, as compared with extinction conditions (<i>F</i><sub>(1,6)</sub> = 19.5, <i>p</i> < 0.01). In examining the effect of pretreatment of <b>5</b> before the priming injection of nicotine, the overall ANOVA indicated a significant effect that <b>5</b> decreased responding to a nicotine priming (<i>F</i><sub>(2,12)</sub> = 3.9, <i>p</i> < 0.05). Post hoc comparisons revealed that both doses of 0.3 and 1.0 mg/kg significantly decreased responding (<i>p</i> < 0.05 for both doses).</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01250/20171221/images/medium/jm-2017-01250w_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01250/20171221/images/large/jm-2017-01250w_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effect of <b>5</b> on relapse-like behavior. <b>5</b> blocked nicotine priming-induced as well as cue-induced reinstatement of nicotine seeking. (A) There was significant reinstatement induction by subcutaneous administration of a nicotine priming dose of 0.15 mg/kg. Pretreatment with <b>5</b> (0.3 and 1 mg/kg) returned lever pressing to the extinction (EXT) levels. (B) Reinstatement of lever pressing was also obtained upon presentation of stimuli (cue light, orange odor) previously associated with nicotine. Pretreatment with <b>5</b> (1 mg/kg) abolished reinstatement. Values represent the mean (±SEM) number of total responses on the nicotine-associated lever in 60 min for both reinstatement paradigms: (#) <i>p</i> < 0.05, (##) <i>p</i> < 0.01 difference from EXT; (∗) <i>p</i> < 0.05 difference from vehicle (<b>5</b>, 0 mg/kg). For detailed statistics, see “<a class="ref internalNav" href="#sec2" aria-label="Results">Results</a>”.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01250/20171221/images/large/jm-2017-01250w_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01250&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Conditioned stimuli previously associated with nicotine infusions were also able to elicit reinstatement of nicotine seeking (<i>F</i><sub>(1,6)</sub> = 7.9, <i>p</i> < 0.05). <b>5</b> could attenuate this effect [<i>F</i><sub>(2,6)</sub> = 5.1, <i>p</i> < 0.05]. Post hoc comparison tests revealed that <b>5</b> at the dose of 1 mg/kg resulted in a diminished number of responses as compared with those of the vehicle group (<i>p</i> < 0.05, <a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>B).</div><div class="NLM_p"><b>5</b> was tested to determine whether it could block nicotine-induced hypothermia, an effect that can be mimicked by other selective and nonselective nAChR agonists.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Overall treatments significantly modified body temperature. ANOVA showed “treatment” × “time point” interaction (<i>F</i><sub>(12,84)</sub> = 7.3, <i>p</i> < 0.001) with pairwise comparisons showing reduced rat core body temperature due to subcutaneous (sc) administration of 0.5 mg/kg of nicotine (<i>p</i> < 0.001 at 15 and 30 min time point). However, <b>5</b> (1.0 mg/kg, sc) was neither able to induce hypothermia in rats nor able to block nicotine-induced hypothermia (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>). These data suggest that nAChR subunits other than α4β2 could be implicated in mediating thermoregulatory effects of nicotine.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01250/20171221/images/medium/jm-2017-01250w_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01250/20171221/images/large/jm-2017-01250w_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Assessment of body temperature. <b>5</b> failed to block nicotine-induced hypothermia and did not induce per se hypothermia. Baseline rectal temperature was measured just prior to injection of 5 (1.0 mg/kg, sc) or vehicle (0.9% saline). Ten minutes later, nicotine (0.5 mg/kg, sc) or vehicle (0.9% saline) was injected, and temperature was measured again after 15, 30, 60, and 120 min. Values represent the mean (±SEM) body temperature (°C): (###) <i>p</i> < 0.001 difference from <i>T</i> = 0 for the nicotine group; (∗∗∗) <i>p</i> < 0.001 difference from <b>5</b>/VEH and VEH/VEH at <i>T</i> = 15 and <i>T</i> = 30. For detailed statistics, see “<a class="ref internalNav" href="#sec2" aria-label="Results">Results</a>”.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01250/20171221/images/large/jm-2017-01250w_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01250&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To determine the pharmacokinetic parameters of <b>5</b>, relative blood content and blood–brain barrier penetration were examined in rats following sc administration of <b>5</b> (2.0 mg/kg). Results indicate that <b>5</b> is taken up rapidly into the blood (<i>F</i><sub>(3,9)</sub> = 17.7, <i>p</i> < 0.001) and brain (<i>F</i><sub>(3,9)</sub> = 8.7, <i>p</i> < 0.01), reaching maximal concentration within 10 min, with a half-life of less than 1 h (blood, <i>T</i> = 10, <i>p</i> < 0.001; <i>T</i> = 30, <i>p</i> < 0.05; brain, <i>T</i> = 10, <i>p</i> < 0.01; <i>T</i> = 30, <i>p</i> < 0.01; <a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>). During this time, the brain concentration of <b>5</b> approached that of the blood concentration. These data are consistent with the short acting effect that we have demonstrated on nicotine self-administration.</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01250/20171221/images/medium/jm-2017-01250w_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01250/20171221/images/large/jm-2017-01250w_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Detection of <b>5</b> in rat blood and brain using LC–MS–MS. <b>5</b> contents were determined in rat blood and brain 0, 10, 30, and 60 min following sc injection at the dose of 2 mg/kg. Values represent the ratio between the peak area of the analyte (AN) and the peak area of the internal standard (IS). Average (±SEM) for each time point is plotted. For detailed statistics, see “<a class="ref internalNav" href="#sec2" aria-label="Results">Results</a>”.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01250/20171221/images/large/jm-2017-01250w_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01250&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43767" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43767" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Agents active at the nAChR have been actively studied for their ability to attenuate both nicotine and alcohol use in both preclinical and clinical settings. The most successful compound has been varenicline. This compound, which has had several billion dollars in sales as Chantix, is a potent α4β2 nAChR partial agonist. Although very potent and selective in binding studies (1000-fold selective for α4β2 over α3β4 or α7 nAChR), in vitro efficacy studies have determined that it is in fact a relatively low efficacy partial agonist at α4β2 nAChR, with EC<sub>50</sub> in the 1 μM range. Surprisingly, varenicline has somewhat similar potency and full agonist activity at α3β4 and α7 nAChR.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> However, varenicline potently desensitizes the receptor and thereby acts as a functional antagonist at nanomolar concentrations in vitro.<a onclick="showRef(event, 'ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref25 ref26">(25, 26)</a> It may be desensitization combined with partial agonist activity<a onclick="showRef(event, 'ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref27 ref28">(27, 28)</a> that leads to the full complement of varenicline’s activities in vivo. Other investigators have suggested conversely that the α3β4 or α7 activity might be the component that reduces nicotine consumption.<a onclick="showRef(event, 'ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref24 ref25">(24, 25)</a> In fact varenicline blocks self-administration of both nicotine and alcohol, and it has been suggested that the α3β4 nAChR activity mediates the reduction in consumption of both drugs.<a onclick="showRef(event, 'ref25 ref29'); return false;" href="javascript:void(0);" class="ref ref25 ref29">(25, 29)</a> Our previous work suggests otherwise, as we have demonstrated that the selective α3β4 nAChR partial agonist <i>N</i>-(2-bromophenyl)-9-methyl-9-azabicyclo[3.3.1]nonan-3-amine (AT-1001) can block nicotine self-administration at doses that do not affect alcohol self-administration.<a onclick="showRef(event, 'ref26 ref30'); return false;" href="javascript:void(0);" class="ref ref26 ref30">(26, 30)</a> Furthermore, activation of α4-containing nAChRs has been shown to be necessary and sufficient for varenicline to reduce alcohol consumption.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Varenicline as a smoking cessation medication has also been plagued by reports of neuropsychiatric side effects.<a onclick="showRef(event, 'ref7 ref32'); return false;" href="javascript:void(0);" class="ref ref7 ref32">(7, 32)</a> Although the black box warning has been removed by the FDA, labeling still states postmarketing studies have reported serious or clinically significant neuropsychiatric adverse events in patients treated with the drug. Finally, although better than placebo and other medications in double blind studies, a recent open label study for smoking cessation has found varenicline to be equivalent to nicotine replacement therapy at 6 month and year time points.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Ultimately it is not clear whether the side effects and moderate efficacy are due to the fact that varenicline has partial agonist activity at α4β2 nAChR or that it has agonist activity at other nAChR such as α3β4 and α7 nAChR.</div><div class="NLM_p">Many additional nAChR active agents have been tested in animal models and clinical trials. Cytisine, a nAChR partial agonist and a close analog of varenicline, is self-administered in mice<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> and has shown some efficacy in a limited number of clinical trials for smoking cessation.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> The partial agonist sazetidine-A can also attenuate nicotine self-administration as well as alcohol self-administration in alcohol preferring rats.<a onclick="showRef(event, 'ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref36 ref37">(36, 37)</a> Positive allosteric modulators of α4β2 nAChRs attenuate nicotine taking and seeking.<a onclick="showRef(event, 'ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref38 ref39">(38, 39)</a> The classical nonselective nAChR antagonist mecamylamine has also shown efficacy in blocking nicotine self-administration<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> and some efficacy in clinical trials when combined with a nicotine patch.<a onclick="showRef(event, 'ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref40 ref41">(40, 41)</a> The selective α4β2 nAChR antagonist DHβE has also been demonstrated to attenuate nicotine self-administration in rats.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> However, this compound, although very selective, has only moderate affinity and therefore rather poor potency for inhibition of the receptor in vitro.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> Over the past several years, Carroll and colleagues have identified a number of epibatidine analogs with very high affinity and selective α4β2 nAChR agonist and antagonist activity.<a onclick="showRef(event, 'ref43 ref44 ref45'); return false;" href="javascript:void(0);" class="ref ref43 ref44 ref45">(43-45)</a> One antagonist in particular, 4-nitro-PFEB, has near picomolar binding affinity to the α4β2 nAChR and inhibits receptor activity in vitro in the nanomolar range,<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> although more recent studies have suggested partial agonist activity for this compound as well.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> 4-Nitro-PFEB has also been demonstrated to block nicotine self-administration in rats and nicotine conditioned place preference in mice<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a></div><div class="NLM_p"><b>5</b> appears to have properties different from the compounds discussed above. <b>5</b> was not developed based upon known nicotinic structures but rather by traditional medicinal chemistry starting, a priori, from very large, small molecule, mixture libraries.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> By utilization of the hits that were identified in the original screening campaign as starting points, a set of truncated analogs were synthesized and screened in order to identify the critical structural features driving potency and selectivity. This led to the monocyclic guanidine hits. A further medicinal chemistry effort was then undertaken to assess the potency and selectivity changes observed from a range of different R1 and R2 functionalities around the core monocyclic guanidine. <b>5</b> and its analog <b>13</b> have high affinity and selectivity in binding to the α4β2 nAChR as compared to α4β4, α3β2, and α3β4α5 nAChR. Affinity and selectivity are considerably higher than the “prototypical” α4β2 nAChR antagonist DHβE, though not as high as the epibatidine analogs. These compounds have no apparent agonist activity in cells transfected with α4β2 nAChR and potently inhibit receptor activity in vitro at concentration equivalent to their binding affinities. They have moderate activity at α3β4 nAChR at very high concentrations and no apparent effect on α7 nAChR. Lack of agonist activity in vitro is consistent with the inability of <b>5</b> to induce hypothermia.</div><div class="NLM_p last">When used in a preclinical model to determine potential efficacy as a smoking cessation medication, <b>5</b> potently (1 mg/kg) attenuated nicotine self-administration. However, the duration of action was short, reducing nicotine self-administration only in the first 30 min of the self-administration session. This is consistent with the time course of blood and brain concentration after systemic administration. However, <b>5</b> was more effective in reducing nicotine seeking in a model of relapse, completely inhibiting both nicotine prime-induced and cue-induced reinstatement of nicotine seeking.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74448" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74448" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">We have identified a novel high affinity and selective α4β2 nAChR antagonist (<b>5</b>) that was originally derived from a small molecule mixture combinatorial library. <b>5</b> and analog <b>13</b> have low nanomolar affinity for α4β2 nAChR. In vitro these compounds are devoid of agonist activity in cells transfected with rat α4β2 nAChR, act as antagonists of epibatidine at nanomolar concentrations, and have very weak partial agonist activity at α3β4 nAChR. In vivo <b>5</b> is also devoid of agonist activity and potently inhibits nicotine self-administration, as well as reinstatement of nicotine seeking. These results demonstrate that compounds like this could both reduce smoking and block relapse, suggesting that <b>5</b>, with appropriate formulation to increase duration of action, has potential as a smoking cessation medication.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_82328" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_82328" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5-1" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Chemistry</h3><div class="NLM_p">The compounds were synthesized as described in the <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. The synthetic approach utilized was modified from a previously reported approcah for obtaining cyclic guanidines from resin bound polyamines.<a onclick="showRef(event, 'ref21 ref48'); return false;" href="javascript:void(0);" class="ref ref21 ref48">(21, 48)</a> The solid phase synthesis was performed using the “tea-bag” methodology.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> Initially, 100 mg of <i>p</i>-methylbenzhydrylamine (MBHA) resin (1.1 mmol/g, 100–200 mesh) was sealed in a mesh “tea bag”, neutralized with 5% diisopropylethylamine (DIEA) in dichloromethane (DCM) and subsequently swelled with additional DCM washes. A Boc-amino acid (6 equiv) was coupled in dimethylformamide (0.1 M DMF) for 120 min in the presence of diisopropylcarbodiimide (DIC, 6 equiv) and 1-hydroxybenzotriazole hydrate (HOBt, 6 equiv) (<b>1</b>, <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). The Boc protecting group was removed with 55% trifluoroacetic acid (TFA)/DCM for 30 min and subsequently neutralized with 5% DIEA/DCM (3×). Carboxylic acids were coupled using 6 equiv in the presence of DIC (10 equiv) and HOBt (10 equiv) in DMF (0.1M) for 120 min (<b>2</b>, <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). All coupling reactions were monitored for completion by the ninhydrin test. The reduction was performed in a 4000 mL Wilmad LabGlass vessel under nitrogen. Borane in 1.0 M tetrahydrofuran complex solution was used in 40-fold excess for each amide bond. The vessel was heated to 65 °C and maintained at temperature for 72 h. The solution was then discarded, and the bags were washed with THF and methanol. Once completely dry, the bags were treated overnight with piperidine at 65 °C and washed several times with methanol, DMF, and DCM (<b>3</b>, <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). As previously reported, the reduction of polyamides with borane is free of racemization.<a onclick="showRef(event, 'ref50 ref51'); return false;" href="javascript:void(0);" class="ref ref50 ref51">(50, 51)</a> Before proceeding, completion of reduction was monitored by a control cleavage and analyzed by LCMS. Guanidine cyclization (d, <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>) was performed with a 5-fold excess of cyanogen bromide (CNBr) in a 0.1 M anhydrous DCM solution. Following the cyclization, the bags were rinsed with DMF and DCM. The resin was cleaved with HF in the presence of anisole in an ice bath at 0 °C for 90 min (<b>5</b>, <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). The products were extracted using 95% acetic acid. Samples were then repeatedly frozen and lyophilized in 50% acetonitrile and water. Confirmation of the desired product was obtained by reverse phase LC–MS analysis using a Shimadzu 2010 LCMS system, consisting of a LC-20AD binary solvent pump, a DGU-20A degasser unit, a CTO-20A column oven, SIL-20A HT autosampler, and SPD-M20A diode array set to scan 190–600 nm. Separation was achieved using a Phenomenex Luna C18 column (5 μm, 50 mm × 4.6 mm i.d.) protecting with a Phenomenex C18 column guard (5 μm, 4 mm × 3.0 mm i.d.).</div><figure id="sch1" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01250/20171221/images/medium/jm-2017-01250w_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01250/20171221/images/large/jm-2017-01250w_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Synthetic Scheme Used for the Synthesis of Core A Type Compounds<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01250/20171221/images/large/jm-2017-01250w_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01250&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Standard Boc coupling protocol utilizing repetitive (a1) 5% DIEA/95% DCM; (a2) Boc-AA, DIC, HOBt, DMF; <b>1</b>. (b1) 55% TFA/45% DCM; (b2) 5% DIEA/95% DCM; COOH, DIC, HOBt, DMF; <b>2</b>. (c) 40× BH<sub>3</sub>/THF (65 °C, 72 h); piperidine (65 °C, 18 h); <b>3</b>. (d) 5× BrCN/0.1 M DCM (shaking12 h); <b>4</b>. (e) HF/anisole, (0 °C, 7 hr); <b>5</b>.</p></p></figure><div class="NLM_p">The crude product was purified using reverse phase mode on a Shimadzu Prominence preparative HPLC system consisting of LC-8A binary solvent pumps, a SCL-10A system controller, a SIL-10AP autosampler, a FRC-10A fraction collector, and a Shimadzu SPD-20A UV detector. The wavelength was set at 214 nm during analysis. Chromatographic separations were obtained using a Phenomenex Luna C18 preparative column (5 μm, 150 mm × 21.5 mm i.d.). The column was protected by a Phenomenex C18 column guard (5 μm, 15 mm × 21.2 mm i.d.). Prominence prep software was used to set all detection and collection parameters. The mobile phases for HPLC purification were HPLC grade obtained from Sigma-Aldrich and Fisher Scientific. The mobile phase A consisted of water with 0.1% TFA, and mobile phase B consisted of acetonitrile with 0.1% trifluoroacetic acid. Initial setting was set to 2% mobile phase B and was gradually increased over time to achieve ideal separation for each compound. The peak corresponding to calculated <i>m</i>/<i>z</i> of the desired product was collected and concentrated. Most of compounds exhibited a gooey (soft and sticky) status except compound 8 (white, solid powder). The concentrated pure product was analyzed on LC–MS and determined to be ≥95% purity based on peak area.</div><div class="NLM_p">The <sup>1</sup>H and <sup>13</sup>C NMR spectra were obtained utilizing the Bruker 400 Ascend (400 and 100 MHz, respectively). <sup>1</sup>H NMR chemical shifts were reported in δ (ppm) using the δ 7.26 signal of CHCl<sub>3</sub>, the δ 4.79 signal of D<sub>2</sub>O, and the δ 2.50 signal of DMSO-<i>d</i><sub>6</sub> as internal standards. <sup>13</sup>C NMR chemical shifts were reported in δ (ppm) using the δ 77.16 signal of CDCl<sub>3</sub>, the δ 39.52 signal of DMSO-<i>d</i><sub>6</sub> as internal standards. Melting points were measured using Stuart’s SMP40 melting point apparatus (Staffordshire, U.K.), and specfic optical rotations were measured using Autopol IV automatic polarimeter (Rudolph Research Analytical, NJ, USA).</div><div class="NLM_p"><b>1-(3,4-Dichlorophenethyl)imidazolidin-2-imine</b> (<b>1</b>) was synthesized with Boc-glycine for the R1 reagent used in step a and 3,4-dichlorophenylacetic acid used for the R2 reagent in step b. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.1 (s, 1H), 8.58 (s, 1H), 7.37 (d, <i>J</i> = 4.0 Hz, 1H), 7.36 (d, <i>J</i> = 2.0 Hz, 1H), 7.11 (dd, <i>J</i> = 8.4, 2.0 Hz, 1H), 3.61–3.56 (m, 4H), 3.49–3.45 (m, 2H), 2.89–2.95(m, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 159.33, 139.49, 130.97, 130.87, 130.41, 129.40, 129.07, 47.04, 44.46, 40.34, 31.43. LC–MS (ESI+) (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>11</sub>H<sub>14</sub>Cl<sub>2</sub>N<sub>3</sub> 258.1; found, 257.9 and 259.9.</div><div class="NLM_p"><b>1-(Pyridin-4-ylmethyl)imidazolidin-2-imine</b> (<b>2</b>) was synthesized with Boc-<span class="smallcaps smallerCapital">l</span>-glycine for the R1 reagent used in step a and isonicotinic acid used for the R2 reagent in step b. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.60 (dd, <i>J</i> = 4.4, 1.6 Hz, 2H), 8.45 (s, 1H), 7.19 (d, <i>J</i> = 6.0 Hz, 2H), 4.59 (s, 2H), 3.67–3.60 (m, 2H), 3.52–3.48 (m, 2H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 160.34, 150.63, 143.75, 122.56, 47.82, 47.74, 41.20. LC–MS (ESI+) (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>9</sub>H<sub>13</sub>N<sub>4</sub> 177.1; found, 177.0.</div><div class="NLM_p"><b>1-Phenethylimidazolidin-2-imine</b> (<b>3</b>) was synthesized with Boc-glycine for the R1 reagent used in step a and phenylacetic acid used for the R2 reagent in step b. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.57 (s, 1H), 7.32 (t, <i>J</i> = 7.2 Hz, 2H), 7.25–7.22 (m, 2H), 3.57–3.54 (m, 4H), 3.42 (t, <i>J</i> = 8.0 Hz, 2H), 2.91 (t, <i>J</i> = 6.8 Hz, 2H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 159.93, 137.76, 129.08, 128.81, 127.22, 48.38, 46.46, 41.06, 31.05. LC–MS (ESI+) (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>11</sub>H<sub>16</sub>N<sub>3</sub>190.1; found,190.0.</div><div class="NLM_p"><b>(<i>S</i>)-5-Benzyl-1-(2-(pyridin-3-yl)ethyl)imidazolidin-2-imine</b> (<b>4</b>) was synthesized with Boc-<span class="smallcaps smallerCapital">l</span>-phenylalanine for the R1 reagent used in step a and 3-pyridinylacetic acid for the R2 reagent used in step b. [α]<sup>20</sup><sub>D</sub> 26.6 (0.5, DMSO). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.49 (s, 1H), 8.41 (s, 1H), 7.57 (d, <i>J</i> = 8.0 Hz, 1H), 7.35–7.31 (m, 2H), 7.30–7.28 (m, 1H), 7.26–7.23 (m, 1H), 7.11–7.09 (m, 2H), 3.91–3.81 (m, 2H), 3.49 (t, <i>J</i> = 9.2 Hz, 1H), 3.34–3.28 (m, 2H), 3.01 (dd, <i>J</i> = 14.0, 5.6 Hz, 1H), 2.93–2.85 (m, 2H), 2.69 (q, <i>J</i> = 8.0 Hz, 1H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 159.45, 150.00, 148.50, 136.72, 135.58, 133.27, 129.27, 129.07, 127.59, 123.89, 60.36, 46.55, 43.71, 38.83, 30.92. LC–MS (ESI+) (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>17</sub>H<sub>21</sub>N<sub>4</sub> 281.1; found, 281.0.</div><div class="NLM_p"><b>(<i>S</i>)-5-Methyl-1-(2-(pyridin-3-yl)ethyl)imidazolidin-2-imine</b> (<b>5</b>) was synthesized with Boc-<span class="smallcaps smallerCapital">l</span>-alanine for the R1 reagent used in step a and 3-pyridinylacetic acid for the R2 reagent used in step b. [α]<sup>20</sup><sub>D</sub> 26.8 (0.25, 50% DMSO). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.49 (d, <i>J</i> = 6.0 Hz, 2H), 8.40 (s, 1H), 7.71 (d, <i>J</i> = 7.6 Hz, 1H), 7.28–7.25 (m, 1H), 3.89–3.81 (m, 2H), 3.71 (t, <i>J</i> = 9.2 Hz, 1H), 3.46–3.39 (m, 1H), 3.21 (q, <i>J</i> = 7.2 Hz, 1H), 2.98–2.85 (m, 2H), 1.25 (d, <i>J</i> = 6.0 Hz, 3H). <sup>13</sup>C NMR (100 MHz, D<sub>2</sub>O) δ 158.12, 146.54, 144.99, 141.12, 135.73, 125.41, 55.30, 47.86, 42.25, 29.84, 16.93. LC–MS (ESI+) (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>11</sub>H<sub>17</sub>N<sub>4</sub> 205.1; found, 205.0.</div><div class="NLM_p"><b>(<i>S</i>)-5-Isobutyl-1-(2-(pyridin-3-yl)ethyl)imidazolidin-2-imine</b> (<b>6</b>) was synthesized with Boc-<span class="smallcaps smallerCapital">l</span>-leucine isoleucine for the R1 reagent used in step a and 3-pyridinylacetic acid for the R2 reagent used in step b. [α]<sup>20</sup><sub>D</sub> 24.6 (0.5, 50% DMSO). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.57 (s, 1H), 8.49 (s, 2H), 7.64 (d, <i>J</i> = 8.0 Hz, 1H), 7.27–7.23 (m, 1H), 3.83–3.76 (m, 1H), 3.66–3.60 (m, 2H), 3.42–3.34 (m, 1H), 3.24–3.18 (m, 1H), 2.96–2.83 (m, 2H), 1.54–1.50 (m, 1H), 1.45 (td, <i>J</i> = 12.4, 3.5 Hz, 1H), 1.37–1.30 (m, 1H), 0.92 (d, <i>J</i> = 6.4 Hz, 3H), 0.83 (d, <i>J</i> = 6.4 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 159.46, 150.11, 148.52, 136.65, 133.43, 123.83, 57.96, 47.12, 43.15, 41.11, 30.99, 24.74, 23.78. LC–MS (ESI+) (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>14</sub>H<sub>23</sub>N<sub>4</sub> 247.1; found, 247.0.</div><div class="NLM_p"><b>(<i>S</i>)-5-((<i>R</i>)-<i>sec</i>-Butyl)-1-(2-(pyridin-3-yl)ethyl)imidazolidin-2-imine</b> (<b>7</b>) was synthesized with Boc-<span class="smallcaps smallerCapital">l</span>-isoleucine for the R1 reagent used in step a and 3-pyridinylacetic acid for the R2 reagent used in step b. [α]<sup>20</sup><sub>D</sub> 26.8 (0.5, 50% DMSO). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.64 (s, 1H), 8.49 (d, <i>J</i> = 9.6 Hz, 2H), 7.74 (d, <i>J</i> = 8.0 Hz, 1H), 7.27–7.24 (m, 1H), 4.01–3.97 (m, 1H), 3.76–3.73 (m, 1H), 3.47 (t, <i>J</i> = 9.6 Hz, 1H), 3.66–3.25 (m, 2H), 2.92 (q, <i>J</i> = 6.4 Hz, 2H), 1.80–1.74 (m, 1H), 1.22–1.13 (m, 2H), 0.96 (t, <i>J</i> = 7.2 Hz, 3H), 0.80 (d, <i>J</i> = 6.8 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 159.36, 150.06, 148.48, 136.83, 133.27, 123.87, 62.13, 42.93, 41.45, 34.39, 31.03, 30.57, 25.63, 12.00. LC–MS (ESI+) (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>14</sub>H<sub>23</sub>N<sub>4</sub> 247.1; found, 247.0.</div><div class="NLM_p"><b>1-(2-(Pyridin-3-yl)ethyl)imidazolidin-2-imine</b> (<b>8</b>) was synthesized with Boc-glycine for the R1 reagent used in step a and 3-pyridinylacetic acid for the R2 reagent used in step b. Melting point: 197.1–197.6 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.52 (d, <i>J</i> = 2.0 Hz, 1H), 8.45 (dd, <i>J</i> = 4.8, 1.6 Hz, 1H), 8.40 (s, 1H), 7.74 (dt, <i>J</i> = 8.0, 1.6 Hz, 1H), 7.34 (q, <i>J</i> = 4.8 Hz, 1H), 3.63–3.58 (m, 2H), 3.55–3.51 (m, 2H), 3.49–3.46 (m, 2H), 2.86 (t, <i>J</i> = 7.6 Hz, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 159.08, 150.04, 147.77, 136.40, 133.68, 123.42, 46.98, 44.54, 30.67, 29.56. LC–MS (ESI+) (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>10</sub>H<sub>15</sub>N<sub>4</sub> 191.1; found,191.0.</div><div class="NLM_p"><b>(<i>S</i>)-5-Isopropyl-1-(2-(pyridin-3-yl)ethyl)imidazolidin-2-imine</b> (<b>9</b>) was synthesized with Boc-<span class="smallcaps smallerCapital">l</span>-valine for the R1 reagent used in step a and 3-pyridinylacetic acid for the R2 reagent used in step b. [α]<sup>20</sup><sub>D</sub> 18.0 (1.0, DMSO). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.54 (d, <i>J</i> = 1.6 Hz, 1H), 8.45 (dd, <i>J</i> = 4.8, 2.0 Hz, 1H), 8.41 (s, 1H), 7.77 (dt, <i>J</i> = 7.6, 2.0 Hz, 1H), 7.34 (ddd, <i>J</i> = 8.0, 4.8, 0.8 Hz, 1H), 3.94–3.89 (m, 1H), 3.75–3.68 (m, 1H), 3.44 (t, <i>J</i> = 6.0 Hz, 1H), 3.31–3.30 (m, 1H), 3.30–3.27 (m, 1H), 2.95–2.88 (m, 1H), 2.81–2.74 (m, 1H), 2.18–2.13 (m, 1H), 0.85 (d, <i>J</i> = 7.2 Hz, 3H), 0.75 (d, <i>J</i> = 7.2 Hz, 3H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 158.84, 150.11, 147.75, 136.46, 133.60, 123.35, 61.65, 41.87, 30.66, 29.39, 26.76, 17.56. LC–MS (ESI+) (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>13</sub>H<sub>21</sub>N<sub>4</sub> 233.2; found, 233.0.</div><div class="NLM_p"><b>(<i>S</i>)-1-(3-(2-Imino-3-(2-(pyridin-3-yl)ethyl)imidazolidin-4-yl)propyl)guanidine</b> (<b>10</b>) was synthesized with Boc-<span class="smallcaps smallerCapital">l</span>-arginine isoleucine for the R1 reagent used in step a and 3-pyridinylacetic acid for the R2 reagent used in step b. [α]<sup>20</sup><sub>D</sub> 68.8 (0.25, 50% DMSO). <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O): δ 8.51 (s, 2H), 7.92 (d, <i>J</i> = 7.6 Hz, 1H), 7.56–7.53 (m, 1H), 4.01–3.95 (m, 1H), 3.75–3.68 (m, 2H), 3.66–3.59 (m, 1H), 3.38–3.34 (m, 1H), 3.22 (t, <i>J</i> = 6.4 Hz, 2H), 3.05 (t, <i>J</i> = 6.4 Hz, 2H), 1.73–1.68 (m, 2H), 1.56–1.50 (m, 2H). <sup>13</sup>C NMR (100 MHz, D<sub>2</sub>O) δ 158.22, 156.78, 148.14, 146.49, 139.08, 134.95, 124.73, 58.49, 45.54, 42.70, 40.77, 29.84, 27.92, 22.59. LC–MS (ESI+) (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>14</sub>H<sub>24</sub>N<sub>7</sub> 290.2; found, 290.</div><div class="NLM_p"><b>(<i>S</i>)-4-((2-Imino-3-(2-(pyridin-3-yl)ethyl)imidazolidin-4-yl)methyl)phenol</b> (<b>11</b>) was synthesized with Boc-<span class="smallcaps smallerCapital">l</span>-tyrosine for the R1 reagent used in step a and 3-pyridinylacetic acid for the R2 reagent used in step b. [α]<sup>20</sup><sub>D</sub> 14.4 (0.5, DMSO). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.51 (d, <i>J</i> = 2.4 Hz, 1H), 8.44 (dd, <i>J</i> = 4.8, 1.6 Hz, 1H), 8.41 (s, 1H), 7.72 (dt, <i>J</i> = 8.0, 2.0 Hz, 1H), 7.34 (ddd, <i>J</i> = 7.6, 4.8, 0.8 Hz, 1H), 7.04 (d, <i>J</i> = 8.8 Hz, 2H), 6.70 (d, <i>J</i> = 8.4 Hz, 2H), 4.12–4.06 (m, 1H), 3.74–3.67 (m, 1H), 3.45–3.42 (m, 1H), 3.41–3.38 (m, 1H), 3.21 (q, <i>J</i> = 6.0 Hz,1H), 2.96 (d, <i>J</i> = 13.6, 4.4 Hz, 1H), 2.89 (q, <i>J</i> = 5.2 Hz, 1H), 2.82–2.75 (m, 1H), 2.61 (q, <i>J</i> = 8.4 Hz, 1H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 158.52, 156.26, 150.13, 147.75, 136.50, 133.60, 130.23, 126.09, 123.35, 115.30, 58.77, 45.17, 42.30, 36.26, 30.66. LC–MS (ESI+) (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>17</sub>H<sub>21</sub>N<sub>4</sub>O 297.1; found, 297.0.</div><div class="NLM_p"><b>(<i>S</i>)-5-(2-(Methylthio)ethyl)-1-(2-(pyridin-3-yl)ethyl)imidazolidin-2-imine</b> (<b>12</b>) was synthesized with Boc-<span class="smallcaps smallerCapital">l</span>-methionine for the R1 reagent used in step a and 3-pyridinylacetic acid for the R2 reagent used in step b. [α]<sup>20</sup><sub>D</sub> 13.6 (0.25, 50% DMSO). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.53 (d, <i>J</i> = 2.0 Hz, 1H), 8.45 (dd, <i>J</i> = 4.8, 1.6 Hz, 1H), 8.41 (s, 1H), 7.75 (dt, <i>J</i> = 8.0, 2.0 Hz, 1H), 7.34 (ddd, <i>J</i> = 7.6, 4.8, 0.8 Hz, 1H), 3.99–3.93 (m, 1H), 3.70–3.64 (m, 1H), 3.59 (t, <i>J</i> = 9.6 Hz, 1H), 3.28 (q, <i>J</i> = 6.8 Hz, 1H), 3.20 (q, <i>J</i> = 6.8 Hz, 1H), 2.94–2.87 (m, 1H), 2.81–2.73 (m, 1H), 2.44 (t, <i>J</i> = 8.0 Hz, 2H), 2.17 (s, 3H), 2.00–1.94 (m, 1H), 1.76–1.71 (m, 1H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 158.76, 150.09, 147.77, 136.46, 133.58, 123.38, 57.03, 45.44, 42.01, 30.65, 30.61, 29.63, 27.94. LC–MS (ESI+) (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>13</sub>H<sub>21</sub>N<sub>4</sub>S 265.1; found, 265.0.</div><div class="NLM_p"><b>(<i>R</i>)-(2-Imino-3-(2-(pyridin-3-yl)ethyl)imidazolidin-4-yl)methanol</b> (<b>13</b>) was synthesized with Boc-<span class="smallcaps smallerCapital">l</span>-serine for the R1 reagent used in step a and 3-pyridinylacetic acid for the R2 reagent used in step b. [α]<sup>20</sup><sub>D</sub> 28.4 (0.25, 50% DMSO). <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O): δ 8.59 (s, 1H), 8.49 (s, 1H), 8.10 (d, <i>J</i> = 8.0 Hz, 1H), 7.69–7.66 (m, 1H), 4.12–4.08 (m, 1H), 3.90 (dd, <i>J</i> = 12.8, 3.2 Hz, 1H), 3.80–3.73 (m, 2H), 3.71–3.66 (m, 2H), 3.54 (dd, <i>J</i> = 10.0, 6.0 Hz, 1H), 3.13–3.10 (m, 2H). <sup>13</sup>C NMR (100 MHz, D<sub>2</sub>O) δ 158.44, 146.43, 144.93, 141.04, 135.65, 125.34, 59.81, 59.52, 43.04, 42.72, 29.66. LC–MS (ESI+) (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>11</sub>H<sub>17</sub>N<sub>4</sub>O 221.1; found, 221.0.</div><div class="NLM_p"><b>(<i>S</i>)-5-Methyl-1-(pyridin-3-ylmethyl)imidazolidin-2-imine</b> (<b>14</b>) was synthesized with Boc-<span class="smallcaps smallerCapital">l</span>-alanine for the R1 reagent used in step a and nicotinic acid used for the R2 reagent in step b. [α]<sup>20</sup><sub>D</sub> −2.8 (0.25, 50% DMSO). <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O): δ 8.55–8.41 (m, 2H), 7.86 (d, <i>J</i> = 8.0 Hz, 1H), 7.50 (dd, <i>J</i> = 7.6, 5.2 Hz, 1H), 4.65–4.53 (m, 2H), 4.03–3.98 (m, 1H), 3.77 (t, <i>J</i> = 9.6 Hz, 1H), 3.29–3.25 (m, 1H), 1.22 (d, <i>J</i> = 6.4 Hz, 3H). <sup>13</sup>C NMR (100 MHz, D<sub>2</sub>O) δ 158.60, 147.67, 146.72, 137.31, 131.97, 124.78, 55.82, 48.00, 43.30, 17.13. MS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup>: 191. LC–MS (ESI+) (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>10</sub>H<sub>15</sub>N<sub>4</sub> 191.1; found, 191.0.</div><div class="NLM_p"><b>1-(Pyridin-3-ylmethyl)imidazolidin-2-imine</b> (<b>15</b>) was synthesized with Boc-glycine for the R1 reagent used in step a and nicotinic acid used for the R2 reagent in step b. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.60 (dd, <i>J</i> = 4.4, 1.6 Hz, 2H), 8.45 (s, 1H), 7.19 (d, <i>J</i> = 6.0 Hz, 2H), 4.59 (s, 2H), 3.67–3.60 (m, 2H), 3.52–3.48 (m, 2H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 160.34, 150.63, 143.75, 122.56, 47.82, 47.74, 41.20. LC–MS (ESI+) (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>9</sub>H<sub>13</sub>N<sub>4</sub> 177.1; found, 177.0.</div><div class="NLM_p"><b>(<i>S</i>)-5-Methyl-1-phenethylimidazolidin-2-imine</b> (<b>16</b>) was synthesized with Boc-<span class="smallcaps smallerCapital">l</span>-alanine for the R1 reagent used in step a and phenylacetic acid used for the R2 reagent in step b. LC–MS (ESI+) (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>12</sub>H<sub>18</sub>N<sub>3</sub> 204.1; found, 204.0. <b>16</b> has a very weak binding affinity and was not further purified for additional chemical characteraization.</div><div class="NLM_p"><b>(<i>R</i>)-(3-(3,4-Dichlorophenethyl)-2-iminoimidazolidin-4-yl)methanol</b> (<b>17</b>) was synthesized with Boc-<span class="smallcaps smallerCapital">l</span>-serine serine for the R1 reagent used in step a and 3,4-dichlorophenylacetic acid used for the R2 reagent in step b. [α]<sup>20</sup><sub>D</sub> 26.4 (0.25, 50% DMSO). <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O): δ 8.52 (s, 1H), 7.54 (d, <i>J</i> = 8.0 Hz,1H), 7.52 (d, <i>J</i> = 2.4 Hz, 1H), 4.01–3.96 (m, 1H), 3.86 (dd, <i>J</i> = 12.8, 3.6 Hz, 1H), 3.74–3.69 (m, 2H), 3.67–3.64 (m, 1H), 3.63–3.57 (m, 1H), 3.51 (q, <i>J</i> = 6.0 Hz, 1H), 2.96 (td, <i>J</i> = 6.0, 2.0 Hz, 2H). <sup>13</sup>C NMR (100 MHz, D<sub>2</sub>O) δ 158.40, 138.72, 131.76, 130.80, 130.64, 130.18, 128.84, 59.74, 59.49, 43.01, 43.00, 31.58. LC–MS (ESI+) (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>12</sub>H<sub>16</sub>Cl<sub>2</sub>N<sub>3</sub>O 288.1; found, 287.8 and 289.9.</div><div class="NLM_p"><b>1-(3-Fluorophenethyl)imidazolidin-2-imine</b> (<b>18</b>) was synthesized with Boc-glycine for the R1 reagent used in step a and 3-fluorophenylacetic acid for the R2 reagent used in step b. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.41 (s, 1H), 8.06 (s, 1H), 7.32–7.28 (m, 1H), 7.01 (d, <i>J</i> = 7.6 Hz, 1H), 6.95 (d, <i>J</i> = 9.2 Hz, 2H), 3.61 (t, <i>J</i> = 6.8 Hz, 2H), 3.57–3.55 (m, 2H), 3.45–3.41 (m, 2H), 2.91 (t, <i>J</i> = 6.8 Hz, 2H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 159.96, 140.15, 131.87, 130.50, 130.19, 127.58, 122.85, 48.30, 45.91, 41.01, 33.44. LC–MS (ESI+) (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>11</sub>H<sub>15</sub>FN<sub>3</sub> 208.1; found, 208.0.</div><div class="NLM_p"><b>(<i>S</i>)-1-(3-Fluorophenethyl)-5-methylimidazolidin-2-imine</b> (<b>19</b>) with Boc-<span class="smallcaps smallerCapital">l</span>-alanine for the R1 reagent used in step a and 3-fluorophenylacetic acid used for the R2 reagent in step b. [α]<sup>20</sup><sub>D</sub> 13.6 (0.5, 50% DMSO). <sup>1</sup>H NMR (400 MHz, DMSO-d6): δ 8.50 (s, 1H), 7.45–7.39 (m, 1H), 7.01 (d, <i>J</i> = 7.6 Hz, 1H), 7.17 (d, <i>J</i> = 8.0 Hz, 1H), 7.14–7.07 (m, 2H), 4.02–3.95 (m, 1H), 3.71 (t, <i>J</i> = 9.6 Hz, 1H), 3.62–3.55 (m, 2H), 3.22 (q, <i>J</i> = 6.8 Hz, 1H), 2.99–2.95 (m, 2H), 1.27 (d, <i>J</i> = 6.4 Hz, 3H). <sup>13</sup>C NMR (100 MHz, D<sub>2</sub>O) δ 162.79 (d, <i>J</i> = 242 Hz), 157.96, 140.95 (d, <i>J</i> = 7 Hz), 130.49 (d, <i>J</i> = 9 Hz), 124.91 (d, <i>J</i> = 3 Hz), 115.67 (d, <i>J</i> = 21 Hz), 113.62 (d, <i>J</i> = 21 Hz), 55.13, 47.77, 42.63, 32.25, 16.80. MS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup>: 222. LC–MS (ESI+) (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>12</sub>H<sub>17</sub>FN<sub>3</sub> 222.1; found, 222.0.</div><div class="NLM_p"><b>(<i>R</i>)-(3-(3-Fluorophenethyl)-2-iminoimidazolidin-4-yl)methanol</b> (<b>20</b>) was synthesized with Boc-<span class="smallcaps smallerCapital">l</span>-serine for the R1 reagent used in step a and 3-fluorophenylacetic acid used for the R2 reagent in step b. [α]<sup>20</sup><sub>D</sub> 3.4 (0.5, DMSO). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.50 (s, 1H), 7.43 (q, <i>J</i> = 7.6 Hz, 1H), 7.18 (d, <i>J</i> = 7.6 Hz, 1H), 7.16–7.09 (m, 2H), 4.01–3.95 (m, 1H), 3.88 (dd, <i>J</i> = 12.8, 3.6 Hz,1H), 3.78–3.73 (m, 1H), 3.70 (d, <i>J</i> = 10.0 Hz, 1H), 3.67–3.65 (m, 1H), 3.64–3.60 (m, 1H), 3.51 (q, <i>J</i> = 6.0 Hz, 1H), 3.03–2.99 (m, 2H). <sup>13</sup>C NMR (100 MHz, D<sub>2</sub>O) δ 162.5 (<i>J</i> = 242.1 Hz), 158.44, 140.77 (<i>J</i> = 7.4 Hz), 130.55 (<i>J</i> = 8.3 Hz), 124.87 (<i>J</i> = 2.7 Hz), 115.64 (<i>J</i> = 21.2 Hz), 113.69 (<i>J</i> = 20.8 Hz), 59.70, 59.51, 43.16, 43.00, 32.13 (<i>J</i> = 1.3 Hz). MS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup>: 238. LC–MS (ESI+) (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>12</sub>H<sub>17</sub>FN<sub>3</sub>O 238.1; found, 238.0.</div><div class="NLM_p"><b>1-(3-Bromophenethyl)imidazolidin-2-imine</b> (<b>21</b>) was synthesized with Boc-glycine for the R1 reagent used in step a and 3-bromophenylacetic acid used for the R2 reagent in step b. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.59 (s, 1H), 7.39 (s, 1H), 7.36 (dt, <i>J</i> = 6.8, 2.0 Hz, 1H), 7.18–7.14 (m, 2H), 3.58 (t, <i>J</i> = 7.2 Hz, 2H), 3.53 (d, <i>J</i> = 8.8 Hz, 2H), 3.41 (t, <i>J</i> = 8.4 Hz, 2H), 2.86 (t, <i>J</i> = 7.6 Hz, 2H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 159.95, 140.15, 131.87, 130.50, 130.18, 127.58, 122.85, 48.30, 45.90, 41.01, 33.44. LC–MS (ESI+) (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>11</sub>H<sub>15</sub>BrN<sub>3</sub> 268.1; found, 267.9 and 269.9.</div><div class="NLM_p"><b>(<i>S</i>)-1-(3-Bromophenethyl)-5-methylimidazolidin-2-imine</b> (<b>22</b>) was synthesized with Boc-<span class="smallcaps smallerCapital">l</span>-alanine for the R1 reagent used in step a and 3-bromophenylacetic acid used for the R2 reagent in step b. [α]<sup>20</sup><sub>D</sub> 19.3 (1.0, DMSO). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>):δ 8.50 (s, 1H), 7.55 (s, 1H), 7.53–7.52 (m, 1H), 7.33 (d, <i>J</i> = 4.8 Hz, 2H), 4.01–3.95 (m, 1H), 3.72 (t, <i>J</i> = 9.6 Hz, 1H), 3.66–3.52 (m, 2H), 3.21 (q, <i>J</i> = 7.6 Hz, 1H), 2.94 (t, <i>J</i> = 6.4 Hz, 2H), 1.26 (d, <i>J</i> = 6.4 Hz, 3H). <sup>13</sup>C NMR (100 MHz, D<sub>2</sub>O) δ 157.94, 140.80, 131.87, 130.58, 129.83, 127.92, 122.03, 55.12, 47.76, 42.64, 32.16, 16.82. LC–MS (ESI+) (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>12</sub>H<sub>17</sub>BrN<sub>3</sub> 282.1; found, 28.8 and 283.9.</div><div class="NLM_p"><b>(<i>R</i>)-(3-(3-Bromophenethyl)-2-iminoimidazolidin-4-yl)methanol</b> (<b>23</b>) was synthesized with Boc-<span class="smallcaps smallerCapital">l</span>-serine for the R1 reagent used in step a and 3-bromophenylacetic acid used for the R2 reagent in step b. [α]<sup>20</sup><sub>D</sub> 7.4 (0.5, DMSO). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.53 (s, 1H), 7.56 (s, 1H), 7.54–7.3 (m, 1H), 7.34 (s, 1H), 7.31 (d, <i>J</i> = 0.8 Hz, 1H), 3.99–3.94 (m, 1H), 3.86 (ddd, <i>J</i> = 12.4, 3.2, 0.8 Hz, 1H), 3.74–3.72 (m, 1H), 3.70–3.69 (m, 1H), 3.65–3.58 (m, 2H), 3.51 (ddd, <i>J</i> = 9.6, 5.6, 0.8 Hz, 1H), 3.00–2.96 (m, 2H). <sup>13</sup>C NMR (100 MHz, D<sub>2</sub>O) δ 158.42, 140.62, 131.85, 130.63, 129.90, 127.88, 122.08, 59.74, 59.48, 43.18, 43.00, 32.03. LC–MS (ESI+) (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>12</sub>H<sub>17</sub>BrN<sub>3</sub>O 298.1; found, 297.8 and 299.7.</div><div class="NLM_p"><b>(<i>S</i>)-1-(2-(6-Chloropyridin-3-yl)ethyl)-5-methylimidazolidin-2-imine</b> (<b>24</b>) was synthesized with Boc-<span class="smallcaps smallerCapital">l</span>-alanine for the R1 reagent used in step a and 2-(6-chloropyridin-3-yl)acetic acid used for the R2 reagent in step b. [α]<sup>20</sup><sub>D</sub> 20.4 (0.25, 50% DMSO). <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O): δ 8.28 (d, <i>J</i> = 2.4 Hz, 1H), 7.82 (dd, <i>J</i> = 8.0, 2.4 Hz, 1H), 7.50 (d, <i>J</i> = 8.4 Hz, 1H), 4.07–4.02 (m, 1H), 3.74 (t, <i>J</i> = 9.6 Hz, 1H), 3.64–3.60 (m, 2H), 3.24 (q, <i>J</i> = 7.2 Hz, 1H), 3.00 (q, <i>J</i> = 6.8 Hz, 2H), 1.27 (d, <i>J</i> = 6.4 Hz, 3H). <sup>13</sup>C NMR (100 MHz, D<sub>2</sub>O) δ 158.10, 149.36, 149.04, 141.04, 133.65, 124.80, 55.26, 47.84, 42.30, 29.17, 16.92. LC–MS (ESI+) (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>11</sub>H<sub>16</sub>ClN<sub>4</sub> 239.1; found,239.0.</div><div class="NLM_p"><b>1-(2-(6-Chloropyridin-3-yl)ethyl)imidazolidin-2-imine</b> (<b>25</b>) was synthesized with Boc-<span class="smallcaps smallerCapital">l</span>-glycine tyrosine for the R1 reagent used in step a and 2-(6-chloropyridin-3-yl)acetic acid for the R2 reagent used in step b. <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O): δ 8.29 (d, <i>J</i> = 2.4 Hz, 1H), 7.83 (dd, <i>J</i> = 8.4, 2.4 Hz, 1H), 7.51 (d, <i>J</i> = 8.4 Hz, 1H), 3.74–3.69 (m, 2H), 3.64–3.63 (m, 2H), 3.62–3.60 (m, 2H), 3.02 (q, J = 6.8 Hz, 2H). <sup>13</sup>C NMR (100 MHz, D<sub>2</sub>O) δ 158.70, 149.30, 149.04, 140.93, 133.65, 124.80, 47.69, 45.00, 40.63, 29.03. LC–MS (ESI+) (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>10</sub>H<sub>14</sub>ClN<sub>4</sub> 225.1; found,225.0.</div><div class="NLM_p last"><b>(<i>R</i>)-(3-(2-(6-Chloropyridin-3-yl)ethyl)-2-iminoimidazolidin-4-yl)methanol</b> (<b>26</b>) was synthesized with Boc-<span class="smallcaps smallerCapital">l</span>-serine for the R1 reagent used in step a and 2-(6-chloropyridin-3-yl)acetic acid used for the R2 reagent in step b. [α]<sup>20</sup><sub>D</sub> 39.52 (0.17, 50% DMSO). <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O): δ 8.31 (s, 1H), 7.85 (dd, <i>J</i> = 8.4, 2.4 Hz, 1H), 7.53 (d, <i>J</i> = 8.4 Hz, 1H), 4.10–4.06 (m, 1H), 3.90 (dd, <i>J</i> = 12.4, 3.2 Hz, 1H), 3.78–3.73 (m, 2H), 3.71–3.67 (m, 2H), 3.54 (dd, <i>J</i> = 10.0, 5.6 Hz, 1H), 3.05 (t, <i>J</i> = 6.4 Hz, 2H). <sup>13</sup>C NMR (100 MHz, D<sub>2</sub>O) δ 158.43, 149.24, 149.04, 140.93, 133.40, 124.76, 59.76, 59.42, 42.99, 42.71, 28.96. LC–MS (ESI+) (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>11</sub>H<sub>16</sub>ClN<sub>4</sub>O 255.1; found, 255.0.</div></div><div id="sec5-2" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Cell Culture</h3><div class="NLM_p last">HEK cells, stably expressing rat α3β4, α4β4, α4β2, and α3β2 nAChR (obtained from Drs. Kenneth Kellar and Yingxian Xiao, Georgetown University) and α3β4α5 nAChR (obtained from Dr. Jon Martin Lindstrom) were cultured in Dulbecco’s modified Eagle’s medium (DMEM), supplemented with 10% fetal bovine serum (FBS), 0.5% penicillin/streptomycin, and 0.4 mg/mL of Geneticin and were maintained in an atmosphere of 7.5% CO<sub>2</sub> in a humidified incubator at 37 °C. For binding assays, cells were passaged on 150 mm dishes and harvested when confluent.</div></div><div id="sec5-3" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Binding Assays</h3><div class="NLM_p last">Cells were harvested by scraping the plates with a rubber policeman, suspended in 50 mM Tris buffer, pH 7.4, homogenized using a Polytron homogenizer, and the centrifugation was repeated twice at 20 000<i>g</i> (13 500 rpm) for 20 min. For binding, the cell membranes were incubated with the test compounds or mixtures in the presence of 0.3 nM [<sup>3</sup>H]epibatidine. After 2 h of incubation, at room temperature, samples were filtered, using a Tomtec cell harvester, through glass fiber filters that had been presoaked in 0.05% polyethylenimine. Filters were counted on a betaplate reader (Wallac). Nonspecific binding was determined by using 0.1 μM unlabeled epibatidine for α3β4and α4β2 nAChR, respectively. IC<sub>50</sub> values were determined by using the program GraphPad Prism. <i>K</i><sub>i</sub> values were calculated using the Cheng–Prusoff transformation: <i>K</i><sub>i</sub> = IC<sub>50</sub>/(1 + <i>L</i>/<i>K</i><sub>d</sub>), where <i>L</i> is radioligand concentration and <i>K</i><sub>d</sub> is the binding affinity of the radioligand, as determined previously by saturation analysis.</div></div><div id="sec5-4" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> nAChR Functional Assays</h3><div class="NLM_p last">nAChR functional activity was determined by measuring nAChR-induced membrane potential change, which can be directly read by Molecular Devices membrane potential assay kit (Blue Dye) (Molecular Devices, Sunnyvale, CA) using the FlexStation 3 microplate reader (Molecular Devices, Sunnyvale, CA). The HEK cells with stably expressing α3β4 or α4β2 nAChR were seeded in a 96-well plate (4000 cells per well) 1 day prior to the experiments. For agonist assays, after brief washing, the cells were loaded with 225 μL of HBSS assay buffer (Hank’s balanced salt solution with 20 mM of HEPES, pH 7.4), containing the blue dye, and incubated at 37 °C. After 30 min, 25 μL of the appropriate compounds were dispensed into the wells by the FlexStation and nAChR stimulation-mediated membrane potential change was recorded every 3 s for 120 s by reading 565 nm fluorescence excited at 530 nm wavelength. For the antagonist assay, the cells were loaded with 200 μL HBSS buffer containing the blue dye and incubated at 37 °C. After 20 min, 25 μL of test compounds was added, and after another 10 min, 25 μL of epibatidine (or nicotine) was added by the FlexStation, to a final concentration of 100 nM, with fluorescence measured as described above. The change in fluorescence represents the maximum response minus the minimum response for each well. GraphPad Prism was used to determine the EC<sub>50</sub> and IC<sub>50</sub> values.</div></div><div id="sec5-5" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Animals</h3><div class="NLM_p last">Male Sprague Dawley rats obtained from Charles River (Portage, MI) and weighing 200–225 g at their arrival were used in this study. Rats were housed in groups of two in a room with a reverse 12 h light/12 h dark cycle (lights off at 07:30 a.m.). All behavioral experiments were conducted during the dark phase of the cycle. Animals were acclimatized for 7 days with water and chow (Teklad Diets, Madison, WI) and handled 3 times before the experiments were started. All animal experiments performed in this manuscript were conducted in compliance with U.S. Institutional Animal Care and Use Committee (IACUC)</div></div><div id="sec5-6" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Drugs and Chemicals</h3><div class="NLM_p last"><b>5</b> was dissolved in a vehicle of 0.9% saline and injected subcutaneously at doses of (0.0, 0.3, 1.0 mg/kg). The injection volume was 1 mL/kg. Nicotine hydrogen tartrate salt was purchased from Sigma (St. Louis, MO). Nicotine solution for iv injection (30 (μg/kg)/0.1 mL infusion) was obtained by dissolving the salt in 0.9% saline and the pH adjusted to 7.0–7.4 with 3 M sodium hydroxide. Nicotine self-administration dose is reported as free base concentration.</div></div><div id="sec5-7" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Apparatus</h3><div class="NLM_p last">The self-administration boxes consisted of operant conditioning chambers (Med Associates, Inc., St. Albans, VT) enclosed in lit, sound attenuating, ventilated environmental cubicles. Each chamber was equipped with two retractable levers located in the front panel, laterally to a food pellet magazine. A pellet dispenser was positioned behind the front panel of the boxes. Chambers were also equipped with auditory stimuli presented via a speaker and visual stimuli located above the levers (cue light). Infusions occurred by means of syringe pumps (Med Associates, Inc., St. Albans, VT) and liquid swivels (Instech Solomon, Plymouth Meeting, PA) connected to plastic tubing protected by a flexible metal sheath for attachment to the external catheter terminus. To allow delivery of nicotine, an infusion pump was activated by responses on the right (active) lever, while responses on the left (inactive) lever were recorded but did not result in any programmed consequences. Activation of the pump resulted in a delivery of 0.1 mL of the reinforcer. A microcomputer controlled the delivery of nicotine, presentation of auditory and visual stimuli, and recording of the behavioral data.</div></div><div id="sec5-8" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Food Training and Intravenous (iv) Catheterization</h3><div class="NLM_p last">One week after arrival, all rats were trained to lever-press for 45 mg of food pellets (test diet, 5-TUM, Richmond, IN) under a fixed ratio 1 (FR-1) schedule of reinforcement in 30 min sessions for 3 days. Then, animals underwent iv surgery that occurred under isoflurane anesthesia. Incisions were made to expose the right jugular vein. A catheter made from microrenathane tubing (inner diameter = 0.020 in., outside diameter = 0.037 in.) was subcutaneously positioned between the vein and the back as described in refs <a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">26</a> and <a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">52</a>. For the duration of the experiment, the catheters were flushed daily with 0.2 mL of heparinized saline solution containing enrofloxacin (0.7 mg/mL). The self-administration experiments began 1 week after recovery from surgery.</div></div><div id="sec5-9" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Effect of <b>5</b> on Nicotine Self-Administration</h3><div class="NLM_p last">Rats (<i>n</i> = 7) were trained to self-administer nicotine under a FR-1 schedule of reinforcement for 6 days of 2 h daily sessions and under a fixed ratio 3 (FR-3) for additional 9 sessions. Every three active lever presses resulted in the delivery of one nicotine dose (0.03 (mg/kg)/0.1 mL infusion). Following each nicotine infusion, a 20 s time out (TO) period occurred, during which responses at the active lever did not lead to programmed consequences. This TO period was concurrent with illumination of a cue light located above the active lever to signal delivery of the positive reinforcement. Additionally, an intermittent tone (7 kHz, 70 dB) was sounded throughout the 2 h nicotine sessions. The rats were trained to self-administer nicotine until a stable baseline of reinforcement was established. A Latin square within-subject design was used for the drug treatment. The rats were injected subcutaneously with the drug (0.0, 0.3, and 1.0 mg/kg) 10 min before the beginning of the session. The animals were subjected to all treatments in counterbalanced order at least at 48 h intervals between the drug test days.</div></div><div id="sec5-10" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Effect of <b>5</b> on Nicotine Priming-Induced Reinstatement of Nicotine Seeking</h3><div class="NLM_p last">Rats (<i>n</i> = 7) were trained to self-administer nicotine at the dose of 0.03 (mg/kg)/infusion in daily 2 h sessions under a FR-1 followed by FR-3 schedule of reinforcement as described above. Following each nicotine infusion (0.1 mL), a 20 s TO period occurred, during which pressing the active lever did not lead to programmed consequences. The TO was accompanied by illumination of a cue light located above the active lever to signal delivery of the positive reinforcement, while an intermittent tone was sounded throughout the sessions. Then, an extinction phase was conducted for 14 consecutive sessions. During 1 h extinction sessions, the lever presses were no longer associated with nicotine delivery while all cues were presented to allow for their concomitant extinction. The day after the last extinction session, the rats were subjected to the reinstatement test by the subcutaneous injection of nicotine at the dose of 0.15 mg/kg. To evaluate the effect of <b>5</b> on nicotine priming-induced reinstatement, rats were administered the drug (0.3 and 1.0 mg/kg) or its vehicle (0.0 mg/kg) in a counterbalanced order (Latin square) 10 min before nicotine injection that was in turn administered 10 min before the 1 h reinstatement session. A 3-day interval occurred between drug tests, during which the animals were subjected to extinction sessions. The nicotine dose, time of injection, and experimental design have been previously described.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></div></div><div id="sec5-11" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Effect of <b>5</b> on Cue-Induced Reinstatement of Nicotine Seeking</h3><div class="NLM_p last">Rats (<i>n</i> = 7) were trained to lever-press for nicotine at the dose of 0.03 mg/kg in daily 2 h sessions under a FR-1 schedule of reinforcement for 6 days and under FR-3 for additional 9 days. Concurrently with the lever pressing, a 20 s TO period that was concurrent to presentation of a cue light was in effect. A stimulus predictive of nicotine (orange odor) was also presented immediately after the animals were placed in the operant chambers and immediately before the onset of every conditioning session.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Furthermore, an intermittent tone (7 kHz, 70 dB) was sounded throughout the 2 h nicotine sessions. Nicotine-reinforced responding was then extinguished in daily 1 h sessions that continued for 14 days. In this phase, neither nicotine nor the tone, the cue light, or the orange odor was available. On the day following the last extinction session, a 1 h reinstatement session was carried out without any drug treatment. Tone, odor, and cue light, but not nicotine, were presented, and reinstatement response rates (i.e., responses on the previously nicotine-associated lever) were recorded. These response rates were used to assign animals to treatment groups balanced for response rates for the drug treatment experiment that followed. To assess the effects of <b>5</b>, reinstatement experiments were then conducted every third day. In a Latin-square counterbalanced order that paralleled that used for the self-administration studies, animals were pretreated with <b>5</b> (0.0, 0.3, 1.0 mg/kg, sc) 10 min prior the onset of the reinstatement sessions.</div></div><div id="sec5-12" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Assessment of Body Temperature</h3><div class="NLM_p last">Baseline rectal temperature was measured in rats (<i>n</i> = 8) just prior to injection of <b>5</b> (1.0 mg/kg, sc) or vehicle (0.9% saline) using a Latin square within-subject design. Ten minutes later, nicotine (0.5 mg/kg, sc) or vehicle (0.9% saline) was injected, and temperature was measured again after 15, 30, 60, and 120 min.</div></div><div id="sec5-13" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Detection of Compound in Rat Blood and Brain Using LC–MS/MS</h3><div class="NLM_p last">Rats (<i>n</i> = 3–4 per group) were sc injected with <b>5</b> (2 mg/kg) and blood as well as brain samples taken at various time points (10, 30, and 60 min) following drug administration. Samples of rats treated with vehicle (time point 0) were also taken. Blood (100 μL) was obtained by cardiac puncture and collected into a corresponding microcentrifuge tube that contained 1.0 mL of cold acetonitrile with 10 ng/mL of cotinine which was used as internal standard. Samples were then centrifuged at 3000 rpm for 5 min. The supernatant was dried in a speed vacuum. Samples were reconstituted in 100 μL of 5% acetonitrile in water. Next, samples were centrifuged at 13 000 rpm for 5 min. A volume of 10 μL of supernatant was used for analysis. Brain samples were collected following perfusion with PBS and homogenized on ice in 500 μL of PBS buffer. Protein precipitation was achieved by adding 1.0 mL of cold acetonitrile with 10 ng/mL internal standard. Samples were centrifuged at 10 000 rpm for 10 min. The supernatant was dried in a speed vacuum. Samples were reconstituted in 100 μL of 5% acetonitrile in water. Analysis was conducted by using high performance liquid chromatography (HPLC, 20AD Shimadzu Prominence)/tandem mass spectrometry (LC–MS/MS) AbSciex 3200 QTrap triple-quadrupole linear ion trap mass spectrometer fitted with a TurboIonSpray interface (Applied Biosystems/MDS Sciex, Darmstadt, Germany). In brief, to achieve separation on the HPLC of the analyte and the internal standard, reverse phase mode with a gradient of 1–10% acetonitrile over 15 min was used on a C-18 reverse phase column (Phenomenex Gemini NX 110A 50 mm × 4.6 mm). Mobile phase A was LCMS grade water with 0.1% formic acid (Fisher Optima catalog no. LS118-4). Mobile phase B was acetonitrile with 0.1% formic acid (Fluka catalog no. 34668). The MS/MS analysis was performed in multiple reaction monitoring (MRM) mode using the three largest fragments of the parent ions. MS instrument parameters were spray voltage 5.5 kV, curtain gas 20 psi, source temperature 650 °C, ion source gas 150 psi and gas 240 psi. The ion transitions monitored were 205.225/106.1, 205.225/100.3, 205.225/78.2 and 177.163/80.2, 177.163/98.1, 177.163/53.2. Blank solvent injections were run between each sample to minimize analyte carry over. The counts for the ion transitions were summed to give the peak area. The ratio of the analyte peak area to the internal standard peak area was calculated for each rat. The average was calculated and plotted for each time point.</div></div><div id="sec5-14" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Data Analysis</h3><div class="NLM_p last">Data were analyzed by using Statistica 7 software.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> The effects of <b>5</b> on nicotine self-administration and nicotine-induced changes in body temperature were analyzed by means of a two-way ANOVA that used two within-subject factors (i.e., “time interval”, which is the number of infusions in fractions of 30 min, or “time point” and “treatment dose” or “treatment”, respectively). To establish that reinstatement was successfully induced, responding during the last EXT session was compared to the respective reinstatement session of the vehicle-treated group by one-way within-subject ANOVA. The effect of systemic <b>5</b> on reinstatement experiments was analyzed using one-way repeated measures ANOVA with treatment (drug dose) as a within-subject factor. Blood and brain contents were analyzed by one-way ANOVA that used time point as between factor. The level of significance was set at <i>p</i> < 0.05. ANOVAs were followed, where appropriate, by Student–Newman–Keuls post hoc tests.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i27"><a href="/doi/suppl/10.1021/acs.jmedchem.7b01250">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21265" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21265" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.7b01250" class="ext-link">10.1021/acs.jmedchem.7b01250</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Molecular formula strings and some data (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01250/suppl_file/jm7b01250_si_001.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01250/suppl_file/jm7b01250_si_001.csv">jm7b01250_si_001.csv (1.58 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.7b01250" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74821" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74821" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jinhua Wu</span> - <span class="hlFld-Affiliation affiliation">Torrey
Pines Institute for Molecular Studies, 11350 SW Village Parkway, Port St. Lucie, Florida 34987, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Assuage
Pharmaceuticals, Inc, 11350 SW Village Parkway, Port St. Lucie, Florida 34987, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-3733-5616" title="Orcid link">http://orcid.org/0000-0003-3733-5616</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#7e14090b3e0a0e17130d50110c19"><span class="__cf_email__" data-cfemail="ec869b99ac989c85819fc2839e8b">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marc A. Giulianotti</span> - <span class="hlFld-Affiliation affiliation">Torrey
Pines Institute for Molecular Studies, 11350 SW Village Parkway, Port St. Lucie, Florida 34987, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Assuage
Pharmaceuticals, Inc, 11350 SW Village Parkway, Port St. Lucie, Florida 34987, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#7a171d130f16131b14150e0e133a0e0a1317095415081d"><span class="__cf_email__" data-cfemail="a2cfc5cbd7cecbc3cccdd6d6cbe2d6d2cbcfd18ccdd0c5">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrea Cippitelli</span> - <span class="hlFld-Affiliation affiliation">Torrey
Pines Institute for Molecular Studies, 11350 SW Village Parkway, Port St. Lucie, Florida 34987, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yaohong Zhang</span> - <span class="hlFld-Affiliation affiliation">Torrey
Pines Institute for Molecular Studies, 11350 SW Village Parkway, Port St. Lucie, Florida 34987, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Institute
of Materia Medica, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, P. R.
China</span>; 
    <span class="hlFld-Affiliation affiliation">School
of Chemistry and Chemical Engineering, Zhejiang Key Laboratory of
Alternative Technologies for Fine Chemicals Process, Shaoxing University, Shaoxing 312000, Zhejiang, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ginamarie Debevec</span> - <span class="hlFld-Affiliation affiliation">Torrey
Pines Institute for Molecular Studies, 11350 SW Village Parkway, Port St. Lucie, Florida 34987, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jennifer Schoch</span> - <span class="hlFld-Affiliation affiliation">Torrey
Pines Institute for Molecular Studies, 11350 SW Village Parkway, Port St. Lucie, Florida 34987, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Akihiko Ozawa</span> - <span class="hlFld-Affiliation affiliation">Torrey
Pines Institute for Molecular Studies, 11350 SW Village Parkway, Port St. Lucie, Florida 34987, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yongping Yu</span> - <span class="hlFld-Affiliation affiliation">Torrey
Pines Institute for Molecular Studies, 11350 SW Village Parkway, Port St. Lucie, Florida 34987, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Institute
of Materia Medica, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, P. R.
China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Huan Liu</span> - <span class="hlFld-Affiliation affiliation">Institute
of Materia Medica, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, P. R.
China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wenteng Chen</span> - <span class="hlFld-Affiliation affiliation">Institute
of Materia Medica, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, P. R.
China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Richard A. Houghten</span> - <span class="hlFld-Affiliation affiliation">Torrey
Pines Institute for Molecular Studies, 11350 SW Village Parkway, Port St. Lucie, Florida 34987, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Assuage
Pharmaceuticals, Inc, 11350 SW Village Parkway, Port St. Lucie, Florida 34987, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gregory S. Welmaker</span> - <span class="hlFld-Affiliation affiliation">Torrey
Pines Institute for Molecular Studies, 11350 SW Village Parkway, Port St. Lucie, Florida 34987, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Assuage
Pharmaceuticals, Inc, 11350 SW Village Parkway, Port St. Lucie, Florida 34987, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lawrence Toll</span> - <span class="hlFld-Affiliation affiliation">Torrey
Pines Institute for Molecular Studies, 11350 SW Village Parkway, Port St. Lucie, Florida 34987, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Assuage
Pharmaceuticals, Inc, 11350 SW Village Parkway, Port St. Lucie, Florida 34987, United States</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>J.W., A.C., and Y.Z. contributed equally to this work. All authors have given approval to the final version of the manuscript. J.W., A.C., Y.Z., G.D., J.S., and A.O. conducted the experiments. J.W., A.C., M.A.G., and L.T. designed the overall study. Y.Z., G.D., H.L., W.C., G.S.W., R.A.H., M.A.G., and Y.Y. designed or performed chemical synthesis. J.W., A.C., M.A.G., and L.T. wrote the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i29">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01407" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01407" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by both NIH Grants R43 DA036968 and R44 DA036968 to J.W. and the State of Florida, Executive Office of the Governor’s Department of Economic Opportunity. We thank Drs. Yingxian Xiao and Kenneth Kellar (Georgetown University, Washington, DC) for kindly providing the ratα3β4, α4β4, α4β2, and α3β2 nAChR HEK293 cell lines, and we thank Dr. Jon Lindstrom (University of Pennsylvania, PA) for providing α3β4α5 nAChR HEK293 cell line used in the functional assays.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i30" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i30"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i31" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i31"> Abbreviations Used</h2><tr><td class="NLM_term">nAChR</td><td class="NLM_def"><p class="first last">nicotinic acetylcholine receptor</p></td></tr><tr><td class="NLM_term">DhβE</td><td class="NLM_def"><p class="first last">dihydro-β-erythroidine</p></td></tr><tr><td class="NLM_term">4-nitro-PFEB</td><td class="NLM_def"><p class="first last">2-fluoro-3-(4-nitrophenyl)deschloroepibatidine</p></td></tr><tr><td class="NLM_term">VTA</td><td class="NLM_def"><p class="first last">ventral tegmental area</p></td></tr><tr><td class="NLM_term">TPIMS</td><td class="NLM_def"><p class="first last">The Torrey Pines Institute for Molecular Studies</p></td></tr><tr><td class="NLM_term">ANOVA</td><td class="NLM_def"><p class="first last">analysis of variance</p></td></tr><tr><td class="NLM_term">MBHA</td><td class="NLM_def"><p class="first last"><i>p</i>-methylbenzhydrylamine</p></td></tr><tr><td class="NLM_term">DIEA</td><td class="NLM_def"><p class="first last">diisopropylethylamine</p></td></tr><tr><td class="NLM_term">DCM</td><td class="NLM_def"><p class="first last">dichloromethane</p></td></tr><tr><td class="NLM_term">Boc</td><td class="NLM_def"><p class="first last"><i>tert</i>-butyloxycarbonyl</p></td></tr><tr><td class="NLM_term">DIC</td><td class="NLM_def"><p class="first last">diisopropylcarbodiimide</p></td></tr><tr><td class="NLM_term">HOBt</td><td class="NLM_def"><p class="first last">hydroxybenzotriazole hydrate</p></td></tr><tr><td class="NLM_term">TFA</td><td class="NLM_def"><p class="first last">trifluoroacetic acid</p></td></tr><tr><td class="NLM_term">CNBr</td><td class="NLM_def"><p class="first last">cyanogen bromide</p></td></tr><tr><td class="NLM_term">LC–MS</td><td class="NLM_def"><p class="first last">liquid chromatography–mass spectrometry</p></td></tr><tr><td class="NLM_term">sc</td><td class="NLM_def"><p class="first last">subcutaneous</p></td></tr><tr><td class="NLM_term">FR-1</td><td class="NLM_def"><p class="first last">fixed ratio 1</p></td></tr><tr><td class="NLM_term">FR-3</td><td class="NLM_def"><p class="first last">fixed ratio 3</p></td></tr><tr><td class="NLM_term">AN</td><td class="NLM_def"><p class="first last">analyte</p></td></tr><tr><td class="NLM_term">IS</td><td class="NLM_def"><p class="first last">internal control</p></td></tr><tr><td class="NLM_term">TO</td><td class="NLM_def"><p class="first last">time out</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i32">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88605" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88605" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 53 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span> </span><span class="NLM_article-title">The health consequences of smoking—50 years of progress: A report of the surgeon general</span>. <span class="NLM_publisher-name">U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion: Office on Smoking and Health, U.S. Government Printing Office</span>: <span class="NLM_publisher-loc">Washington, DC</span>,<span class="NLM_x"> </span><span class="NLM_year">2014</span><span class="NLM_x">, </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=The+health+consequences+of+smoking%E2%80%9450+years+of+progress%3A+A+report+of+the+surgeon+general.+U.S.+Department+of+Health+and+Human+Services%2C+Centers+for+Disease+Control+and+Prevention%2C+National+Center+for+Chronic+Disease+Prevention+and+Health+Promotion%3A+Office+on+Smoking+and+Health%2C+U.S.+Government+Printing+Office%3A+Washington%2C+DC%2C+2014%2C+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26atitle%3DThe%2520health%2520consequences%2520of%2520smoking%25E2%2580%259450%2520years%2520of%2520progress%253A%2520A%2520report%2520of%2520the%2520surgeon%2520general%26pub%3DU.S.%2520Department%2520of%2520Health%2520and%2520Human%2520Services%252C%2520Centers%2520for%2520Disease%2520Control%2520and%2520Prevention%252C%2520National%2520Center%2520for%2520Chronic%2520Disease%2520Prevention%2520and%2520Health%2520Promotion%253A%2520Office%2520on%2520Smoking%2520and%2520Health%252C%2520U.S.%2520Government%2520Printing%2520Office%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Xu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bishop, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simpson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pechacek, T.</span><span> </span><span class="NLM_article-title">Annual healthcare spending attributable to cigarette smoking: An update</span> <span class="citation_source-journal">Am. J. Prev. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">326</span><span class="NLM_x">–</span> <span class="NLM_lpage">333</span><span class="refDoi"> DOI: 10.1016/j.amepre.2014.10.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=10.1016%2Fj.amepre.2014.10.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=25498551" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=1%3ACAS%3A280%3ADC%252BC2MzntlSnsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2015&pages=326-333&author=X.+Xuauthor=E.+Bishopauthor=S.+Kennedyauthor=S.+Simpsonauthor=T.+Pechacek&title=Annual+healthcare+spending+attributable+to+cigarette+smoking%3A+An+update&doi=10.1016%2Fj.amepre.2014.10.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Annual healthcare spending attributable to cigarette smoking: an update</span></div><div class="casAuthors">Xu Xin; Bishop Ellen E; Kennedy Sara M; Simpson Sean A; Pechacek Terry F</div><div class="citationInfo"><span class="NLM_cas:title">American journal of preventive medicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">326-33</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Fifty years after the first Surgeon General's report, tobacco use remains the nation's leading preventable cause of death and disease, despite declines in adult cigarette smoking prevalence.  Smoking-attributable healthcare spending is an important part of overall smoking-attributable costs in the U.S.  PURPOSE:  To update annual smoking-attributable healthcare spending in the U.S. and provide smoking-attributable healthcare spending estimates by payer (e.g., Medicare, Medicaid, private insurance) or type of medical services.  METHODS:  Analyses used data from the 2006-2010 Medical Expenditure Panel Survey linked to the 2004-2009 National Health Interview Survey.  Estimates from two-part models were combined to predict the share of annual healthcare spending that could be attributable to cigarette smoking.  The analysis was conducted in 2013.  RESULTS:  By 2010, 8.7% (95% CI=6.8%, 11.2%) of annual healthcare spending in the U.S. could be attributed to cigarette smoking, amounting to as much as $170 billion per year.  More than 60% of the attributable spending was paid by public programs, including Medicare, other federally sponsored programs, or Medicaid.  CONCLUSIONS:  These findings indicate that comprehensive tobacco control programs and policies are still needed to continue progress toward ending the tobacco epidemic in the U.S. 50 years after the release of the first Surgeon General's report on smoking and health.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTTJKUGDwGDoLxanA7vODO6fW6udTcc2eaFdU62EvWk0rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MzntlSnsg%253D%253D&md5=3d6057b3c13a43d3d0c12658ab335360</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.amepre.2014.10.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.amepre.2014.10.012%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DX.%26aulast%3DBishop%26aufirst%3DE.%26aulast%3DKennedy%26aufirst%3DS.%26aulast%3DSimpson%26aufirst%3DS.%26aulast%3DPechacek%26aufirst%3DT.%26atitle%3DAnnual%2520healthcare%2520spending%2520attributable%2520to%2520cigarette%2520smoking%253A%2520An%2520update%26jtitle%3DAm.%2520J.%2520Prev.%2520Med.%26date%3D2015%26volume%3D48%26spage%3D326%26epage%3D333%26doi%3D10.1016%2Fj.amepre.2014.10.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span> </span><span class="NLM_article-title">WHO report on the global tobacco epidemic</span>. <span class="NLM_publisher-name">World Health Organization</span>: <span class="NLM_publisher-loc">Geneva</span>,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=WHO+report+on+the+global+tobacco+epidemic.+World+Health+Organization%3A+Geneva%2C+2011."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26atitle%3DWHO%2520report%2520on%2520the%2520global%2520tobacco%2520epidemic%26pub%3DWorld%2520Health%2520Organization%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Jorenby, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hays, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rigotti, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azoulay, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watsky, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billing, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reeves, K. R.</span><span> </span><span class="NLM_article-title">Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: A randomized controlled trial</span> <span class="citation_source-journal">JAMA</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">296</span><span class="NLM_x">, </span> <span class="NLM_fpage">56</span><span class="NLM_x">–</span> <span class="NLM_lpage">63</span><span class="refDoi"> DOI: 10.1001/jama.296.1.56</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=10.1001%2Fjama.296.1.56" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=296&publication_year=2006&pages=56-63&author=D.+E.+Jorenbyauthor=J.+T.+Haysauthor=N.+A.+Rigottiauthor=S.+Azoulayauthor=E.+J.+Watskyauthor=K.+E.+Williamsauthor=C.+B.+Billingauthor=J.+Gongauthor=K.+R.+Reeves&title=Efficacy+of+varenicline%2C+an+alpha4beta2+nicotinic+acetylcholine+receptor+partial+agonist%2C+vs+placebo+or+sustained-release+bupropion+for+smoking+cessation%3A+A+randomized+controlled+trial&doi=10.1001%2Fjama.296.1.56"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1001%2Fjama.296.1.56&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Fjama.296.1.56%26sid%3Dliteratum%253Aachs%26aulast%3DJorenby%26aufirst%3DD.%2BE.%26aulast%3DHays%26aufirst%3DJ.%2BT.%26aulast%3DRigotti%26aufirst%3DN.%2BA.%26aulast%3DAzoulay%26aufirst%3DS.%26aulast%3DWatsky%26aufirst%3DE.%2BJ.%26aulast%3DWilliams%26aufirst%3DK.%2BE.%26aulast%3DBilling%26aufirst%3DC.%2BB.%26aulast%3DGong%26aufirst%3DJ.%26aulast%3DReeves%26aufirst%3DK.%2BR.%26atitle%3DEfficacy%2520of%2520varenicline%252C%2520an%2520alpha4beta2%2520nicotinic%2520acetylcholine%2520receptor%2520partial%2520agonist%252C%2520vs%2520placebo%2520or%2520sustained-release%2520bupropion%2520for%2520smoking%2520cessation%253A%2520A%2520randomized%2520controlled%2520trial%26jtitle%3DJAMA%26date%3D2006%26volume%3D296%26spage%3D56%26epage%3D63%26doi%3D10.1001%2Fjama.296.1.56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Reus, V. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, B. J.</span><span> </span><span class="NLM_article-title">Multimodal techniques for smoking cessation: A review of their efficacy and utilisation and clinical practice guidelines</span> <span class="citation_source-journal">Int. J. Clin. Pract.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">1753</span><span class="NLM_x">–</span> <span class="NLM_lpage">1768</span><span class="refDoi"> DOI: 10.1111/j.1742-1241.2008.01885.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=10.1111%2Fj.1742-1241.2008.01885.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=18795968" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=1%3ACAS%3A280%3ADC%252BD1M%252FntVGhtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2008&pages=1753-1768&author=V.+I.+Reusauthor=B.+J.+Smith&title=Multimodal+techniques+for+smoking+cessation%3A+A+review+of+their+efficacy+and+utilisation+and+clinical+practice+guidelines&doi=10.1111%2Fj.1742-1241.2008.01885.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Multimodal techniques for smoking cessation: a review of their efficacy and utilisation and clinical practice guidelines</span></div><div class="casAuthors">Reus V I; Smith B J</div><div class="citationInfo"><span class="NLM_cas:title">International journal of clinical practice</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1753-68</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">AIMS:  Nicotine addiction is a complex, chronic condition with physiological and psychological/behavioural aspects that make smoking cessation extremely difficult.  This paper reviews current recommendations for smoking cessation and the efficacy of pharmacotherapy and behavioural modification techniques, used either alone or in combination, for smoking cessation.  RESULTS:  Abstinence rates for pharmacotherapies range from approximately 16% to approximately 30% at 1-year follow-up, with efficacy odds ratios (ORs) compared with placebo of approximately 1.7 for nicotine replacement therapy (NRT), approximately 1.9 for bupropion sustained release and approximately 3.0 for varenicline.  Behaviour modification therapies have achieved quit rates of between 8% and 43% for up to 1 year, with ORs in comparison to no treatment of between approximately 1.2 and approximately 2.2.  No direct comparisons have been made between pharmacotherapy alone and psychological behaviour strategies alone.  However, combining physiological approaches with counselling significantly increases the odds of quitting compared with either technique alone.  CONCLUSIONS:  Applying multimodal techniques for the treatment of nicotine addiction is the recommended approach and has demonstrated the potential to improve rates of permanent abstinence in smokers attempting cessation.  While the numbers of patients receiving help and advice regarding smoking cessation is increasing, the multimodal approach appears to be currently underutilised by clinicians and therefore smoking cessation strategies are not being optimised.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSwDF94IoprsbBItaL1WaVAfW6udTcc2eaFdU62EvWk0rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M%252FntVGhtg%253D%253D&md5=9427fa7892026767fe8f78b45494e2a8</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1111%2Fj.1742-1241.2008.01885.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1742-1241.2008.01885.x%26sid%3Dliteratum%253Aachs%26aulast%3DReus%26aufirst%3DV.%2BI.%26aulast%3DSmith%26aufirst%3DB.%2BJ.%26atitle%3DMultimodal%2520techniques%2520for%2520smoking%2520cessation%253A%2520A%2520review%2520of%2520their%2520efficacy%2520and%2520utilisation%2520and%2520clinical%2520practice%2520guidelines%26jtitle%3DInt.%2520J.%2520Clin.%2520Pract.%26date%3D2008%26volume%3D62%26spage%3D1753%26epage%3D1768%26doi%3D10.1111%2Fj.1742-1241.2008.01885.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Rigotti, N. A.</span><span> </span><span class="NLM_article-title">Clinical practice. Treatment of tobacco use and dependence</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">346</span><span class="NLM_x">, </span> <span class="NLM_fpage">506</span><span class="NLM_x">–</span> <span class="NLM_lpage">512</span><span class="refDoi"> DOI: 10.1056/NEJMcp012279</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=10.1056%2FNEJMcp012279" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=11844853" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=1%3ACAS%3A280%3ADC%252BD387ht1Oltg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=346&publication_year=2002&pages=506-512&author=N.+A.+Rigotti&title=Clinical+practice.+Treatment+of+tobacco+use+and+dependence&doi=10.1056%2FNEJMcp012279"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical practice. Treatment of tobacco use and dependence</span></div><div class="casAuthors">Rigotti Nancy A</div><div class="citationInfo"><span class="NLM_cas:title">The New England journal of medicine</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">346</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">506-12</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQShDhmCcUbGo2y4bB4mnvYfW6udTcc2eaxhD9CLu67G7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD387ht1Oltg%253D%253D&md5=a126dfdfcaa18f5b4bcce1b043c1befe</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1056%2FNEJMcp012279&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMcp012279%26sid%3Dliteratum%253Aachs%26aulast%3DRigotti%26aufirst%3DN.%2BA.%26atitle%3DClinical%2520practice.%2520Treatment%2520of%2520tobacco%2520use%2520and%2520dependence%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2002%26volume%3D346%26spage%3D506%26epage%3D512%26doi%3D10.1056%2FNEJMcp012279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Moore, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furberg, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glenmullen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maltsberger, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, S.</span><span> </span><span class="NLM_article-title">Suicidal behavior and depression in smoking cessation treatments</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">e27016</span><span class="refDoi"> DOI: 10.1371/journal.pone.0027016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=10.1371%2Fjournal.pone.0027016" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=e27016&author=T.+J.+Mooreauthor=C.+D.+Furbergauthor=J.+Glenmullenauthor=J.+T.+Maltsbergerauthor=S.+Singh&title=Suicidal+behavior+and+depression+in+smoking+cessation+treatments&doi=10.1371%2Fjournal.pone.0027016"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0027016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0027016%26sid%3Dliteratum%253Aachs%26aulast%3DMoore%26aufirst%3DT.%2BJ.%26aulast%3DFurberg%26aufirst%3DC.%2BD.%26aulast%3DGlenmullen%26aufirst%3DJ.%26aulast%3DMaltsberger%26aufirst%3DJ.%2BT.%26aulast%3DSingh%26aufirst%3DS.%26atitle%3DSuicidal%2520behavior%2520and%2520depression%2520in%2520smoking%2520cessation%2520treatments%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26spage%3De27016%26doi%3D10.1371%2Fjournal.pone.0027016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Picciotto, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rimondini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lena, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marubio, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pich, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuxe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Changeux, J. P.</span><span> </span><span class="NLM_article-title">Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">391</span><span class="NLM_x">, </span> <span class="NLM_fpage">173</span><span class="NLM_x">–</span> <span class="NLM_lpage">177</span><span class="refDoi"> DOI: 10.1038/34413</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=10.1038%2F34413" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=391&publication_year=1998&pages=173-177&author=M.+R.+Picciottoauthor=M.+Zoliauthor=R.+Rimondiniauthor=C.+Lenaauthor=L.+M.+Marubioauthor=E.+M.+Pichauthor=K.+Fuxeauthor=J.+P.+Changeux&title=Acetylcholine+receptors+containing+the+beta2+subunit+are+involved+in+the+reinforcing+properties+of+nicotine&doi=10.1038%2F34413"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2F34413&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F34413%26sid%3Dliteratum%253Aachs%26aulast%3DPicciotto%26aufirst%3DM.%2BR.%26aulast%3DZoli%26aufirst%3DM.%26aulast%3DRimondini%26aufirst%3DR.%26aulast%3DLena%26aufirst%3DC.%26aulast%3DMarubio%26aufirst%3DL.%2BM.%26aulast%3DPich%26aufirst%3DE.%2BM.%26aulast%3DFuxe%26aufirst%3DK.%26aulast%3DChangeux%26aufirst%3DJ.%2BP.%26atitle%3DAcetylcholine%2520receptors%2520containing%2520the%2520beta2%2520subunit%2520are%2520involved%2520in%2520the%2520reinforcing%2520properties%2520of%2520nicotine%26jtitle%3DNature%26date%3D1998%26volume%3D391%26spage%3D173%26epage%3D177%26doi%3D10.1038%2F34413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Stolerman, I. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoaib, M.</span><span> </span><span class="NLM_article-title">The neurobiology of tobacco addiction</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">467</span><span class="NLM_x">–</span> <span class="NLM_lpage">473</span><span class="refDoi"> DOI: 10.1016/0165-6147(91)90638-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=10.1016%2F0165-6147%2891%2990638-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1991&pages=467-473&author=I.+P.+Stolermanauthor=M.+Shoaib&title=The+neurobiology+of+tobacco+addiction&doi=10.1016%2F0165-6147%2891%2990638-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2F0165-6147%2891%2990638-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0165-6147%252891%252990638-9%26sid%3Dliteratum%253Aachs%26aulast%3DStolerman%26aufirst%3DI.%2BP.%26aulast%3DShoaib%26aufirst%3DM.%26atitle%3DThe%2520neurobiology%2520of%2520tobacco%2520addiction%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D1991%26volume%3D12%26spage%3D467%26epage%3D473%26doi%3D10.1016%2F0165-6147%2891%2990638-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Perry, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gold, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntosh, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pezzullo, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kellar, K. J.</span><span> </span><span class="NLM_article-title">Chronic nicotine differentially regulates alpha6- and beta3-containing nicotinic cholinergic receptors in rat brain</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">322</span><span class="NLM_x">, </span> <span class="NLM_fpage">306</span><span class="NLM_x">–</span> <span class="NLM_lpage">315</span><span class="refDoi"> DOI: 10.1124/jpet.107.121228</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=10.1124%2Fjpet.107.121228" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=17446303" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=1%3ACAS%3A528%3ADC%252BD2sXntl2jtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=322&publication_year=2007&pages=306-315&author=D.+C.+Perryauthor=D.+Maoauthor=A.+B.+Goldauthor=J.+M.+McIntoshauthor=J.+C.+Pezzulloauthor=K.+J.+Kellar&title=Chronic+nicotine+differentially+regulates+alpha6-+and+beta3-containing+nicotinic+cholinergic+receptors+in+rat+brain&doi=10.1124%2Fjpet.107.121228"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Chronic nicotine differentially regulates α6- and β3-containing nicotinic cholinergic receptors in rat brain</span></div><div class="casAuthors">Perry, David C.; Mao, Danyan; Gold, Allison B.; McIntosh, J. Michael; Pezzullo, John C.; Kellar, Kenneth J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">322</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">306-315</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The authors investigated the effects of chronic nicotine on α6- and β3-contg. nicotinic acetylcholine receptors (nAChRs) in 2 rat brain regions using 3 methodol. approaches: radioligand binding, immunopptn., and nicotine-stimulated synaptosomal release of dopamine.  Nicotine was administered by osmotic minipumps for 2 wk.  Quant. autoradiog. with [125I]α-conotoxin MII to selectively label α6* nAChRs showed a 28% decrease in binding in the striatum but no change in the superior colliculus.  Immunopptn. of nAChRs labeled by [3H]epibatidine in these 2 regions showed that chronic nicotine increased α4- and β2-contg. nAChRs by 39 to 67%.  In contrast, chronic nicotine caused a 39% decrease in α6-contg. nAChRs in the striatum but no change in the superior colliculus.  No changes in β3-contg. nAChRs were seen in either region after chronic nicotine.  The decreased expression of α6-contg. nAChRs persisted for at least 3 days, recovering to baseline by 7 days after removal of the pumps.  There was a small but significant decrease in total nicotine-stimulated dopamine release in striatal synaptosomes after nicotine exposure.  However, the component of dopamine release that was resistant to α-conotoxin MII blockade was unaffected, whereas dopamine release that was sensitive to blockade by α-conotoxin MII was decreased by 56%.  Apparently, the α6* nAChR is regulated differently from other nAChR subtypes, and the inclusion of a β3 subunit with α6 may serve to inhibit nicotine-induced down-regulation of these receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpf3ZipLqKbBbVg90H21EOLACvtfcHk0livzH-ukeAKkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXntl2jtLY%253D&md5=4c5bcca04504d53d03749e58f9ddbb76</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1124%2Fjpet.107.121228&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.107.121228%26sid%3Dliteratum%253Aachs%26aulast%3DPerry%26aufirst%3DD.%2BC.%26aulast%3DMao%26aufirst%3DD.%26aulast%3DGold%26aufirst%3DA.%2BB.%26aulast%3DMcIntosh%26aufirst%3DJ.%2BM.%26aulast%3DPezzullo%26aufirst%3DJ.%2BC.%26aulast%3DKellar%26aufirst%3DK.%2BJ.%26atitle%3DChronic%2520nicotine%2520differentially%2520regulates%2520alpha6-%2520and%2520beta3-containing%2520nicotinic%2520cholinergic%2520receptors%2520in%2520rat%2520brain%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2007%26volume%3D322%26spage%3D306%26epage%3D315%26doi%3D10.1124%2Fjpet.107.121228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Perry, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, H. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Musachio, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davila-Garcia, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kellar, K. J.</span><span> </span><span class="NLM_article-title">Measuring nicotinic receptors with characteristics of alpha4beta2, alpha3beta2 and alpha3beta4 subtypes in rat tissues by autoradiography</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">468</span><span class="NLM_x">–</span> <span class="NLM_lpage">481</span><span class="refDoi"> DOI: 10.1046/j.1471-4159.2002.00951.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=10.1046%2Fj.1471-4159.2002.00951.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=12153472" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=1%3ACAS%3A528%3ADC%252BD38Xmt1ejs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2002&pages=468-481&author=D.+C.+Perryauthor=Y.+Xiaoauthor=H.+N.+Nguyenauthor=J.+L.+Musachioauthor=M.+I.+Davila-Garciaauthor=K.+J.+Kellar&title=Measuring+nicotinic+receptors+with+characteristics+of+alpha4beta2%2C+alpha3beta2+and+alpha3beta4+subtypes+in+rat+tissues+by+autoradiography&doi=10.1046%2Fj.1471-4159.2002.00951.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Measuring nicotinic receptors with characteristics of α4β2, α3β2 and α3β4 subtypes in rat tissues by autoradiography</span></div><div class="casAuthors">Perry, David C.; Xiao, Yingxian; Nguyen, Henry N.; Musachio, John L.; Davila-Garcia, Martha I.; Kellar, Kenneth J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">468-481</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">Comparison of [125I]epibatidine and [125I]A-85380 autoradiog. showed evidence for nicotinic receptor heterogeneity.  To identify the receptor subtypes, we performed [125I]epibatidine autoradiog. in the presence of cytisine or A-85380.  By comparing these results with binding data from human embryonic kidney (HEK) 293 cells stably transfected with different combinations of rat nicotinic receptor subunits, we were able to quantify three distinct populations of [125I]epibatidine binding sites with characteristics of α4β2, α3β2 and α3β4 receptors.  Although the predominant subtype in rat brain was α4β2, non-α4β2 binding sites were prominent in many regions.  In the habenulo-peduncular system, cerebellum, substantia gelatinosa, and many medullary nuclei, α3β4-like binding accounted for more than 40% of [125I]epibatidine binding, and nearly all binding in superior cervical ganglion and pineal gland.  Other regions enriched in α3β4-like binding included locus ceruleus, dorsal tegmentum, subiculum and anteroventral thalamic nucleus.  Regions enriched in α3β2-like binding included the habenulo-peduncular system, many visual system structures, certain geniculate nuclei, and dopaminergic regions.  The combination of autoradiog. using a broad spectrum radioligand in the presence of selective competitors, and data from binding to defined receptor subtypes in expression systems, allowed us to quantify the relative populations of these three subtypes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovDTZ1PG0SkbVg90H21EOLACvtfcHk0lgDGyjrej319Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xmt1ejs7s%253D&md5=d8ab0027dff45775f4f70b27ad3d0911</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.2002.00951.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.2002.00951.x%26sid%3Dliteratum%253Aachs%26aulast%3DPerry%26aufirst%3DD.%2BC.%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DNguyen%26aufirst%3DH.%2BN.%26aulast%3DMusachio%26aufirst%3DJ.%2BL.%26aulast%3DDavila-Garcia%26aufirst%3DM.%2BI.%26aulast%3DKellar%26aufirst%3DK.%2BJ.%26atitle%3DMeasuring%2520nicotinic%2520receptors%2520with%2520characteristics%2520of%2520alpha4beta2%252C%2520alpha3beta2%2520and%2520alpha3beta4%2520subtypes%2520in%2520rat%2520tissues%2520by%2520autoradiography%26jtitle%3DJ.%2520Neurochem.%26date%3D2002%26volume%3D82%26spage%3D468%26epage%3D481%26doi%3D10.1046%2Fj.1471-4159.2002.00951.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Epping-Jordan, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picciotto, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Changeux, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pich, E. M.</span><span> </span><span class="NLM_article-title">Assessment of nicotinic acetylcholine receptor subunit contributions to nicotine self-administration in mutant mice</span> <span class="citation_source-journal">Psychopharmacology (Berl)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">147</span><span class="NLM_x">, </span> <span class="NLM_fpage">25</span><span class="NLM_x">–</span> <span class="NLM_lpage">26</span><span class="refDoi"> DOI: 10.1007/s002130051135</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=10.1007%2Fs002130051135" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=10591862" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=1%3ACAS%3A528%3ADC%252BD3cXpslOjsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=147&publication_year=1999&pages=25-26&author=M.+P.+Epping-Jordanauthor=M.+R.+Picciottoauthor=J.+P.+Changeuxauthor=E.+M.+Pich&title=Assessment+of+nicotinic+acetylcholine+receptor+subunit+contributions+to+nicotine+self-administration+in+mutant+mice&doi=10.1007%2Fs002130051135"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Assessment of nicotinic acetylcholine receptor subunit contributions to nicotine self-administration in mutant mice</span></div><div class="casAuthors">Epping-Jordan, Mark P.; Picciotto, Marina R.; Changeux, Jean-Pierre; Pich, Emilio Merlo</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Berlin)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">147</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">25-26</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">Genetic deletion of neuronal nicotine acetylcholine receptors (nAChrs) combined with mouse i.v. self-administration has provided a powerful approach for understanding the neuropharmacol. substrates of nicotine reinforcement.  Because nAChr mutant mice lack responsiveness to nicotine, a substitution procedure was employed.  Mice were first trained to self-administer cocaine until this behavior was stable.  Nicotine was then substituted for cocaine to det. if nicotine could maintain self-administration in wild type (WT) and mutant (Mut) mice.  A sep. group of WT mice received saline substituted for cocaine to demonstrate extinction of self-administration in a relevant control group.  This procedure allowed the detn. if contribution of β2-contg. nAChrs is specific to nicotine reinforcement or if these receptors play a more general role in operant learning or reinforcement.  A significant role for β2-contg. nAChrs in nicotine self-administration was demonstrated using a nicotine substitution self-administration procedure.  Further, the role of β2-contg. nAChrs appears to be specific to nicotine reinforcement because β2 Mut mice acquired a cocaine-reinforced discriminated operant response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeMGT1n2GIi7Vg90H21EOLACvtfcHk0lgDGyjrej319Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXpslOjsg%253D%253D&md5=d5c58b33da2c363ed2e1ff4c51726140</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1007%2Fs002130051135&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs002130051135%26sid%3Dliteratum%253Aachs%26aulast%3DEpping-Jordan%26aufirst%3DM.%2BP.%26aulast%3DPicciotto%26aufirst%3DM.%2BR.%26aulast%3DChangeux%26aufirst%3DJ.%2BP.%26aulast%3DPich%26aufirst%3DE.%2BM.%26atitle%3DAssessment%2520of%2520nicotinic%2520acetylcholine%2520receptor%2520subunit%2520contributions%2520to%2520nicotine%2520self-administration%2520in%2520mutant%2520mice%26jtitle%3DPsychopharmacology%2520%2528Berl%2529%26date%3D1999%26volume%3D147%26spage%3D25%26epage%3D26%26doi%3D10.1007%2Fs002130051135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Tobey, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walentiny, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiley, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damaj, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azar, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koob, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">George, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vann, R. E.</span><span> </span><span class="NLM_article-title">Effects of the specific alpha4beta2 nachr antagonist, 2-fluoro-3-(4-nitrophenyl) deschloroepibatidine, on nicotine reward-related behaviors in rats and mice</span> <span class="citation_source-journal">Psychopharmacology (Berl)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">223</span><span class="NLM_x">, </span> <span class="NLM_fpage">159</span><span class="NLM_x">–</span> <span class="NLM_lpage">168</span><span class="refDoi"> DOI: 10.1007/s00213-012-2703-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=10.1007%2Fs00213-012-2703-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=22526534" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=1%3ACAS%3A280%3ADC%252BC38rnsVygsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=223&publication_year=2012&pages=159-168&author=K.+M.+Tobeyauthor=D.+M.+Walentinyauthor=J.+L.+Wileyauthor=F.+I.+Carrollauthor=M.+I.+Damajauthor=M.+R.+Azarauthor=G.+F.+Koobauthor=O.+Georgeauthor=L.+S.+Harrisauthor=R.+E.+Vann&title=Effects+of+the+specific+alpha4beta2+nachr+antagonist%2C+2-fluoro-3-%284-nitrophenyl%29+deschloroepibatidine%2C+on+nicotine+reward-related+behaviors+in+rats+and+mice&doi=10.1007%2Fs00213-012-2703-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of the specific α4β2 nAChR antagonist, 2-fluoro-3-(4-nitrophenyl) deschloroepibatidine, on nicotine reward-related behaviors in rats and mice</span></div><div class="casAuthors">Tobey K M; Walentiny D M; Wiley J L; Carroll F I; Damaj M I; Azar M R; Koob G F; George O; Harris L S; Vann R E</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">223</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">159-68</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">RATIONALE:  Alleviating addiction to tobacco products could prevent millions of deaths.  Investigating novel compounds selectively targeting α4β2 nAChRs hypothesized to have a key role in the rewarding effects of nicotine may be a useful approach for future treatment.  OBJECTIVES:  The present study was designed to evaluate 2-fluoro-3-(4-nitrophenyl) deschloroepibatidine (4-nitro-PFEB), a potent competitive antagonist of neuronal α4β2 nAChRs, in several animal models related to nicotine reward: drug discrimination, intracranial self-stimulation (ICSS), conditioned place preference, and limited access to self-administration.  METHODS:  Long Evans rats were trained in a two-lever discrimination procedure to discriminate 0.4 mg/kg nicotine (s.c.) from saline.  Male Sprague-Dawley rats were stereotaxically implanted with electrodes and trained to respond for direct electrical stimulation of the medial forebrain bundle.  ICR mice were evaluated using an unbiased place preference paradigm, and finally, male Wistar rats were implanted with intrajugular catheters and tested for nicotine self-administration under limited access (1 h/day).  RESULTS:  4-Nitro-PFEB attenuated the discriminative stimulus effects of nicotine, but alone did not produce nicotine-like discriminative stimulus effects.  Nicotine-induced facilitation of ICSS reward thresholds was reversed by 4-nitro-PFEB, which alone had no effect on thresholds. 4-Nitro-PFEB also blocked the conditioned place preference produced by nicotine, but alone had no effect on conditioned place preference.  Finally, 4-nitro-PFEB dose-dependently decreased nicotine self-administration.  CONCLUSIONS:  These results support the hypothesis that neuronal α4β2 nAChRs play a key role in mediating the rewarding effects of nicotine and further suggest that targeting α4β2 nAChRs may yield a potential candidate for the treatment of nicotine dependence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR1DbbUUbK00yEJCPKhJPuqfW6udTcc2eZnWhGtVV9Sxrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38rnsVygsQ%253D%253D&md5=aef646d06eebc0f193974a9758607da1</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1007%2Fs00213-012-2703-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-012-2703-3%26sid%3Dliteratum%253Aachs%26aulast%3DTobey%26aufirst%3DK.%2BM.%26aulast%3DWalentiny%26aufirst%3DD.%2BM.%26aulast%3DWiley%26aufirst%3DJ.%2BL.%26aulast%3DCarroll%26aufirst%3DF.%2BI.%26aulast%3DDamaj%26aufirst%3DM.%2BI.%26aulast%3DAzar%26aufirst%3DM.%2BR.%26aulast%3DKoob%26aufirst%3DG.%2BF.%26aulast%3DGeorge%26aufirst%3DO.%26aulast%3DHarris%26aufirst%3DL.%2BS.%26aulast%3DVann%26aufirst%3DR.%2BE.%26atitle%3DEffects%2520of%2520the%2520specific%2520alpha4beta2%2520nachr%2520antagonist%252C%25202-fluoro-3-%25284-nitrophenyl%2529%2520deschloroepibatidine%252C%2520on%2520nicotine%2520reward-related%2520behaviors%2520in%2520rats%2520and%2520mice%26jtitle%3DPsychopharmacology%2520%2528Berl%2529%26date%3D2012%26volume%3D223%26spage%3D159%26epage%3D168%26doi%3D10.1007%2Fs00213-012-2703-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Watkins, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Epping-Jordan, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koob, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markou, A.</span><span> </span><span class="NLM_article-title">Blockade of nicotine self-administration with nicotinic antagonists in rats</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">743</span><span class="NLM_x">–</span> <span class="NLM_lpage">751</span><span class="refDoi"> DOI: 10.1016/S0091-3057(98)00226-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=10.1016%2FS0091-3057%2898%2900226-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=10208381" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=1%3ACAS%3A528%3ADyaK1MXitVCgsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=1999&pages=743-751&author=S.+S.+Watkinsauthor=M.+P.+Epping-Jordanauthor=G.+F.+Koobauthor=A.+Markou&title=Blockade+of+nicotine+self-administration+with+nicotinic+antagonists+in+rats&doi=10.1016%2FS0091-3057%2898%2900226-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Blockade of nicotine self-administration with nicotinic antagonists in rats</span></div><div class="casAuthors">Watkins, Shelly S.; Epping-Jordan, Mark P.; Koob, George F.; Markou, Athina</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology, Biochemistry and Behavior</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">743-751</span>CODEN:
                <span class="NLM_cas:coden">PBBHAU</span>;
        ISSN:<span class="NLM_cas:issn">0091-3057</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">The reinforcing properties of a variety of drugs abused by humans have been investigated using the technique of i.v. self-administration in the rat.  To examine the effect of nicotine dose on nicotine self-administration.  Wistar rats were allowed to self-administer various doses of nicotine using a within-subjects Latin square design.  An inverted U-shaped dose-response curve was obtained, with the highest rates of responding at the 0.03 mg/kg/inf dose.  With 1-h daily nicotine self-administration sessions, rats did not appear dependent on nicotine 24 h later, as indicated by the absence of somatic signs of withdrawal after s.c. injection of a nicotinic acetylcholine receptor antagonist, mecamylamine (0.57 mg/kg).  In another set of studies, pretreatment with s.c. mecamylamine or dihydro-β-erythroidine, two nicotinic acetylcholine receptor antagonists, resulted in significant dose-dependent redns. in nicotine self-administration, at two nicotine doses (0.03 and 0.06 mg/kg/inf).  These results indicate that nicotine is an effective reinforcer in Wistar rats under the present parameters, and that these reinforcing effects are mediated by activation of nicotinic acetylcholine receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5IH2IsK3dy7Vg90H21EOLACvtfcHk0lgDGyjrej319Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXitVCgsLw%253D&md5=9210da30662bc26091400fa9a4397303</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2FS0091-3057%2898%2900226-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0091-3057%252898%252900226-3%26sid%3Dliteratum%253Aachs%26aulast%3DWatkins%26aufirst%3DS.%2BS.%26aulast%3DEpping-Jordan%26aufirst%3DM.%2BP.%26aulast%3DKoob%26aufirst%3DG.%2BF.%26aulast%3DMarkou%26aufirst%3DA.%26atitle%3DBlockade%2520of%2520nicotine%2520self-administration%2520with%2520nicotinic%2520antagonists%2520in%2520rats%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D1999%26volume%3D62%26spage%3D743%26epage%3D751%26doi%3D10.1016%2FS0091-3057%2898%2900226-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Fowler, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marks, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenny, P. J.</span><span> </span><span class="NLM_article-title">Habenular α5 nicotinic receptor subunit signalling controls nicotine intake</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">471</span><span class="NLM_x">, </span> <span class="NLM_fpage">597</span><span class="NLM_x">–</span> <span class="NLM_lpage">601</span><span class="refDoi"> DOI: 10.1038/nature09797</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=10.1038%2Fnature09797" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=471&publication_year=2011&pages=597-601&author=C.+D.+Fowlerauthor=Q.+Luauthor=P.+M.+Johnsonauthor=M.+J.+Marksauthor=P.+J.+Kenny&title=Habenular+%CE%B15+nicotinic+receptor+subunit+signalling+controls+nicotine+intake&doi=10.1038%2Fnature09797"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fnature09797&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature09797%26sid%3Dliteratum%253Aachs%26aulast%3DFowler%26aufirst%3DC.%2BD.%26aulast%3DLu%26aufirst%3DQ.%26aulast%3DJohnson%26aufirst%3DP.%2BM.%26aulast%3DMarks%26aufirst%3DM.%2BJ.%26aulast%3DKenny%26aufirst%3DP.%2BJ.%26atitle%3DHabenular%2520%25CE%25B15%2520nicotinic%2520receptor%2520subunit%2520signalling%2520controls%2520nicotine%2520intake%26jtitle%3DNature%26date%3D2011%26volume%3D471%26spage%3D597%26epage%3D601%26doi%3D10.1038%2Fnature09797" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Frahm, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slimak, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrarese, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santos-Torres, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antolin-Fontes, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filkin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pons, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fontaine, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsetlin, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maskos, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ibanez-Tallon, I.</span><span> </span><span class="NLM_article-title">Aversion to nicotine is regulated by the balanced activity of beta4 and alpha5 nicotinic receptor subunits in the medial habenula</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">522</span><span class="NLM_x">–</span> <span class="NLM_lpage">535</span><span class="refDoi"> DOI: 10.1016/j.neuron.2011.04.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=10.1016%2Fj.neuron.2011.04.013" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2011&pages=522-535&author=S.+Frahmauthor=M.+A.+Slimakauthor=L.+Ferrareseauthor=J.+Santos-Torresauthor=B.+Antolin-Fontesauthor=S.+Auerauthor=S.+Filkinauthor=S.+Ponsauthor=J.+F.+Fontaineauthor=V.+Tsetlinauthor=U.+Maskosauthor=I.+Ibanez-Tallon&title=Aversion+to+nicotine+is+regulated+by+the+balanced+activity+of+beta4+and+alpha5+nicotinic+receptor+subunits+in+the+medial+habenula&doi=10.1016%2Fj.neuron.2011.04.013"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2011.04.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2011.04.013%26sid%3Dliteratum%253Aachs%26aulast%3DFrahm%26aufirst%3DS.%26aulast%3DSlimak%26aufirst%3DM.%2BA.%26aulast%3DFerrarese%26aufirst%3DL.%26aulast%3DSantos-Torres%26aufirst%3DJ.%26aulast%3DAntolin-Fontes%26aufirst%3DB.%26aulast%3DAuer%26aufirst%3DS.%26aulast%3DFilkin%26aufirst%3DS.%26aulast%3DPons%26aufirst%3DS.%26aulast%3DFontaine%26aufirst%3DJ.%2BF.%26aulast%3DTsetlin%26aufirst%3DV.%26aulast%3DMaskos%26aufirst%3DU.%26aulast%3DIbanez-Tallon%26aufirst%3DI.%26atitle%3DAversion%2520to%2520nicotine%2520is%2520regulated%2520by%2520the%2520balanced%2520activity%2520of%2520beta4%2520and%2520alpha5%2520nicotinic%2520receptor%2520subunits%2520in%2520the%2520medial%2520habenula%26jtitle%3DNeuron%26date%3D2011%26volume%3D70%26spage%3D522%26epage%3D535%26doi%3D10.1016%2Fj.neuron.2011.04.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Harrington, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vinals, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrera-Solis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flores, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faure, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maldonado, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maskos, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robledo, P.</span><span> </span><span class="NLM_article-title">Role of beta4* nicotinic acetylcholine receptors in the habenulo-interpeduncular pathway in nicotine reinforcement in mice</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">1790</span><span class="NLM_x">–</span> <span class="NLM_lpage">1802</span><span class="refDoi"> DOI: 10.1038/npp.2015.346</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=10.1038%2Fnpp.2015.346" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2016&pages=1790-1802&author=L.+Harringtonauthor=X.+Vinalsauthor=A.+Herrera-Solisauthor=A.+Floresauthor=C.+Morelauthor=S.+Toluauthor=P.+Faureauthor=R.+Maldonadoauthor=U.+Maskosauthor=P.+Robledo&title=Role+of+beta4*+nicotinic+acetylcholine+receptors+in+the+habenulo-interpeduncular+pathway+in+nicotine+reinforcement+in+mice&doi=10.1038%2Fnpp.2015.346"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2015.346&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2015.346%26sid%3Dliteratum%253Aachs%26aulast%3DHarrington%26aufirst%3DL.%26aulast%3DVinals%26aufirst%3DX.%26aulast%3DHerrera-Solis%26aufirst%3DA.%26aulast%3DFlores%26aufirst%3DA.%26aulast%3DMorel%26aufirst%3DC.%26aulast%3DTolu%26aufirst%3DS.%26aulast%3DFaure%26aufirst%3DP.%26aulast%3DMaldonado%26aufirst%3DR.%26aulast%3DMaskos%26aufirst%3DU.%26aulast%3DRobledo%26aufirst%3DP.%26atitle%3DRole%2520of%2520beta4%252A%2520nicotinic%2520acetylcholine%2520receptors%2520in%2520the%2520habenulo-interpeduncular%2520pathway%2520in%2520nicotine%2520reinforcement%2520in%2520mice%26jtitle%3DNeuropsychopharmacology%26date%3D2016%26volume%3D41%26spage%3D1790%26epage%3D1802%26doi%3D10.1038%2Fnpp.2015.346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Morel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fattore, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pons, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hay, Y. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambolez, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Biasi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lathrop, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fratta, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maskos, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faure, P.</span><span> </span><span class="NLM_article-title">Nicotine consumption is regulated by a human polymorphism in dopamine neurons</span> <span class="citation_source-journal">Mol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">930</span><span class="NLM_x">–</span> <span class="NLM_lpage">936</span><span class="refDoi"> DOI: 10.1038/mp.2013.158</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=10.1038%2Fmp.2013.158" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=24296975" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFent7nL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2014&pages=930-936&author=C.+Morelauthor=L.+Fattoreauthor=S.+Ponsauthor=Y.+A.+Hayauthor=F.+Martiauthor=B.+Lambolezauthor=M.+De+Biasiauthor=M.+Lathropauthor=W.+Frattaauthor=U.+Maskosauthor=P.+Faure&title=Nicotine+consumption+is+regulated+by+a+human+polymorphism+in+dopamine+neurons&doi=10.1038%2Fmp.2013.158"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Nicotine consumption is regulated by a human polymorphism in dopamine neurons</span></div><div class="casAuthors">Morel, C.; Fattore, L.; Pons, S.; Hay, Y. A.; Marti, F.; Lambolez, B.; De Biasi, M.; Lathrop, M.; Fratta, W.; Maskos, U.; Faure, P.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Psychiatry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">930-936</span>CODEN:
                <span class="NLM_cas:coden">MOPSFQ</span>;
        ISSN:<span class="NLM_cas:issn">1359-4184</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Smoking is the most important preventable cause of morbidity and mortality worldwide.  Recent genome-wide assocn. studies highlighted a human haplotype on chromosome 15 underlying the risk for tobacco dependence and lung cancer.  Several polymorphisms in the CHRNA3-CHRNA5-CHRNB4 cluster coding for the nicotinic acetylcholine receptor (nAChR) α3, α5 and β4 subunits were implicated.  In mouse models, we define a key role in the control of sensitivity to nicotine for the α5 subunit in dopaminergic (DAergic) neurons of the ventral tegmental area (VTA).  We first investigated the reinforcing effects of nicotine in drug-naive α5-/- mice using an acute i.v. nicotine self-administration task and ex vivo and in vivo electrophysiol. recordings of nicotine-elicited DA cell activation.  We designed lentiviral re-expression vectors to achieve targeted re-expression of wild-type or mutant α5 in the VTA, in general, or in DA neurons exclusively.  Our results establish a crucial role for α5*-nAChRs in DAergic neurons.  These receptors are key regulators that det. the min. nicotine dose necessary for DA cell activation and thus nicotine reinforcement.  Finally, we demonstrate that a single-nucleotide polymorphism, the non-synonymous α5 variant rs16969968, frequent in many human populations, exhibits a partial loss of function of the protein in vivo.  This leads to increased nicotine consumption in the self-administration paradigm.  We thus define a crit. link between a human predisposition marker, its expression in DA neurons and nicotine intake.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0HXYJq7vF07Vg90H21EOLACvtfcHk0lgSDhhSOZLzHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFent7nL&md5=24748cfd2d7781cf2eeb5685d015af51</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fmp.2013.158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fmp.2013.158%26sid%3Dliteratum%253Aachs%26aulast%3DMorel%26aufirst%3DC.%26aulast%3DFattore%26aufirst%3DL.%26aulast%3DPons%26aufirst%3DS.%26aulast%3DHay%26aufirst%3DY.%2BA.%26aulast%3DMarti%26aufirst%3DF.%26aulast%3DLambolez%26aufirst%3DB.%26aulast%3DDe%2BBiasi%26aufirst%3DM.%26aulast%3DLathrop%26aufirst%3DM.%26aulast%3DFratta%26aufirst%3DW.%26aulast%3DMaskos%26aufirst%3DU.%26aulast%3DFaure%26aufirst%3DP.%26atitle%3DNicotine%2520consumption%2520is%2520regulated%2520by%2520a%2520human%2520polymorphism%2520in%2520dopamine%2520neurons%26jtitle%3DMol.%2520Psychiatry%26date%3D2014%26volume%3D19%26spage%3D930%26epage%3D936%26doi%3D10.1038%2Fmp.2013.158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Houghten, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinilla, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giulianotti, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Appel, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dooley, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nefzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ostresh, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maggiora, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medina-Franco, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunner, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, J.</span><span> </span><span class="NLM_article-title">Strategies for the use of mixture-based synthetic combinatorial libraries: Scaffold ranking, direct testing in vivo, and enhanced deconvolution by computational methods</span> <span class="citation_source-journal">J. Comb. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">19</span><span class="refDoi"> DOI: 10.1021/cc7001205</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cc7001205" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVWgurfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2008&pages=3-19&author=R.+A.+Houghtenauthor=C.+Pinillaauthor=M.+A.+Giulianottiauthor=J.+R.+Appelauthor=C.+T.+Dooleyauthor=A.+Nefziauthor=J.+M.+Ostreshauthor=Y.+Yuauthor=G.+M.+Maggioraauthor=J.+L.+Medina-Francoauthor=D.+Brunnerauthor=J.+Schneider&title=Strategies+for+the+use+of+mixture-based+synthetic+combinatorial+libraries%3A+Scaffold+ranking%2C+direct+testing+in+vivo%2C+and+enhanced+deconvolution+by+computational+methods&doi=10.1021%2Fcc7001205"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Strategies for the Use of Mixture-Based Synthetic Combinatorial Libraries: Scaffold Ranking, Direct Testing In Vivo, and Enhanced Deconvolution by Computational Methods</span></div><div class="casAuthors">Houghten, Richard A.; Pinilla, Clemencia; Giulianotti, Marc A.; Appel, Jon R.; Dooley, Colette T.; Nefzi, Adel; Ostresh, John M.; Yu, Yongping; Maggiora, Gerald M.; Medina-Franco, Jose L.; Brunner, Daniela; Schneider, Jeff</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Combinatorial Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-19</span>CODEN:
                <span class="NLM_cas:coden">JCCHFF</span>;
        ISSN:<span class="NLM_cas:issn">1520-4766</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHw0Bw1Gl2KLVg90H21EOLACvtfcHk0lgKkKvvQiMK1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVWgurfK&md5=9693c04842ee3232043fd2d8a5dabd44</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fcc7001205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcc7001205%26sid%3Dliteratum%253Aachs%26aulast%3DHoughten%26aufirst%3DR.%2BA.%26aulast%3DPinilla%26aufirst%3DC.%26aulast%3DGiulianotti%26aufirst%3DM.%2BA.%26aulast%3DAppel%26aufirst%3DJ.%2BR.%26aulast%3DDooley%26aufirst%3DC.%2BT.%26aulast%3DNefzi%26aufirst%3DA.%26aulast%3DOstresh%26aufirst%3DJ.%2BM.%26aulast%3DYu%26aufirst%3DY.%26aulast%3DMaggiora%26aufirst%3DG.%2BM.%26aulast%3DMedina-Franco%26aufirst%3DJ.%2BL.%26aulast%3DBrunner%26aufirst%3DD.%26aulast%3DSchneider%26aufirst%3DJ.%26atitle%3DStrategies%2520for%2520the%2520use%2520of%2520mixture-based%2520synthetic%2520combinatorial%2520libraries%253A%2520Scaffold%2520ranking%252C%2520direct%2520testing%2520in%2520vivo%252C%2520and%2520enhanced%2520deconvolution%2520by%2520computational%2520methods%26jtitle%3DJ.%2520Comb.%2520Chem.%26date%3D2008%26volume%3D10%26spage%3D3%26epage%3D19%26doi%3D10.1021%2Fcc7001205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Lopez-Vallejo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giulianotti, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houghten, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medina-Franco, J. L.</span><span> </span><span class="NLM_article-title">Expanding the medicinally relevant chemical space with compound libraries</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">718</span><span class="NLM_x">–</span> <span class="NLM_lpage">726</span><span class="refDoi"> DOI: 10.1016/j.drudis.2012.04.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=10.1016%2Fj.drudis.2012.04.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=22515962" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=1%3ACAS%3A528%3ADC%252BC38XmtFektL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2012&pages=718-726&author=F.+Lopez-Vallejoauthor=M.+A.+Giulianottiauthor=R.+A.+Houghtenauthor=J.+L.+Medina-Franco&title=Expanding+the+medicinally+relevant+chemical+space+with+compound+libraries&doi=10.1016%2Fj.drudis.2012.04.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Expanding the medicinally relevant chemical space with compound libraries</span></div><div class="casAuthors">Lopez-Vallejo, Fabian; Giulianotti, Marc A.; Houghten, Richard A.; Medina-Franco, Jose L.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">13-14</span>),
    <span class="NLM_cas:pages">718-726</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Anal. of marketed drugs and com. vendor libraries used in high-throughput screening suggests that the medicinally relevant chem. space may be expanded to unexplored regions.  Novel regions of the chem. space can be conveniently explored with structurally unique mols. with increased complexity and balanced physicochem. properties.  As a case study, we discuss the chemoinformatic profile of natural products in the Traditional Chinese Medicine (TCM) database and a large collection assembled from 30 small-mol. combinatorial libraries with emphasis on assessing mol. complexity.  The herein surveyed combinatorial libraries have been successfully used over the past 20 years to identify novel bioactive compds. across different therapeutic areas.  Combinatorial libraries and natural products are suitable sources to expand the traditional relevant medicinal chem. space.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhT55nczC7sbVg90H21EOLACvtfcHk0lgKkKvvQiMK1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmtFektL0%253D&md5=e47776f21c5f0154c37094db030b2b9a</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2012.04.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2012.04.001%26sid%3Dliteratum%253Aachs%26aulast%3DLopez-Vallejo%26aufirst%3DF.%26aulast%3DGiulianotti%26aufirst%3DM.%2BA.%26aulast%3DHoughten%26aufirst%3DR.%2BA.%26aulast%3DMedina-Franco%26aufirst%3DJ.%2BL.%26atitle%3DExpanding%2520the%2520medicinally%2520relevant%2520chemical%2520space%2520with%2520compound%2520libraries%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2012%26volume%3D17%26spage%3D718%26epage%3D726%26doi%3D10.1016%2Fj.drudis.2012.04.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Wu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maida, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santos, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welmaker, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaVoi, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nefzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houghten, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toll, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giulianotti, M. A.</span><span> </span><span class="NLM_article-title">Scaffold ranking and positional scanning utilized in the discovery of nachr-selective compounds suitable for optimization studies</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">10103</span><span class="NLM_x">–</span> <span class="NLM_lpage">10117</span><span class="refDoi"> DOI: 10.1021/jm401543h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401543h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=10103-10117&author=J.+Wuauthor=Y.+Zhangauthor=L.+E.+Maidaauthor=R.+G.+Santosauthor=G.+S.+Welmakerauthor=T.+M.+LaVoiauthor=A.+Nefziauthor=Y.+Yuauthor=R.+A.+Houghtenauthor=L.+Tollauthor=M.+A.+Giulianotti&title=Scaffold+ranking+and+positional+scanning+utilized+in+the+discovery+of+nachr-selective+compounds+suitable+for+optimization+studies&doi=10.1021%2Fjm401543h"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm401543h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401543h%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DMaida%26aufirst%3DL.%2BE.%26aulast%3DSantos%26aufirst%3DR.%2BG.%26aulast%3DWelmaker%26aufirst%3DG.%2BS.%26aulast%3DLaVoi%26aufirst%3DT.%2BM.%26aulast%3DNefzi%26aufirst%3DA.%26aulast%3DYu%26aufirst%3DY.%26aulast%3DHoughten%26aufirst%3DR.%2BA.%26aulast%3DToll%26aufirst%3DL.%26aulast%3DGiulianotti%26aufirst%3DM.%2BA.%26atitle%3DScaffold%2520ranking%2520and%2520positional%2520scanning%2520utilized%2520in%2520the%2520discovery%2520of%2520nachr-selective%2520compounds%2520suitable%2520for%2520optimization%2520studies%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D10103%26epage%3D10117%26doi%3D10.1021%2Fjm401543h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Pajouhesh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenz, G. R.</span><span> </span><span class="NLM_article-title">Medicinal chemical properties of successful central nervous system drugs</span> <span class="citation_source-journal">NeuroRx</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">541</span><span class="NLM_x">–</span> <span class="NLM_lpage">553</span><span class="refDoi"> DOI: 10.1602/neurorx.2.4.541</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=10.1602%2Fneurorx.2.4.541" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=16489364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=1%3ACAS%3A280%3ADC%252BD28%252FpvVKqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2005&pages=541-553&author=H.+Pajouheshauthor=G.+R.+Lenz&title=Medicinal+chemical+properties+of+successful+central+nervous+system+drugs&doi=10.1602%2Fneurorx.2.4.541"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal chemical properties of successful central nervous system drugs</span></div><div class="casAuthors">Pajouhesh Hassan; Lenz George R</div><div class="citationInfo"><span class="NLM_cas:title">NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">541-53</span>
        ISSN:<span class="NLM_cas:issn">1545-5343</span>.
    </div><div class="casAbstract">Fundamental physiochemical features of CNS drugs are related to their ability to penetrate the blood-brain barrier affinity and exhibit CNS activity.  Factors relevant to the success of CNS drugs are reviewed.  CNS drugs show values of molecular weight, lipophilicity, and hydrogen bond donor and acceptor that in general have a smaller range than general therapeutics.  Pharmacokinetic properties can be manipulated by the medicinal chemist to a significant extent.  The solubility, permeability, metabolic stability, protein binding, and human ether-ago-go-related gene inhibition of CNS compounds need to be optimized simultaneously with potency, selectivity, and other biological parameters.  The balance between optimizing the physiochemical and pharmacokinetic properties to make the best compromises in properties is critical for designing new drugs likely to penetrate the blood brain barrier and affect relevant biological systems.  This review is intended as a guide to designing CNS therapeutic agents with better drug-like properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT_ncsy3yuEinl8icjszYl0fW6udTcc2eZRlRXItx3xtbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28%252FpvVKqsg%253D%253D&md5=0815084e2d107b9243b785d0782dfc3a</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1602%2Fneurorx.2.4.541&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1602%252Fneurorx.2.4.541%26sid%3Dliteratum%253Aachs%26aulast%3DPajouhesh%26aufirst%3DH.%26aulast%3DLenz%26aufirst%3DG.%2BR.%26atitle%3DMedicinal%2520chemical%2520properties%2520of%2520successful%2520central%2520nervous%2520system%2520drugs%26jtitle%3DNeuroRx%26date%3D2005%26volume%3D2%26spage%3D541%26epage%3D553%26doi%3D10.1602%2Fneurorx.2.4.541" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Carroll, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ware, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brieaddy, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navarro, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damaj, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, B. R.</span><span> </span><span class="NLM_article-title">Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 2′-fluoro-3′-(substituted phenyl)deschloroepibatidine analogues. Novel nicotinic antagonist</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">4588</span><span class="NLM_x">–</span> <span class="NLM_lpage">4594</span><span class="refDoi"> DOI: 10.1021/jm040078g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm040078g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=4588-4594&author=F.+I.+Carrollauthor=R.+Wareauthor=L.+E.+Brieaddyauthor=H.+A.+Navarroauthor=M.+I.+Damajauthor=B.+R.+Martin&title=Synthesis%2C+nicotinic+acetylcholine+receptor+binding%2C+and+antinociceptive+properties+of+2%E2%80%B2-fluoro-3%E2%80%B2-%28substituted+phenyl%29deschloroepibatidine+analogues.+Novel+nicotinic+antagonist&doi=10.1021%2Fjm040078g"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm040078g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm040078g%26sid%3Dliteratum%253Aachs%26aulast%3DCarroll%26aufirst%3DF.%2BI.%26aulast%3DWare%26aufirst%3DR.%26aulast%3DBrieaddy%26aufirst%3DL.%2BE.%26aulast%3DNavarro%26aufirst%3DH.%2BA.%26aulast%3DDamaj%26aufirst%3DM.%2BI.%26aulast%3DMartin%26aufirst%3DB.%2BR.%26atitle%3DSynthesis%252C%2520nicotinic%2520acetylcholine%2520receptor%2520binding%252C%2520and%2520antinociceptive%2520properties%2520of%25202%25E2%2580%25B2-fluoro-3%25E2%2580%25B2-%2528substituted%2520phenyl%2529deschloroepibatidine%2520analogues.%2520Novel%2520nicotinic%2520antagonist%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D4588%26epage%3D4594%26doi%3D10.1021%2Fjm040078g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Mihalak, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luetje, C. W.</span><span> </span><span class="NLM_article-title">Varenicline is a partial agonist at alpha4beta2 and a full agonist at alpha7 neuronal nicotinic receptors</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">801</span><span class="NLM_x">–</span> <span class="NLM_lpage">805</span><span class="refDoi"> DOI: 10.1124/mol.106.025130</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=10.1124%2Fmol.106.025130" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2006&pages=801-805&author=K.+B.+Mihalakauthor=F.+I.+Carrollauthor=C.+W.+Luetje&title=Varenicline+is+a+partial+agonist+at+alpha4beta2+and+a+full+agonist+at+alpha7+neuronal+nicotinic+receptors&doi=10.1124%2Fmol.106.025130"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1124%2Fmol.106.025130&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.106.025130%26sid%3Dliteratum%253Aachs%26aulast%3DMihalak%26aufirst%3DK.%2BB.%26aulast%3DCarroll%26aufirst%3DF.%2BI.%26aulast%3DLuetje%26aufirst%3DC.%2BW.%26atitle%3DVarenicline%2520is%2520a%2520partial%2520agonist%2520at%2520alpha4beta2%2520and%2520a%2520full%2520agonist%2520at%2520alpha7%2520neuronal%2520nicotinic%2520receptors%26jtitle%3DMol.%2520Pharmacol.%26date%3D2006%26volume%3D70%26spage%3D801%26epage%3D805%26doi%3D10.1124%2Fmol.106.025130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Chatterjee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steensland, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simms, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holgate, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coe, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurst, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaffer, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rollema, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartlett, S. E.</span><span> </span><span class="NLM_article-title">Partial agonists of the alpha3beta4* neuronal nicotinic acetylcholine receptor reduce ethanol consumption and seeking in rats</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">603</span><span class="NLM_x">–</span> <span class="NLM_lpage">615</span><span class="refDoi"> DOI: 10.1038/npp.2010.191</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=10.1038%2Fnpp.2010.191" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2011&pages=603-615&author=S.+Chatterjeeauthor=P.+Steenslandauthor=J.+A.+Simmsauthor=J.+Holgateauthor=J.+W.+Coeauthor=R.+S.+Hurstauthor=C.+L.+Shafferauthor=J.+Loweauthor=H.+Rollemaauthor=S.+E.+Bartlett&title=Partial+agonists+of+the+alpha3beta4*+neuronal+nicotinic+acetylcholine+receptor+reduce+ethanol+consumption+and+seeking+in+rats&doi=10.1038%2Fnpp.2010.191"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2010.191&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2010.191%26sid%3Dliteratum%253Aachs%26aulast%3DChatterjee%26aufirst%3DS.%26aulast%3DSteensland%26aufirst%3DP.%26aulast%3DSimms%26aufirst%3DJ.%2BA.%26aulast%3DHolgate%26aufirst%3DJ.%26aulast%3DCoe%26aufirst%3DJ.%2BW.%26aulast%3DHurst%26aufirst%3DR.%2BS.%26aulast%3DShaffer%26aufirst%3DC.%2BL.%26aulast%3DLowe%26aufirst%3DJ.%26aulast%3DRollema%26aufirst%3DH.%26aulast%3DBartlett%26aufirst%3DS.%2BE.%26atitle%3DPartial%2520agonists%2520of%2520the%2520alpha3beta4%252A%2520neuronal%2520nicotinic%2520acetylcholine%2520receptor%2520reduce%2520ethanol%2520consumption%2520and%2520seeking%2520in%2520rats%26jtitle%3DNeuropsychopharmacology%26date%3D2011%26volume%3D36%26spage%3D603%26epage%3D615%26doi%3D10.1038%2Fnpp.2010.191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Cippitelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaiolini, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercatelli, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoch, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramirez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciccocioppo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khroyan, T. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasuda, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaveri, N. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pascual, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, X. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toll, L.</span><span> </span><span class="NLM_article-title">At-1001: A high-affinity alpha3beta4 nachr ligand with novel nicotine-suppressive pharmacology</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">172</span><span class="NLM_x">, </span> <span class="NLM_fpage">1834</span><span class="NLM_x">–</span> <span class="NLM_lpage">1845</span><span class="refDoi"> DOI: 10.1111/bph.13034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=10.1111%2Fbph.13034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=25440006" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlslemt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=172&publication_year=2015&pages=1834-1845&author=A.+Cippitelliauthor=J.+Wuauthor=K.+A.+Gaioliniauthor=D.+Mercatelliauthor=J.+Schochauthor=M.+Gormanauthor=A.+Ramirezauthor=R.+Ciccocioppoauthor=T.+V.+Khroyanauthor=D.+Yasudaauthor=N.+T.+Zaveriauthor=C.+Pascualauthor=X.+S.+Xieauthor=L.+Toll&title=At-1001%3A+A+high-affinity+alpha3beta4+nachr+ligand+with+novel+nicotine-suppressive+pharmacology&doi=10.1111%2Fbph.13034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">AT-1001: a high-affinity α3β4 nAChR ligand with novel nicotine-suppressive pharmacology</span></div><div class="casAuthors">Cippitelli, Andrea; Wu, Jinhua; Gaiolini, Kelly A.; Mercatelli, Daniela; Schoch, Jennifer; Gorman, Michelle; Ramirez, Alejandra; Ciccocioppo, Roberto; Khroyan, Taline V.; Yasuda, Dennis; Zaveri, Nurulain T.; Pascual, Conrado; Xie, Xinmin; Toll, Lawrence</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">172</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1834-1845</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose : The α3β4 subtype of nicotinic acetylcholine receptors (nAChRs) has been implicated in mediating nicotine reinforcement processes.  AT-1001 has been recently described as a high-affinity and selective α3β4 nAChR antagonist that blocks nicotine self-administration in rats.  The aim of this study was to investigate the mechanism of action underlying the nicotine-suppressive effects of AT-1001.  Exptl. Approach : Effects of AT-1001 were detd. using in vitro assays and rat models of nicotine addiction, and compared with varenicline.  Key Results : AT-1001 and its analog AT-1012 were functionally selective as antagonists for α3β4 over α4β2 nAChRs, but not to the same extent as the binding selectivity, and had partial agonist activity at α3β4 nAChRs.  In contrast, varenicline was a partial agonist at α4β2, a weak agonist at α3β4 and inhibited α4β2 at a much lower concn. than it inhibited α3β4 nAChRs.  AT-1001 and varenicline also had very different in vivo properties.  Firstly, AT-1001 did not exhibit reinforcing properties per se while varenicline was self-administered.  Secondly, systemic treatment with AT-1001 did not induce reinstatement of nicotine seeking but rather attenuated reinstatement induced by varenicline, as well as nicotine.  Finally, unlike varenicline, AT-1001 selectively blocked nicotine self-administration without altering alc. lever pressing as assessed in an operant co-administration paradigm.  Conclusions and Implications : These findings describe a more complex AT-1001 in vitro profile than previously appreciated and provide further support for the potential of AT-1001 and congeners as clin. useful compds. for smoking cessation, with a mechanism of action distinct from currently available medications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIvmIl3YNpC7Vg90H21EOLACvtfcHk0lhjclTrybbIJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlslemt7s%253D&md5=297041f4f7d470f729ff233fca6ea89d</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1111%2Fbph.13034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.13034%26sid%3Dliteratum%253Aachs%26aulast%3DCippitelli%26aufirst%3DA.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DGaiolini%26aufirst%3DK.%2BA.%26aulast%3DMercatelli%26aufirst%3DD.%26aulast%3DSchoch%26aufirst%3DJ.%26aulast%3DGorman%26aufirst%3DM.%26aulast%3DRamirez%26aufirst%3DA.%26aulast%3DCiccocioppo%26aufirst%3DR.%26aulast%3DKhroyan%26aufirst%3DT.%2BV.%26aulast%3DYasuda%26aufirst%3DD.%26aulast%3DZaveri%26aufirst%3DN.%2BT.%26aulast%3DPascual%26aufirst%3DC.%26aulast%3DXie%26aufirst%3DX.%2BS.%26aulast%3DToll%26aufirst%3DL.%26atitle%3DAt-1001%253A%2520A%2520high-affinity%2520alpha3beta4%2520nachr%2520ligand%2520with%2520novel%2520nicotine-suppressive%2520pharmacology%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2015%26volume%3D172%26spage%3D1834%26epage%3D1845%26doi%3D10.1111%2Fbph.13034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Rollema, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chambers, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coe, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glowa, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurst, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebel, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansbach, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mather, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rovetti, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sands, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaeffer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulz, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tingley, F. D.,  3rd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, K. E.</span><span> </span><span class="NLM_article-title">Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">985</span><span class="NLM_x">–</span> <span class="NLM_lpage">994</span><span class="refDoi"> DOI: 10.1016/j.neuropharm.2006.10.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=10.1016%2Fj.neuropharm.2006.10.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=17157884" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhvVyqtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2007&pages=985-994&author=H.+Rollemaauthor=L.+K.+Chambersauthor=J.+W.+Coeauthor=J.+Glowaauthor=R.+S.+Hurstauthor=L.+A.+Lebelauthor=Y.+Luauthor=R.+S.+Mansbachauthor=R.+J.+Matherauthor=C.+C.+Rovettiauthor=S.+B.+Sandsauthor=E.+Schaefferauthor=D.+W.+Schulzauthor=F.+D.+Tingleyauthor=K.+E.+Williams&title=Pharmacological+profile+of+the+alpha4beta2+nicotinic+acetylcholine+receptor+partial+agonist+varenicline%2C+an+effective+smoking+cessation+aid&doi=10.1016%2Fj.neuropharm.2006.10.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological profile of the α4β2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid</span></div><div class="casAuthors">Rollema, H.; Chambers, L. K.; Coe, J. W.; Glowa, J.; Hurst, R. S.; Lebel, L. A.; Lu, Y.; Mansbach, R. S.; Mather, R. J.; Rovetti, C. C.; Sands, S. B.; Schaeffer, E.; Schulz, D. W.; Tingley, F. D.; Williams, K. E.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">985-994</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The preclin. pharmacol. of the α4β2 nicotinic acetylcholine receptor (nAChR) partial agonist varenicline, a novel smoking cessation agent is described.  Varenicline binds with subnanomolar affinity only to α4β2 nAChRs and in vitro functional patch clamp studies in HEK cells expressing nAChRs show that varenicline is a partial agonist with 45% of nicotine's maximal efficacy at α4β2 nAChRs.  In neurochem. models varenicline has significantly lower (40-60%) efficacy than nicotine in stimulating [3H]-dopamine release from rat brain slices in vitro and in increasing dopamine release from rat nucleus accumbens in vivo, while it is more potent than nicotine.  In addn., when combined with nicotine, varenicline effectively attenuates the nicotine-induced dopamine release to the level of the effect of varenicline alone, consistent with partial agonism.  Finally, varenicline reduces nicotine self-administration in rats and supports lower self-administration break points than nicotine.  These data suggest that varenicline can reproduce to some extent the subjective effects of smoking by partially activating α4β2 nAChRs, while preventing full activation of these receptors by nicotine.  Based on these findings, varenicline was advanced into clin. development and recently shown to be an effective and safe aid for smoking cessation treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgBqovXuf1ALVg90H21EOLACvtfcHk0lj3bHRvbEaqng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhvVyqtbw%253D&md5=11199806966b56bd3f075a4a902fe206</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2006.10.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2006.10.016%26sid%3Dliteratum%253Aachs%26aulast%3DRollema%26aufirst%3DH.%26aulast%3DChambers%26aufirst%3DL.%2BK.%26aulast%3DCoe%26aufirst%3DJ.%2BW.%26aulast%3DGlowa%26aufirst%3DJ.%26aulast%3DHurst%26aufirst%3DR.%2BS.%26aulast%3DLebel%26aufirst%3DL.%2BA.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DMansbach%26aufirst%3DR.%2BS.%26aulast%3DMather%26aufirst%3DR.%2BJ.%26aulast%3DRovetti%26aufirst%3DC.%2BC.%26aulast%3DSands%26aufirst%3DS.%2BB.%26aulast%3DSchaeffer%26aufirst%3DE.%26aulast%3DSchulz%26aufirst%3DD.%2BW.%26aulast%3DTingley%26aufirst%3DF.%2BD.%26aulast%3DWilliams%26aufirst%3DK.%2BE.%26atitle%3DPharmacological%2520profile%2520of%2520the%2520alpha4beta2%2520nicotinic%2520acetylcholine%2520receptor%2520partial%2520agonist%2520varenicline%252C%2520an%2520effective%2520smoking%2520cessation%2520aid%26jtitle%3DNeuropharmacology%26date%3D2007%26volume%3D52%26spage%3D985%26epage%3D994%26doi%3D10.1016%2Fj.neuropharm.2006.10.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Rollema, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coe, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chambers, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurst, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahl, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, K. E.</span><span> </span><span class="NLM_article-title">Rationale, pharmacology and clinical efficacy of partial agonists of alpha4beta2 nach receptors for smoking cessation</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">316</span><span class="NLM_x">–</span> <span class="NLM_lpage">325</span><span class="refDoi"> DOI: 10.1016/j.tips.2007.05.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=10.1016%2Fj.tips.2007.05.003" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2007&pages=316-325&author=H.+Rollemaauthor=J.+W.+Coeauthor=L.+K.+Chambersauthor=R.+S.+Hurstauthor=S.+M.+Stahlauthor=K.+E.+Williams&title=Rationale%2C+pharmacology+and+clinical+efficacy+of+partial+agonists+of+alpha4beta2+nach+receptors+for+smoking+cessation&doi=10.1016%2Fj.tips.2007.05.003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2007.05.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2007.05.003%26sid%3Dliteratum%253Aachs%26aulast%3DRollema%26aufirst%3DH.%26aulast%3DCoe%26aufirst%3DJ.%2BW.%26aulast%3DChambers%26aufirst%3DL.%2BK.%26aulast%3DHurst%26aufirst%3DR.%2BS.%26aulast%3DStahl%26aufirst%3DS.%2BM.%26aulast%3DWilliams%26aufirst%3DK.%2BE.%26atitle%3DRationale%252C%2520pharmacology%2520and%2520clinical%2520efficacy%2520of%2520partial%2520agonists%2520of%2520alpha4beta2%2520nach%2520receptors%2520for%2520smoking%2520cessation%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2007%26volume%3D28%26spage%3D316%26epage%3D325%26doi%3D10.1016%2Fj.tips.2007.05.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Chatterjee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartlett, S. E.</span><span> </span><span class="NLM_article-title">Neuronal nicotinic acetylcholine receptors as pharmacotherapeutic targets for the treatment of alcohol use disorders</span> <span class="citation_source-journal">CNS Neurol. Disord.: Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">60</span><span class="NLM_x">–</span> <span class="NLM_lpage">76</span><span class="refDoi"> DOI: 10.2174/187152710790966597</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=10.2174%2F187152710790966597" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=20201817" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjtFajs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=60-76&author=S.+Chatterjeeauthor=S.+E.+Bartlett&title=Neuronal+nicotinic+acetylcholine+receptors+as+pharmacotherapeutic+targets+for+the+treatment+of+alcohol+use+disorders&doi=10.2174%2F187152710790966597"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Neuronal nicotinic acetylcholine receptors as pharmacotherapeutic targets for the treatment of alcohol use disorders</span></div><div class="casAuthors">Chatterjee, S.; Bartlett, S. E.</div><div class="citationInfo"><span class="NLM_cas:title">CNS & Neurological Disorders: Drug Targets</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">60-76</span>CODEN:
                <span class="NLM_cas:coden">CNDDA3</span>;
        ISSN:<span class="NLM_cas:issn">1871-5273</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Alc. use disorders (AUDs) are complex and developing effective treatments will require the combination of novel medications and cognitive behavioral therapy approaches.  Epidemiol. studies have shown there is a high correlation between alc. consumption and tobacco use, and the prevalence of smoking in alcoholics is as high as 80% compared to about 30% for the general population.  Both preclin. and clin. data provide evidence that nicotine administration increases alc. intake and non-specific nicotinic receptor antagonists reduce alc.-mediated behaviors.  As nicotine interacts specifically with the neuronal nicotinic acetylcholine receptor (nAChR) system, this suggests that nAChRs play an important role in the behavioral effects of alc.  In this review, we discuss the importance of nAChRs for the treatment of AUDs and argue that the use of FDA approved nAChR ligands, such as varenicline and mecamylamine, approved as smoking cessation aids may prove to be valuable treatments for AUDs.  We also address the importance of combining effective medications with behavioral therapy for the treatment of alc. dependent individuals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFWEmF5pdybLVg90H21EOLACvtfcHk0lj3bHRvbEaqng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjtFajs7Y%253D&md5=925276eab7f62759eb225cc0cea31862</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.2174%2F187152710790966597&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187152710790966597%26sid%3Dliteratum%253Aachs%26aulast%3DChatterjee%26aufirst%3DS.%26aulast%3DBartlett%26aufirst%3DS.%2BE.%26atitle%3DNeuronal%2520nicotinic%2520acetylcholine%2520receptors%2520as%2520pharmacotherapeutic%2520targets%2520for%2520the%2520treatment%2520of%2520alcohol%2520use%2520disorders%26jtitle%3DCNS%2520Neurol.%2520Disord.%253A%2520Drug%2520Targets%26date%3D2010%26volume%3D9%26spage%3D60%26epage%3D76%26doi%3D10.2174%2F187152710790966597" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Cippitelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunori, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaiolini, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaveri, N. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toll, L.</span><span> </span><span class="NLM_article-title">Pharmacological stress is required for the anti-alcohol effect of the alpha3beta4* nachr partial agonist at-1001</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">229</span><span class="NLM_x">–</span> <span class="NLM_lpage">236</span><span class="refDoi"> DOI: 10.1016/j.neuropharm.2015.02.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=10.1016%2Fj.neuropharm.2015.02.005" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=2015&pages=229-236&author=A.+Cippitelliauthor=G.+Brunoriauthor=K.+A.+Gaioliniauthor=N.+T.+Zaveriauthor=L.+Toll&title=Pharmacological+stress+is+required+for+the+anti-alcohol+effect+of+the+alpha3beta4*+nachr+partial+agonist+at-1001&doi=10.1016%2Fj.neuropharm.2015.02.005"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2015.02.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2015.02.005%26sid%3Dliteratum%253Aachs%26aulast%3DCippitelli%26aufirst%3DA.%26aulast%3DBrunori%26aufirst%3DG.%26aulast%3DGaiolini%26aufirst%3DK.%2BA.%26aulast%3DZaveri%26aufirst%3DN.%2BT.%26aulast%3DToll%26aufirst%3DL.%26atitle%3DPharmacological%2520stress%2520is%2520required%2520for%2520the%2520anti-alcohol%2520effect%2520of%2520the%2520alpha3beta4%252A%2520nachr%2520partial%2520agonist%2520at-1001%26jtitle%3DNeuropharmacology%26date%3D2015%26volume%3D93%26spage%3D229%26epage%3D236%26doi%3D10.1016%2Fj.neuropharm.2015.02.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Hendrickson, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao-Shea, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tapper, A. R.</span><span> </span><span class="NLM_article-title">Activation of alpha4* nachrs is necessary and sufficient for varenicline-induced reduction of alcohol consumption</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">10169</span><span class="NLM_x">–</span> <span class="NLM_lpage">10176</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.2601-10.2010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=10.1523%2FJNEUROSCI.2601-10.2010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=20668200" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVahsr%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2010&pages=10169-10176&author=L.+M.+Hendricksonauthor=R.+Zhao-Sheaauthor=X.+Pangauthor=P.+D.+Gardnerauthor=A.+R.+Tapper&title=Activation+of+alpha4*+nachrs+is+necessary+and+sufficient+for+varenicline-induced+reduction+of+alcohol+consumption&doi=10.1523%2FJNEUROSCI.2601-10.2010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of α4* nAChRs is necessary and sufficient for varenicline-induced reduction of alcohol consumption</span></div><div class="casAuthors">Hendrickson, Linzy M.; Zhao-Shea, Rubing; Pang, Xueyan; Gardner, Paul D.; Tapper, Andrew R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">30</span>),
    <span class="NLM_cas:pages">10169-10176</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Recently, the smoking cessation therapeutic varenicline, a nicotinic acetylcholine receptor (nAChR) partial agonist, has been shown to reduce alc. consumption.  However, the mechanism and nAChR subtype(s) involved are unknown.  Here we demonstrate that varenicline and alc. exposure, either alone or in combination, selectively activates dopaminergic (DAergic) neurons within the posterior, but not the anterior, ventral tegmental area (VTA).  To gain insight into which nAChR subtypes may be involved in the response to alc., we analyzed nAChR subunit gene expression in posterior VTA DAergic neurons.  Ethanol-activated DAergic neurons expressed higher levels of α4, α6, and β3 subunit genes compared with nonactivated neurons.  To examine the role of nicotinic receptors contg. the α4 subunit (α4* nAChRs) in varenicline-induced redn. of alc. consumption, we examd. the effect of the drug in two complementary mouse models, a knock-out line that does not express the α4 subunit (α4 KO) and another line that expresses α4* nAChRs hypersensitive to agonist (Leu9'Ala).  While varenicline (0.1-0.3 mg/kg, i.p.) reduced 2% and 20% alc. consumption in wild-type (WT) mice, the drug did not significantly reduce consumption in α4 KO animals.  Conversely, low doses of varenicline (0.0125-0.05 mg/kg, i.p.) that had little effect in WT mice dramatically reduced ethanol intake in Leu9'Ala mice.  Infusion of varenicline into the posterior, but not the anterior VTA was sufficient to reduce alc. consumption.  Together, our data indicate that activation of α4* nAChRs is necessary and sufficient for varenicline redn. of alc. consumption.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNXAkKyyVu_7Vg90H21EOLACvtfcHk0lgOZ3x30QeFiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVahsr%252FF&md5=f0021f4460fa3d691a1b7f0fa6820988</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.2601-10.2010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.2601-10.2010%26sid%3Dliteratum%253Aachs%26aulast%3DHendrickson%26aufirst%3DL.%2BM.%26aulast%3DZhao-Shea%26aufirst%3DR.%26aulast%3DPang%26aufirst%3DX.%26aulast%3DGardner%26aufirst%3DP.%2BD.%26aulast%3DTapper%26aufirst%3DA.%2BR.%26atitle%3DActivation%2520of%2520alpha4%252A%2520nachrs%2520is%2520necessary%2520and%2520sufficient%2520for%2520varenicline-induced%2520reduction%2520of%2520alcohol%2520consumption%26jtitle%3DJ.%2520Neurosci.%26date%3D2010%26volume%3D30%26spage%3D10169%26epage%3D10176%26doi%3D10.1523%2FJNEUROSCI.2601-10.2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Ahmed, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ali, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kramers, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harmark, L. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burger, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoeven, W. M.</span><span> </span><span class="NLM_article-title">Neuropsychiatric adverse events of varenicline: A systematic review of published reports</span> <span class="citation_source-journal">J. Clin. Psychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">55</span><span class="NLM_x">–</span> <span class="NLM_lpage">62</span><span class="refDoi"> DOI: 10.1097/JCP.0b013e31827c0117</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=10.1097%2FJCP.0b013e31827c0117" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=23277249" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlt1ylug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2013&pages=55-62&author=A.+I.+Ahmedauthor=A.+N.+Aliauthor=C.+Kramersauthor=L.+V.+Harmarkauthor=D.+M.+Burgerauthor=W.+M.+Verhoeven&title=Neuropsychiatric+adverse+events+of+varenicline%3A+A+systematic+review+of+published+reports&doi=10.1097%2FJCP.0b013e31827c0117"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Neuropsychiatric Adverse Events of Varenicline: A Systematic Review of Published Reports</span></div><div class="casAuthors">Ahmed, Amir I. A.; Ali, Abdullah N. A.; Kramers, Cees; Haermark, Linda V. D.; Burger, David M.; Verhoeven, Willem M. A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Psychopharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">55-62</span>CODEN:
                <span class="NLM_cas:coden">JCPYDR</span>;
        ISSN:<span class="NLM_cas:issn">0271-0749</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">A review.  Introduction: Over the past years, the impact of varenicline in patients with mental illness has been debated as serious neuropsychiatric adverse events (AEs) have been reported with varenicline use.  Aim: To identify and summarize published case reports of neuropsychiatric AEs ascribed to varenicline and to det. potential risk factors for these AEs.  Methods: A literature search of MEDLINE, the Cochrane Library, EMBASE, and PsychInfo database was conducted for case reports concerning the neuropsychiatric AEs of varenicline published in English from 2006 (approval year by the US Food and Drug Administration and the Dutch Medicines Evaluation Board) to Jan. 1, 2012.  Results: We identified 25 published cases.  In most reports, patients had been admitted to psychiatric hospitals with serious neuropsychiatric AEs due to varenicline.  The av. patient age was 46.4 years, and 56% were men; 68% of patients had a psychiatric history.  The onset of symptoms started 2 days to 3 mo after the initiation of varenicline.  One report described completed suicide in a man with no psychiatric history.  In most cases (84%), the neuropsychiatric symptoms resolved after the discontinuation of varenicline.  Anal. of all reports using the Naranjo causality scale, a method for estg. the probability of adverse drug reactions, indicated probable causality in 76% of the cases and definite causality in 12% of cases.  Conclusion: Varenicline is assocd. with an increased risk of serious neuropsychiatric AEs, esp. in patients with a psychiatric illness.  It is strongly recommended that varenicline be administered only to mentally stable patients and under close monitoring.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHh53xQ6LVlLVg90H21EOLACvtfcHk0lgOZ3x30QeFiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlt1ylug%253D%253D&md5=c0a4e21bca894082a4e303d6a09947cd</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1097%2FJCP.0b013e31827c0117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FJCP.0b013e31827c0117%26sid%3Dliteratum%253Aachs%26aulast%3DAhmed%26aufirst%3DA.%2BI.%26aulast%3DAli%26aufirst%3DA.%2BN.%26aulast%3DKramers%26aufirst%3DC.%26aulast%3DHarmark%26aufirst%3DL.%2BV.%26aulast%3DBurger%26aufirst%3DD.%2BM.%26aulast%3DVerhoeven%26aufirst%3DW.%2BM.%26atitle%3DNeuropsychiatric%2520adverse%2520events%2520of%2520varenicline%253A%2520A%2520systematic%2520review%2520of%2520published%2520reports%26jtitle%3DJ.%2520Clin.%2520Psychopharmacol.%26date%3D2013%26volume%3D33%26spage%3D55%26epage%3D62%26doi%3D10.1097%2FJCP.0b013e31827c0117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Baker, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piper, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stein, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolt, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraser, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiore, M. C.</span><span> </span><span class="NLM_article-title">Effects of nicotine patch vs varenicline vs combination nicotine replacement therapy on smoking cessation at 26 weeks: A randomized clinical trial</span> <span class="citation_source-journal">JAMA</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">315</span><span class="NLM_x">, </span> <span class="NLM_fpage">371</span><span class="NLM_x">–</span> <span class="NLM_lpage">379</span><span class="refDoi"> DOI: 10.1001/jama.2015.19284</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=10.1001%2Fjama.2015.19284" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=315&publication_year=2016&pages=371-379&author=T.+B.+Bakerauthor=M.+E.+Piperauthor=J.+H.+Steinauthor=S.+S.+Smithauthor=D.+M.+Boltauthor=D.+L.+Fraserauthor=M.+C.+Fiore&title=Effects+of+nicotine+patch+vs+varenicline+vs+combination+nicotine+replacement+therapy+on+smoking+cessation+at+26+weeks%3A+A+randomized+clinical+trial&doi=10.1001%2Fjama.2015.19284"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1001%2Fjama.2015.19284&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Fjama.2015.19284%26sid%3Dliteratum%253Aachs%26aulast%3DBaker%26aufirst%3DT.%2BB.%26aulast%3DPiper%26aufirst%3DM.%2BE.%26aulast%3DStein%26aufirst%3DJ.%2BH.%26aulast%3DSmith%26aufirst%3DS.%2BS.%26aulast%3DBolt%26aufirst%3DD.%2BM.%26aulast%3DFraser%26aufirst%3DD.%2BL.%26aulast%3DFiore%26aufirst%3DM.%2BC.%26atitle%3DEffects%2520of%2520nicotine%2520patch%2520vs%2520varenicline%2520vs%2520combination%2520nicotine%2520replacement%2520therapy%2520on%2520smoking%2520cessation%2520at%252026%2520weeks%253A%2520A%2520randomized%2520clinical%2520trial%26jtitle%3DJAMA%26date%3D2016%26volume%3D315%26spage%3D371%26epage%3D379%26doi%3D10.1001%2Fjama.2015.19284" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Rasmussen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swedberg, M. D.</span><span> </span><span class="NLM_article-title">Reinforcing effects of nicotinic compounds: Intravenous self-administration in drug-naive mice</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">567</span><span class="NLM_x">–</span> <span class="NLM_lpage">573</span><span class="refDoi"> DOI: 10.1016/S0091-3057(98)00003-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=10.1016%2FS0091-3057%2898%2900003-3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=1998&pages=567-573&author=T.+Rasmussenauthor=M.+D.+Swedberg&title=Reinforcing+effects+of+nicotinic+compounds%3A+Intravenous+self-administration+in+drug-naive+mice&doi=10.1016%2FS0091-3057%2898%2900003-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2FS0091-3057%2898%2900003-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0091-3057%252898%252900003-3%26sid%3Dliteratum%253Aachs%26aulast%3DRasmussen%26aufirst%3DT.%26aulast%3DSwedberg%26aufirst%3DM.%2BD.%26atitle%3DReinforcing%2520effects%2520of%2520nicotinic%2520compounds%253A%2520Intravenous%2520self-administration%2520in%2520drug-naive%2520mice%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D1998%26volume%3D60%26spage%3D567%26epage%3D573%26doi%3D10.1016%2FS0091-3057%2898%2900003-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Cahill, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindson-Hawley, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fanshawe, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lancaster, T.</span><span> </span><span class="NLM_article-title">Nicotine receptor partial agonists for smoking cessation</span> <span class="citation_source-journal">Cochrane Database Syst. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_fpage">CD006103</span><span class="refDoi"> DOI: 10.1002/14651858.CD006103.pub7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=10.1002%2F14651858.CD006103.pub7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&pages=CD006103&author=K.+Cahillauthor=N.+Lindson-Hawleyauthor=K.+H.+Thomasauthor=T.+R.+Fanshaweauthor=T.+Lancaster&title=Nicotine+receptor+partial+agonists+for+smoking+cessation&doi=10.1002%2F14651858.CD006103.pub7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1002%2F14651858.CD006103.pub7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F14651858.CD006103.pub7%26sid%3Dliteratum%253Aachs%26aulast%3DCahill%26aufirst%3DK.%26aulast%3DLindson-Hawley%26aufirst%3DN.%26aulast%3DThomas%26aufirst%3DK.%2BH.%26aulast%3DFanshawe%26aufirst%3DT.%2BR.%26aulast%3DLancaster%26aufirst%3DT.%26atitle%3DNicotine%2520receptor%2520partial%2520agonists%2520for%2520smoking%2520cessation%26jtitle%3DCochrane%2520Database%2520Syst.%2520Rev.%26date%3D2016%26spage%3DCD006103%26doi%3D10.1002%2F14651858.CD006103.pub7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Levin, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rezvani, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slade, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cauley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hampton, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rose, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paige, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDowell, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kellar, K. J.</span><span> </span><span class="NLM_article-title">Sazetidine-a, a selective alpha4beta2 nicotinic receptor desensitizing agent and partial agonist, reduces nicotine self-administration in rats</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">332</span><span class="NLM_x">, </span> <span class="NLM_fpage">933</span><span class="NLM_x">–</span> <span class="NLM_lpage">939</span><span class="refDoi"> DOI: 10.1124/jpet.109.162073</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=10.1124%2Fjpet.109.162073" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=20007754" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=1%3ACAS%3A528%3ADC%252BC3cXivFCjs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=332&publication_year=2010&pages=933-939&author=E.+D.+Levinauthor=A.+H.+Rezvaniauthor=Y.+Xiaoauthor=S.+Sladeauthor=M.+Cauleyauthor=C.+Wellsauthor=D.+Hamptonauthor=A.+Petroauthor=J.+E.+Roseauthor=M.+L.+Brownauthor=M.+A.+Paigeauthor=B.+E.+McDowellauthor=K.+J.+Kellar&title=Sazetidine-a%2C+a+selective+alpha4beta2+nicotinic+receptor+desensitizing+agent+and+partial+agonist%2C+reduces+nicotine+self-administration+in+rats&doi=10.1124%2Fjpet.109.162073"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Sazetidine-A, a selective α4β2 nicotinic receptor desensitizing agent and partial agonist, reduces nicotine self-administration in rats</span></div><div class="casAuthors">Levin, Edward D.; Rezvani, Amir H.; Xiao, Yingxian; Slade, Susan; Cauley, Marty; Wells, Corinne; Hampton, Dawn; Petro, Ann; Rose, Jed E.; Brown, Milton L.; Paige, Mikell A.; McDowell, Brian E.; Kellar, Kenneth J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">332</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">933-939</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Adequate treatment of tobacco addiction remains problematic.  Part of the problem with treatment is a poor understanding of the pharmacol. aspects of nicotine contributing to addiction.  In addn. to activating nicotinic acetylcholine receptors, nicotine also desensitizes them.  It is currently not known how much of each of nicotine's actions contribute to its particular behavioral effects.  Sazetidine-A (saz-A) is a novel nicotinic receptor-desensitizing agent and partial agonist with high selectivity for α4β2 receptors.  The current expts. were conducted to det. whether saz-A would reduce nicotine self-administration in rats and to characterize its ancillary effects.  Adult male Sprague-Dawley rats were allowed to self-administer nicotine.  After initial food pellet training followed by 10 sessions of nicotine self-administration training, the rats were administered saz-A (0.1-3 mg/kg s.c.) or the saline vehicle in a repeated-measures counterbalanced design.  Saz-A at the 3 mg/kg dose significantly decreased nicotine self-administration relative to performance of the same rats after saline injections.  In a second study, long-term administration of this dose of sazetidine-A over the course of 10 sessions significantly reduced nicotine self-administration with no apparent diminution of effect.  Saz-A in this dose range had only modest effects on locomotor activity, without any overall decrease in activity over a 1-h-long session.  Saz-A significantly reduced food self-administration, but this effect was smaller than its effect on nicotine self-administration.  Saz-A, which is a selective α4β2-desensitizing agent and partial agonist, effectively reduces nicotine self-administration.  This type of treatment holds promise for a new therapy to aid smoking cessation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyXvn7dQpysLVg90H21EOLACvtfcHk0ljJneBiNFa5Kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXivFCjs7s%253D&md5=e6b4e73fc3c6373d3dbc6e249bb8a76c</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1124%2Fjpet.109.162073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.109.162073%26sid%3Dliteratum%253Aachs%26aulast%3DLevin%26aufirst%3DE.%2BD.%26aulast%3DRezvani%26aufirst%3DA.%2BH.%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DSlade%26aufirst%3DS.%26aulast%3DCauley%26aufirst%3DM.%26aulast%3DWells%26aufirst%3DC.%26aulast%3DHampton%26aufirst%3DD.%26aulast%3DPetro%26aufirst%3DA.%26aulast%3DRose%26aufirst%3DJ.%2BE.%26aulast%3DBrown%26aufirst%3DM.%2BL.%26aulast%3DPaige%26aufirst%3DM.%2BA.%26aulast%3DMcDowell%26aufirst%3DB.%2BE.%26aulast%3DKellar%26aufirst%3DK.%2BJ.%26atitle%3DSazetidine-a%252C%2520a%2520selective%2520alpha4beta2%2520nicotinic%2520receptor%2520desensitizing%2520agent%2520and%2520partial%2520agonist%252C%2520reduces%2520nicotine%2520self-administration%2520in%2520rats%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2010%26volume%3D332%26spage%3D933%26epage%3D939%26doi%3D10.1124%2Fjpet.109.162073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Rezvani, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slade, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lumeng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paige, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDowell, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rose, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kellar, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levin, E. D.</span><span> </span><span class="NLM_article-title">Effects of sazetidine-a, a selective alpha4beta2 nicotinic acetylcholine receptor desensitizing agent on alcohol and nicotine self-administration in selectively bred alcohol-preferring (p) rats</span> <span class="citation_source-journal">Psychopharmacology (Berl)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">211</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">174</span><span class="refDoi"> DOI: 10.1007/s00213-010-1878-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=10.1007%2Fs00213-010-1878-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=20535453" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=1%3ACAS%3A528%3ADC%252BC3cXntFGlsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=211&publication_year=2010&pages=161-174&author=A.+H.+Rezvaniauthor=S.+Sladeauthor=C.+Wellsauthor=A.+Petroauthor=L.+Lumengauthor=T.+K.+Liauthor=Y.+Xiaoauthor=M.+L.+Brownauthor=M.+A.+Paigeauthor=B.+E.+McDowellauthor=J.+E.+Roseauthor=K.+J.+Kellarauthor=E.+D.+Levin&title=Effects+of+sazetidine-a%2C+a+selective+alpha4beta2+nicotinic+acetylcholine+receptor+desensitizing+agent+on+alcohol+and+nicotine+self-administration+in+selectively+bred+alcohol-preferring+%28p%29+rats&doi=10.1007%2Fs00213-010-1878-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of sazetidine-A, a selective α4β2 nicotinic acetylcholine receptor desensitizing agent on alcohol and nicotine self-administration in selectively bred alcohol-preferring (P) rats</span></div><div class="casAuthors">Rezvani, Amir H.; Slade, Susan; Wells, Cori; Petro, Ann; Lumeng, Lawrence; Li, Ting-Kai; Xiao, Yingxian; Brown, Milton L.; Paige, Mikell A.; McDowell, Brian E.; Rose, Jed E.; Kellar, Kenneth J.; Levin, Edward D.</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Heidelberg, Germany)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">211</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">161-174</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Rationale: Manipulations of nicotinic cholinergic receptors have been shown to influence both alc. and nicotine intake.  Sazetidine-A [6-(5(((S)-azetidine-2-yl)methoxy)pyridine-3-yl)hex-5-yn-1-ol] is a novel compd. that potently and selectively desensitizes α4β2 nicotinic receptors with only modest receptor activation.  Objectives: The goal of the present study was to examine the effects of sazetidine-A on alc. and nicotine self-administration in alc.-preferring (P) rats.  Methods: P rats were given the choice of water or alc.  Once stable baselines were established, the acute (0, 0.1, 0.3, 1, and 3 mg/kg, s.c.) and chronic (3 mg/kg for 10 days) effects of sazetidine-A on alc. intake were assessed.  Naltrexone (2.5 mg/kg) served as a pos. control.  The effect of sazetidine-A (3 mg/kg) and naltrexone (4 mg/kg) on saccharin (0.2%) preference was also assessed.  In addn., the acute effects of sazetidine-A (3 mg/kg) and naltrexone (4 mg/kg) on alc. intake after alc. deprivation were evaluated.  In another expt., the effects of sazetidine-A (0, 1, or 3 mg/kg) on IV nicotine self-administration in P and NP rats were assessed.  Results: Sazetidine-A caused a dose-dependent redn. in alc. intake.  Chronic sazetidine-A also effectively reduced alc. intake until the seventh day of treatment, when partial tolerance appeared to develop.  In the post-deprivation study, sazetidine-A significantly reduced alc. intake and preference.  Sazetidine-A at 3 mg/kg significantly reduced nicotine self-administration in both lines.  Conclusions: Sazetidine-A significantly reduced alc. and nicotine intake in P rats that self-administer higher levels of both drugs.  Sazetidine-A may hold promise for the treatment of alc. and nicotine addiction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZfW61FFrtlbVg90H21EOLACvtfcHk0ljJneBiNFa5Kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXntFGlsb0%253D&md5=18b4836f096b921e6ef22c8538528ecf</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1007%2Fs00213-010-1878-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-010-1878-8%26sid%3Dliteratum%253Aachs%26aulast%3DRezvani%26aufirst%3DA.%2BH.%26aulast%3DSlade%26aufirst%3DS.%26aulast%3DWells%26aufirst%3DC.%26aulast%3DPetro%26aufirst%3DA.%26aulast%3DLumeng%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DT.%2BK.%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DBrown%26aufirst%3DM.%2BL.%26aulast%3DPaige%26aufirst%3DM.%2BA.%26aulast%3DMcDowell%26aufirst%3DB.%2BE.%26aulast%3DRose%26aufirst%3DJ.%2BE.%26aulast%3DKellar%26aufirst%3DK.%2BJ.%26aulast%3DLevin%26aufirst%3DE.%2BD.%26atitle%3DEffects%2520of%2520sazetidine-a%252C%2520a%2520selective%2520alpha4beta2%2520nicotinic%2520acetylcholine%2520receptor%2520desensitizing%2520agent%2520on%2520alcohol%2520and%2520nicotine%2520self-administration%2520in%2520selectively%2520bred%2520alcohol-preferring%2520%2528p%2529%2520rats%26jtitle%3DPsychopharmacology%2520%2528Berl%2529%26date%3D2010%26volume%3D211%26spage%3D161%26epage%3D174%26doi%3D10.1007%2Fs00213-010-1878-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Hopkins, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rupprecht, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blendy, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, H. D.</span><span> </span><span class="NLM_article-title">Galantamine, an acetylcholinesterase inhibitor and positive allosteric modulator of nicotinic acetylcholine receptors, attenuates nicotine taking and seeking in rats</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">2310</span><span class="NLM_x">–</span> <span class="NLM_lpage">2321</span><span class="refDoi"> DOI: 10.1038/npp.2012.83</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=10.1038%2Fnpp.2012.83" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2012&pages=2310-2321&author=T.+J.+Hopkinsauthor=L.+E.+Rupprechtauthor=M.+R.+Hayesauthor=J.+A.+Blendyauthor=H.+D.+Schmidt&title=Galantamine%2C+an+acetylcholinesterase+inhibitor+and+positive+allosteric+modulator+of+nicotinic+acetylcholine+receptors%2C+attenuates+nicotine+taking+and+seeking+in+rats&doi=10.1038%2Fnpp.2012.83"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2012.83&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2012.83%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DT.%2BJ.%26aulast%3DRupprecht%26aufirst%3DL.%2BE.%26aulast%3DHayes%26aufirst%3DM.%2BR.%26aulast%3DBlendy%26aufirst%3DJ.%2BA.%26aulast%3DSchmidt%26aufirst%3DH.%2BD.%26atitle%3DGalantamine%252C%2520an%2520acetylcholinesterase%2520inhibitor%2520and%2520positive%2520allosteric%2520modulator%2520of%2520nicotinic%2520acetylcholine%2520receptors%252C%2520attenuates%2520nicotine%2520taking%2520and%2520seeking%2520in%2520rats%26jtitle%3DNeuropsychopharmacology%26date%3D2012%26volume%3D37%26spage%3D2310%26epage%3D2321%26doi%3D10.1038%2Fnpp.2012.83" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Maurer, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandager-Nielsen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, H. D.</span><span> </span><span class="NLM_article-title">Attenuation of nicotine taking and seeking in rats by the stoichiometry-selective alpha4beta2 nicotinic acetylcholine receptor positive allosteric modulator ns9283</span> <span class="citation_source-journal">Psychopharmacology (Berl)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">234</span><span class="NLM_x">, </span> <span class="NLM_fpage">475</span><span class="NLM_x">–</span> <span class="NLM_lpage">484</span><span class="refDoi"> DOI: 10.1007/s00213-016-4475-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=10.1007%2Fs00213-016-4475-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=27844094" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=1%3ACAS%3A280%3ADC%252BC2snmtV2hsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=234&publication_year=2017&pages=475-484&author=J.+J.+Maurerauthor=K.+Sandager-Nielsenauthor=H.+D.+Schmidt&title=Attenuation+of+nicotine+taking+and+seeking+in+rats+by+the+stoichiometry-selective+alpha4beta2+nicotinic+acetylcholine+receptor+positive+allosteric+modulator+ns9283&doi=10.1007%2Fs00213-016-4475-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Attenuation of nicotine taking and seeking in rats by the stoichiometry-selective alpha4beta2 nicotinic acetylcholine receptor positive allosteric modulator NS9283</span></div><div class="casAuthors">Maurer John J; Schmidt Heath D; Maurer John J; Schmidt Heath D; Sandager-Nielsen Karin</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">234</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">475-484</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">RATIONALE:  The rewarding and reinforcing effects of nicotine are produced, in large part, by activation of neuronal α4β2* nicotinic acetylcholine receptors (nAChRs), pentameric protein complexes comprised of different stoichiometries of α4 and β2 subunits.  However, little is known about the functional role of distinct subtypes of α4β2* nAChRs in nicotine addiction.  OBJECTIVES:  NS9283 represents a new class of stoichiometry-selective positive allosteric modulators (PAMs) that selectively bind to α4β2 nAChRs containing three α4 and two β2 subunits (3(α4)2(β2) nAChRs).  The present experiments were designed to determine the effects of NS9283 on nicotine self-administration and the reinstatement of nicotine-seeking behavior, an animal model of smoking relapse.  Parallel studies of sucrose self-administration and reinstatement were conducted in separate cohorts of rats to determine if the effects of NS9283 generalized to other reinforced behaviors.  RESULTS:  Acute and repeated administration of NS9283 dose-dependently reduced nicotine self-administration and reinstatement in male Sprague Dawley rats.  These effects were reinforcer specific as no effects of NS9283 on sucrose self-administration and reinstatement were noted.  NS9283 also failed to substitute for nicotine in supporting self-administration behavior suggesting that, at the doses tested, NS9283 alone is not reinforcing.  CONCLUSION:  Taken together, these results provide compelling evidence that stoichiometry-selective PAMs of 3(α4)2(β2) nAChRs attenuate nicotine taking and seeking in rats and suggest that targeting 3(α4)2(β2) nAChRs may represent a promising therapeutic strategy for preventing smoking relapse.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ4YxLjT1wglfSAs_PE1QvifW6udTcc2eaCtU6TavR47bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2snmtV2hsQ%253D%253D&md5=8b7bffca3bbec7ae4cef4f3345129fd2</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1007%2Fs00213-016-4475-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-016-4475-7%26sid%3Dliteratum%253Aachs%26aulast%3DMaurer%26aufirst%3DJ.%2BJ.%26aulast%3DSandager-Nielsen%26aufirst%3DK.%26aulast%3DSchmidt%26aufirst%3DH.%2BD.%26atitle%3DAttenuation%2520of%2520nicotine%2520taking%2520and%2520seeking%2520in%2520rats%2520by%2520the%2520stoichiometry-selective%2520alpha4beta2%2520nicotinic%2520acetylcholine%2520receptor%2520positive%2520allosteric%2520modulator%2520ns9283%26jtitle%3DPsychopharmacology%2520%2528Berl%2529%26date%3D2017%26volume%3D234%26spage%3D475%26epage%3D484%26doi%3D10.1007%2Fs00213-016-4475-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Rose, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behm, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westman, E. C.</span><span> </span><span class="NLM_article-title">Nicotine-mecamylamine treatment for smoking cessation: The role of pre-cessation therapy</span> <span class="citation_source-journal">Exp. Clin. Psychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">331</span><span class="NLM_x">–</span> <span class="NLM_lpage">343</span><span class="refDoi"> DOI: 10.1037/1064-1297.6.3.331</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=10.1037%2F1064-1297.6.3.331" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=9725117" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=1%3ACAS%3A528%3ADyaK1cXlslGntbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1998&pages=331-343&author=J.+E.+Roseauthor=F.+M.+Behmauthor=E.+C.+Westman&title=Nicotine-mecamylamine+treatment+for+smoking+cessation%3A+The+role+of+pre-cessation+therapy&doi=10.1037%2F1064-1297.6.3.331"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Nicotine-mecamylamine treatment for smoking cessation: the role of pre-cessation therapy</span></div><div class="casAuthors">Rose, Jed E.; Behm, Frederique M.; Westman, Eric C.</div><div class="citationInfo"><span class="NLM_cas:title">Experimental and Clinical Psychopharmacology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">331-343</span>CODEN:
                <span class="NLM_cas:coden">ECLPES</span>;
        ISSN:<span class="NLM_cas:issn">1064-1297</span>.
    
            (<span class="NLM_cas:orgname">American Psychological Association</span>)
        </div><div class="casAbstract">The nicotinic antagonist mecamylamine was evaluated in a randomized smoking cessation trial.  Four groups of participants (n = 20 per group) received nicotine plus mecamylamine, nicotine alone, mecamylamine alone, or no drug for 4 wk before cessation.  After the quit-smoking date, all subjects received nicotine plus mecamylamine treatment for 6 wk.  Nicotine skin patches (21 mg/24 h) and mecamylamine capsules (2.5-5.0 mg twice per day) were used.  Precessation mecamylamine significantly prolonged the duration of continuous smoking abstinence; abstinence rates at the end of treatment were 47.5% with mecamylamine and 27.5% without mecamylamine.  Nicotine + mecamylamine reduced ad lib smoking, smoking satisfaction, and craving more than either drug alone.  Moreover, the orthostatic decrease in blood pressure caused by mecamylamine was offset by nicotine.  Mecamylamine before smoking cessation may be an effective adjunct to nicotine patch therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-pcw1gk9p3rVg90H21EOLACvtfcHk0lg-yA28yg_LzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXlslGntbc%253D&md5=f4aee36e6969d6aa1bdf182413cbbe4c</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1037%2F1064-1297.6.3.331&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1037%252F1064-1297.6.3.331%26sid%3Dliteratum%253Aachs%26aulast%3DRose%26aufirst%3DJ.%2BE.%26aulast%3DBehm%26aufirst%3DF.%2BM.%26aulast%3DWestman%26aufirst%3DE.%2BC.%26atitle%3DNicotine-mecamylamine%2520treatment%2520for%2520smoking%2520cessation%253A%2520The%2520role%2520of%2520pre-cessation%2520therapy%26jtitle%3DExp.%2520Clin.%2520Psychopharmacol.%26date%3D1998%26volume%3D6%26spage%3D331%26epage%3D343%26doi%3D10.1037%2F1064-1297.6.3.331" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Rose, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behm, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westman, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levin, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stein, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ripka, G. V.</span><span> </span><span class="NLM_article-title">Mecamylamine combined with nicotine skin patch facilitates smoking cessation beyond nicotine patch treatment alone</span> <span class="citation_source-journal">Clin. Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">86</span><span class="NLM_x">–</span> <span class="NLM_lpage">99</span><span class="refDoi"> DOI: 10.1038/clpt.1994.105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=10.1038%2Fclpt.1994.105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=8033499" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=1%3ACAS%3A528%3ADyaK2cXmslWqurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=1994&pages=86-99&author=J.+E.+Roseauthor=F.+M.+Behmauthor=E.+C.+Westmanauthor=E.+D.+Levinauthor=R.+M.+Steinauthor=G.+V.+Ripka&title=Mecamylamine+combined+with+nicotine+skin+patch+facilitates+smoking+cessation+beyond+nicotine+patch+treatment+alone&doi=10.1038%2Fclpt.1994.105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Mecamylamine combined with nicotine skin patch facilitates smoking cessation beyond nicotine patch treatment alone</span></div><div class="casAuthors">Rose, Jed E.; Behm, Frederique M.; Westman, Eric C.; Levin, Edward D.; Stein, Roy M.; Ripka, Gail V.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacology & Therapeutics (St. Louis, MO, United States)</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">86-99</span>CODEN:
                <span class="NLM_cas:coden">CLPTAT</span>;
        ISSN:<span class="NLM_cas:issn">0009-9236</span>.
    </div><div class="casAbstract">To evaluate concurrent administration of mecamylamine (nicotine antagonist) with nicotine skin patch treatment for smoking cessation.  This was a randomized, double-blind, placebo-controlled trial.  Forty-eight healthy smokers who smoked at least one pack per day were studied at an outpatient smoking cessation research clinic.  The subjects ranged in age from 20 to 40 yr.  Intervention with the nicotine skin patch (6 to 8 wk) plus oral mecamylamine (2.5 to 5 mg twice a day for 5 wk) was compared to nicotine patch plus placebo.  Mecamylamine treatment began 2 wk before smoking cessation.  The primary outcome was continuous abstinence through 7 wk after cessation (1 wk after treatment), confirmed by expired air carbon monoxide measurements.  Secondary measures included point abstinence at 7 wk, continuous abstinence at 6- and 12-mo follow-up, and self-reported withdrawal symptoms.  The continuous abstinence rate at 7 wk was three times higher in the mecamylamine condition: 50% vs. 16.7%, p = 0.015.  Point abstinence at 7 wk was 58% for mecamylamine vs. 29% for placebo, p = 0.044.  At follow-up, continuous abstinence remained higher for mecamylamine: 37.5% vs. 12.5% at 6 mo (p = 0.046) and 37.5% vs. 4.2% at 12 mo (p = 0.004).  Mecamylamine also significantly reduced craving for cigarettes, neg. affect, and appetite.  Agonist-antagonist therapy, consisting of the nicotine patch with oral mecamylamine, may substantially improve current smoking cessation treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvivKy5kYZ57Vg90H21EOLACvtfcHk0lg-yA28yg_LzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXmslWqurs%253D&md5=1ffa5c425a97ff79762dc0380cf702b3</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1038%2Fclpt.1994.105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fclpt.1994.105%26sid%3Dliteratum%253Aachs%26aulast%3DRose%26aufirst%3DJ.%2BE.%26aulast%3DBehm%26aufirst%3DF.%2BM.%26aulast%3DWestman%26aufirst%3DE.%2BC.%26aulast%3DLevin%26aufirst%3DE.%2BD.%26aulast%3DStein%26aufirst%3DR.%2BM.%26aulast%3DRipka%26aufirst%3DG.%2BV.%26atitle%3DMecamylamine%2520combined%2520with%2520nicotine%2520skin%2520patch%2520facilitates%2520smoking%2520cessation%2520beyond%2520nicotine%2520patch%2520treatment%2520alone%26jtitle%3DClin.%2520Pharmacol.%2520Ther.%26date%3D1994%26volume%3D56%26spage%3D86%26epage%3D99%26doi%3D10.1038%2Fclpt.1994.105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Fitch, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kellar, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daly, J. W.</span><span> </span><span class="NLM_article-title">Membrane potential fluorescence: A rapid and highly sensitive assay for nicotinic receptor channel function</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">4909</span><span class="NLM_x">–</span> <span class="NLM_lpage">4914</span><span class="refDoi"> DOI: 10.1073/pnas.0630641100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=10.1073%2Fpnas.0630641100" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2003&pages=4909-4914&author=R.+W.+Fitchauthor=Y.+Xiaoauthor=K.+J.+Kellarauthor=J.+W.+Daly&title=Membrane+potential+fluorescence%3A+A+rapid+and+highly+sensitive+assay+for+nicotinic+receptor+channel+function&doi=10.1073%2Fpnas.0630641100"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0630641100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0630641100%26sid%3Dliteratum%253Aachs%26aulast%3DFitch%26aufirst%3DR.%2BW.%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DKellar%26aufirst%3DK.%2BJ.%26aulast%3DDaly%26aufirst%3DJ.%2BW.%26atitle%3DMembrane%2520potential%2520fluorescence%253A%2520A%2520rapid%2520and%2520highly%2520sensitive%2520assay%2520for%2520nicotinic%2520receptor%2520channel%2520function%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2003%26volume%3D100%26spage%3D4909%26epage%3D4914%26doi%3D10.1073%2Fpnas.0630641100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Carroll, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navarro, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brieaddy, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damaj, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, B. R.</span><span> </span><span class="NLM_article-title">Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 2-exo-2-(2′-substituted-3′-phenyl-5′-pyridinyl)-7-azabicyclo[2.2.1]heptanes. Novel nicotinic antagonist</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">4039</span><span class="NLM_x">–</span> <span class="NLM_lpage">4041</span><span class="refDoi"> DOI: 10.1021/jm015561v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm015561v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=4039-4041&author=F.+I.+Carrollauthor=J.+R.+Leeauthor=H.+A.+Navarroauthor=L.+E.+Brieaddyauthor=P.+Abrahamauthor=M.+I.+Damajauthor=B.+R.+Martin&title=Synthesis%2C+nicotinic+acetylcholine+receptor+binding%2C+and+antinociceptive+properties+of+2-exo-2-%282%E2%80%B2-substituted-3%E2%80%B2-phenyl-5%E2%80%B2-pyridinyl%29-7-azabicyclo%5B2.2.1%5Dheptanes.+Novel+nicotinic+antagonist&doi=10.1021%2Fjm015561v"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fjm015561v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm015561v%26sid%3Dliteratum%253Aachs%26aulast%3DCarroll%26aufirst%3DF.%2BI.%26aulast%3DLee%26aufirst%3DJ.%2BR.%26aulast%3DNavarro%26aufirst%3DH.%2BA.%26aulast%3DBrieaddy%26aufirst%3DL.%2BE.%26aulast%3DAbraham%26aufirst%3DP.%26aulast%3DDamaj%26aufirst%3DM.%2BI.%26aulast%3DMartin%26aufirst%3DB.%2BR.%26atitle%3DSynthesis%252C%2520nicotinic%2520acetylcholine%2520receptor%2520binding%252C%2520and%2520antinociceptive%2520properties%2520of%25202-exo-2-%25282%25E2%2580%25B2-substituted-3%25E2%2580%25B2-phenyl-5%25E2%2580%25B2-pyridinyl%2529-7-azabicyclo%255B2.2.1%255Dheptanes.%2520Novel%2520nicotinic%2520antagonist%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D4039%26epage%3D4041%26doi%3D10.1021%2Fjm015561v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Carroll, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navarro, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brieaddy, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damaj, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, B. R.</span><span> </span><span class="NLM_article-title">Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 2-exo-2-(2′-substituted 5′-pyridinyl)-7-azabicyclo[2.2.1]heptanes. Epibatidine analogues</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">2229</span><span class="NLM_x">–</span> <span class="NLM_lpage">2237</span><span class="refDoi"> DOI: 10.1021/jm0100178</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0100178" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=2229-2237&author=F.+I.+Carrollauthor=F.+Liangauthor=H.+A.+Navarroauthor=L.+E.+Brieaddyauthor=P.+Abrahamauthor=M.+I.+Damajauthor=B.+R.+Martin&title=Synthesis%2C+nicotinic+acetylcholine+receptor+binding%2C+and+antinociceptive+properties+of+2-exo-2-%282%E2%80%B2-substituted+5%E2%80%B2-pyridinyl%29-7-azabicyclo%5B2.2.1%5Dheptanes.+Epibatidine+analogues&doi=10.1021%2Fjm0100178"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fjm0100178&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0100178%26sid%3Dliteratum%253Aachs%26aulast%3DCarroll%26aufirst%3DF.%2BI.%26aulast%3DLiang%26aufirst%3DF.%26aulast%3DNavarro%26aufirst%3DH.%2BA.%26aulast%3DBrieaddy%26aufirst%3DL.%2BE.%26aulast%3DAbraham%26aufirst%3DP.%26aulast%3DDamaj%26aufirst%3DM.%2BI.%26aulast%3DMartin%26aufirst%3DB.%2BR.%26atitle%3DSynthesis%252C%2520nicotinic%2520acetylcholine%2520receptor%2520binding%252C%2520and%2520antinociceptive%2520properties%2520of%25202-exo-2-%25282%25E2%2580%25B2-substituted%25205%25E2%2580%25B2-pyridinyl%2529-7-azabicyclo%255B2.2.1%255Dheptanes.%2520Epibatidine%2520analogues%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D2229%26epage%3D2237%26doi%3D10.1021%2Fjm0100178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Ondachi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luetje, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damaj, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mascarella, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navarro, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, F. I.</span><span> </span><span class="NLM_article-title">Synthesis and nicotinic acetylcholine receptor in vitro and in vivo pharmacological properties of 2′-fluoro-3′-(substituted phenyl)deschloroepibatidine analogues of 2′-fluoro-3′-(4-nitrophenyl)deschloroepibatidine</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">6512</span><span class="NLM_x">–</span> <span class="NLM_lpage">6522</span><span class="refDoi"> DOI: 10.1021/jm300575y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300575y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=6512-6522&author=P.+Ondachiauthor=A.+Castroauthor=C.+W.+Luetjeauthor=M.+I.+Damajauthor=S.+W.+Mascarellaauthor=H.+A.+Navarroauthor=F.+I.+Carroll&title=Synthesis+and+nicotinic+acetylcholine+receptor+in+vitro+and+in+vivo+pharmacological+properties+of+2%E2%80%B2-fluoro-3%E2%80%B2-%28substituted+phenyl%29deschloroepibatidine+analogues+of+2%E2%80%B2-fluoro-3%E2%80%B2-%284-nitrophenyl%29deschloroepibatidine&doi=10.1021%2Fjm300575y"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjm300575y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300575y%26sid%3Dliteratum%253Aachs%26aulast%3DOndachi%26aufirst%3DP.%26aulast%3DCastro%26aufirst%3DA.%26aulast%3DLuetje%26aufirst%3DC.%2BW.%26aulast%3DDamaj%26aufirst%3DM.%2BI.%26aulast%3DMascarella%26aufirst%3DS.%2BW.%26aulast%3DNavarro%26aufirst%3DH.%2BA.%26aulast%3DCarroll%26aufirst%3DF.%2BI.%26atitle%3DSynthesis%2520and%2520nicotinic%2520acetylcholine%2520receptor%2520in%2520vitro%2520and%2520in%2520vivo%2520pharmacological%2520properties%2520of%25202%25E2%2580%25B2-fluoro-3%25E2%2580%25B2-%2528substituted%2520phenyl%2529deschloroepibatidine%2520analogues%2520of%25202%25E2%2580%25B2-fluoro-3%25E2%2580%25B2-%25284-nitrophenyl%2529deschloroepibatidine%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D6512%26epage%3D6522%26doi%3D10.1021%2Fjm300575y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Abdrakhmanova, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damaj, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, B. R.</span><span> </span><span class="NLM_article-title">2-fluoro-3-(4-nitro-phenyl)deschloroepibatidine is a novel potent competitive antagonist of human neuronal alpha4beta2 nachrs</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">1945</span><span class="NLM_x">–</span> <span class="NLM_lpage">1952</span><span class="refDoi"> DOI: 10.1124/mol.105.021782</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=10.1124%2Fmol.105.021782" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2006&pages=1945-1952&author=G.+R.+Abdrakhmanovaauthor=M.+I.+Damajauthor=F.+I.+Carrollauthor=B.+R.+Martin&title=2-fluoro-3-%284-nitro-phenyl%29deschloroepibatidine+is+a+novel+potent+competitive+antagonist+of+human+neuronal+alpha4beta2+nachrs&doi=10.1124%2Fmol.105.021782"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1124%2Fmol.105.021782&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.105.021782%26sid%3Dliteratum%253Aachs%26aulast%3DAbdrakhmanova%26aufirst%3DG.%2BR.%26aulast%3DDamaj%26aufirst%3DM.%2BI.%26aulast%3DCarroll%26aufirst%3DF.%2BI.%26aulast%3DMartin%26aufirst%3DB.%2BR.%26atitle%3D2-fluoro-3-%25284-nitro-phenyl%2529deschloroepibatidine%2520is%2520a%2520novel%2520potent%2520competitive%2520antagonist%2520of%2520human%2520neuronal%2520alpha4beta2%2520nachrs%26jtitle%3DMol.%2520Pharmacol.%26date%3D2006%26volume%3D69%26spage%3D1945%26epage%3D1952%26doi%3D10.1124%2Fmol.105.021782" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Carroll, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navarro, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damaj, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, B. R.</span><span> </span><span class="NLM_article-title">Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 3′-(substituted phenyl)epibatidine analogues. Nicotinic partial agonists</span> <span class="citation_source-journal">J. Nat. Prod.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">306</span><span class="NLM_x">–</span> <span class="NLM_lpage">312</span><span class="refDoi"> DOI: 10.1021/np9006124</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np9006124" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2010&pages=306-312&author=F.+I.+Carrollauthor=W.+Maauthor=L.+Dengauthor=H.+A.+Navarroauthor=M.+I.+Damajauthor=B.+R.+Martin&title=Synthesis%2C+nicotinic+acetylcholine+receptor+binding%2C+and+antinociceptive+properties+of+3%E2%80%B2-%28substituted+phenyl%29epibatidine+analogues.+Nicotinic+partial+agonists&doi=10.1021%2Fnp9006124"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fnp9006124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp9006124%26sid%3Dliteratum%253Aachs%26aulast%3DCarroll%26aufirst%3DF.%2BI.%26aulast%3DMa%26aufirst%3DW.%26aulast%3DDeng%26aufirst%3DL.%26aulast%3DNavarro%26aufirst%3DH.%2BA.%26aulast%3DDamaj%26aufirst%3DM.%2BI.%26aulast%3DMartin%26aufirst%3DB.%2BR.%26atitle%3DSynthesis%252C%2520nicotinic%2520acetylcholine%2520receptor%2520binding%252C%2520and%2520antinociceptive%2520properties%2520of%25203%25E2%2580%25B2-%2528substituted%2520phenyl%2529epibatidine%2520analogues.%2520Nicotinic%2520partial%2520agonists%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2010%26volume%3D73%26spage%3D306%26epage%3D312%26doi%3D10.1021%2Fnp9006124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Giulianotti, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vesely, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azhari, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Souza, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaVoi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houghten, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kyle, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leahy, J. W.</span><span> </span><span class="NLM_article-title">Identification of a hit series of antileishmanial compounds through the use of mixture-based libraries</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">802</span><span class="NLM_x">–</span> <span class="NLM_lpage">807</span><span class="refDoi"> DOI: 10.1021/acsmedchemlett.7b00045</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.7b00045" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=802-807&author=M.+A.+Giulianottiauthor=B.+A.+Veselyauthor=A.+Azhariauthor=A.+Souzaauthor=T.+LaVoiauthor=R.+A.+Houghtenauthor=D.+E.+Kyleauthor=J.+W.+Leahy&title=Identification+of+a+hit+series+of+antileishmanial+compounds+through+the+use+of+mixture-based+libraries&doi=10.1021%2Facsmedchemlett.7b00045"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.7b00045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.7b00045%26sid%3Dliteratum%253Aachs%26aulast%3DGiulianotti%26aufirst%3DM.%2BA.%26aulast%3DVesely%26aufirst%3DB.%2BA.%26aulast%3DAzhari%26aufirst%3DA.%26aulast%3DSouza%26aufirst%3DA.%26aulast%3DLaVoi%26aufirst%3DT.%26aulast%3DHoughten%26aufirst%3DR.%2BA.%26aulast%3DKyle%26aufirst%3DD.%2BE.%26aulast%3DLeahy%26aufirst%3DJ.%2BW.%26atitle%3DIdentification%2520of%2520a%2520hit%2520series%2520of%2520antileishmanial%2520compounds%2520through%2520the%2520use%2520of%2520mixture-based%2520libraries%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D8%26spage%3D802%26epage%3D807%26doi%3D10.1021%2Facsmedchemlett.7b00045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Houghten, R. A.</span><span> </span><span class="NLM_article-title">General method for the rapid solid-phase synthesis of large numbers of peptides: Specificity of antigen-antibody interaction at the level of individual amino acids</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">5131</span><span class="NLM_x">–</span> <span class="NLM_lpage">5135</span><span class="refDoi"> DOI: 10.1073/pnas.82.15.5131</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=10.1073%2Fpnas.82.15.5131" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=2410914" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=1%3ACAS%3A528%3ADyaL2MXkvVKis7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=1985&pages=5131-5135&author=R.+A.+Houghten&title=General+method+for+the+rapid+solid-phase+synthesis+of+large+numbers+of+peptides%3A+Specificity+of+antigen-antibody+interaction+at+the+level+of+individual+amino+acids&doi=10.1073%2Fpnas.82.15.5131"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">General method for the rapid solid-phase synthesis of large numbers of peptides:  Specificity of antigen-antibody interaction at the level of individual amino acids</span></div><div class="casAuthors">Houghten, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">5131-5</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">A novel yet simple method is described that facilitates the synthesis of large nos. of peptides to the extent that the synthesis process need no longer be the limiting factor in many studies involving peptides.  By using the methods described, 10-20 mg of 248 different 13-residue peptides representing single amino acid variants of a segment of the hemagglutinin protein HA1 were prepd. and characterized in <4 wk.  Through examn. of the binding of these analogs to monoclonal antibodies raised against residues 75-110 of HA1, it was found that a single amino acid, aspartic acid of position 101, is of unique importance to the interaction.  Two other residues, aspartic acid-104 and alanine-106, were found to play a lesser but significant role in the binding interaction.  Other single positional residue variations appear to be of little or no importance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAPtOdK8uIsbVg90H21EOLACvtfcHk0lg9FHRSc5DFpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXkvVKis7s%253D&md5=f0f7ad48ed4169a0d072a7790003aea2</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1073%2Fpnas.82.15.5131&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.82.15.5131%26sid%3Dliteratum%253Aachs%26aulast%3DHoughten%26aufirst%3DR.%2BA.%26atitle%3DGeneral%2520method%2520for%2520the%2520rapid%2520solid-phase%2520synthesis%2520of%2520large%2520numbers%2520of%2520peptides%253A%2520Specificity%2520of%2520antigen-antibody%2520interaction%2520at%2520the%2520level%2520of%2520individual%2520amino%2520acids%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1985%26volume%3D82%26spage%3D5131%26epage%3D5135%26doi%3D10.1073%2Fpnas.82.15.5131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Manku, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laplante, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopac, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, D. G.</span><span> </span><span class="NLM_article-title">A mild and general solid-phase method for the synthesis of chiral polyamines. Solution studies on the cleavage of borane-amine intermediates from the reduction of secondary amides</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">874</span><span class="NLM_x">–</span> <span class="NLM_lpage">885</span><span class="refDoi"> DOI: 10.1021/jo005647g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo005647g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhs1yrtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2001&pages=874-885&author=S.+Mankuauthor=C.+Laplanteauthor=D.+Kopacauthor=T.+Chanauthor=D.+G.+Hall&title=A+mild+and+general+solid-phase+method+for+the+synthesis+of+chiral+polyamines.+Solution+studies+on+the+cleavage+of+borane-amine+intermediates+from+the+reduction+of+secondary+amides&doi=10.1021%2Fjo005647g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">A Mild and General Solid-Phase Method for the Synthesis of Chiral Polyamines. Solution Studies on the Cleavage of Borane-Amine Intermediates from the Reduction of Secondary Amides</span></div><div class="casAuthors">Manku, Sukhdev; Laplante, Carmen; Kopac, Dan; Chan, Timothy; Hall, Dennis G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">874-885</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A mild oxidative workup protocol using iodine in an acetic acid-acetate buffer soln. is described for the cleavage of borane-amine adducts arising from the borane-promoted redn. of polyamides supported onto practical trityl-based resins.  Chiral polyamines with diverse side-chain functionalities can be generated as free bases without premature release from the solid support and with essentially no racemization using this method.  A series of model oligomeric secondary diamides contg. various α-amino acid residues (Val, Phe, Tyr, Ser, Cys, Met, Gln, Trp) provided triamine products in high yields and good to excellent purity.  On the other hand, a substrate contg. a tertiary amide formed a rather unusual triaminoborane intermediate that required more stringent workup conditions to liberate the polyamine product.  The redn. of oligomeric tertiary amides was sluggish, but these compds. could nonetheless be obtained in high purity from in situ reductive amination of the corresponding secondary amines.  Control studies, carried out in soln. with a model secondary amide, confirmed the efficiency of the buffered iodine soln. and highlighted several advantages (no heating necessary, no need for strong bases or acids) over existing methods for the cleavage of borane-amine adducts.  A possible mechanism involving all buffer components (iodine, acetic acid, and acetate ion) is proposed in which borane-amine adducts are transformed first to the monoiodoborane-amine and then to the corresponding acetoxyborane-amine adduct of much weaker coordination affinity.  The latter would dissoc. readily and get trapped by the acetic acid to provide the desired secondary amine.  This redn./oxidative workup protocol is useful as a general method for the facile solid-phase synthesis of polyamines for eventual release in soln. and use in various applications.  It is also potentially very useful toward the synthesis and screening of bead-supported libraries of free oligoamines assembled through split-pool methods.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4xZzSfqhUW7Vg90H21EOLACvtfcHk0lg9FHRSc5DFpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhs1yrtw%253D%253D&md5=2df9d03865b805b3faac00cd493d454e</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fjo005647g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo005647g%26sid%3Dliteratum%253Aachs%26aulast%3DManku%26aufirst%3DS.%26aulast%3DLaplante%26aufirst%3DC.%26aulast%3DKopac%26aufirst%3DD.%26aulast%3DChan%26aufirst%3DT.%26aulast%3DHall%26aufirst%3DD.%2BG.%26atitle%3DA%2520mild%2520and%2520general%2520solid-phase%2520method%2520for%2520the%2520synthesis%2520of%2520chiral%2520polyamines.%2520Solution%2520studies%2520on%2520the%2520cleavage%2520of%2520borane-amine%2520intermediates%2520from%2520the%2520reduction%2520of%2520secondary%2520amides%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2001%26volume%3D66%26spage%3D874%26epage%3D885%26doi%3D10.1021%2Fjo005647g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Ostresh, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoner, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamashin, V. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nefzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houghten, R. A.</span><span> </span><span class="NLM_article-title">Solid-phase synthesis of trisubstituted bicyclic guanidines via cyclization of reduced n-acylated dipeptides</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">8622</span><span class="NLM_x">–</span> <span class="NLM_lpage">8623</span><span class="refDoi"> DOI: 10.1021/jo9810617</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo9810617" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=1%3ACAS%3A528%3ADyaK1cXntFKltLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=1998&pages=8622-8623&author=J.+M.+Ostreshauthor=C.+C.+Schonerauthor=V.+T.+Hamashinauthor=A.+Nefziauthor=J.-P.+Meyerauthor=R.+A.+Houghten&title=Solid-phase+synthesis+of+trisubstituted+bicyclic+guanidines+via+cyclization+of+reduced+n-acylated+dipeptides&doi=10.1021%2Fjo9810617"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Solid-Phase Synthesis of Trisubstituted Bicyclic Guanidines via Cyclization of Reduced N-Acylated Dipeptides</span></div><div class="casAuthors">Ostresh, John M.; Schoner, Christa C.; Hamashin, Vince T.; Nefzi, Adel; Meyer, Jean-Philippe; Houghten, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">8622-8623</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel method for the solid-phase synthesis of trisubstituted bicyclic guanidines I (R1 = CH2Ph, Me, CH2CHMe2, Pr; R2 = CH2Ph, Me, Pr; R3 = CH2CH2Ph, Bu, Et) is presented.  The initial reaction step involves the exhaustive redn. of resin-bound N-acylated dipeptides R3CONHCHR2CONHCHR1CONHR (R = polymer support) using borane-THF, followed by cyclization of the resulting triamine with thiocarbonyldiimidazole to generate resin-bound trisubstituted bicyclic guanidines.  Cleavage from the resin using HF yields the desired trisubstituted bicyclic guanidines in excellent yield and purity.  The approaches described enable efficient high-yield and purity syntheses of either polyamines II or bicyclic guanidines.  These methods were applied to the synthesis of both individual compds. and combinatorial libraries.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpP3oHBqwPh_LVg90H21EOLACvtfcHk0lg9FHRSc5DFpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXntFKltLg%253D&md5=e4bd86d14e5d2ba504b76a46783b7fa8</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fjo9810617&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo9810617%26sid%3Dliteratum%253Aachs%26aulast%3DOstresh%26aufirst%3DJ.%2BM.%26aulast%3DSchoner%26aufirst%3DC.%2BC.%26aulast%3DHamashin%26aufirst%3DV.%2BT.%26aulast%3DNefzi%26aufirst%3DA.%26aulast%3DMeyer%26aufirst%3DJ.-P.%26aulast%3DHoughten%26aufirst%3DR.%2BA.%26atitle%3DSolid-phase%2520synthesis%2520of%2520trisubstituted%2520bicyclic%2520guanidines%2520via%2520cyclization%2520of%2520reduced%2520n-acylated%2520dipeptides%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1998%26volume%3D63%26spage%3D8622%26epage%3D8623%26doi%3D10.1021%2Fjo9810617" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Cippitelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoch, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debevec, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunori, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaveri, N. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toll, L.</span><span> </span><span class="NLM_article-title">A key role for the N/OFQ-NOP receptor system in modulating nicotine taking in a model of nicotine and alcohol co-administration</span> <span class="citation_source-journal">Sci. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">26594</span><span class="refDoi"> DOI: 10.1038/srep26594</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=10.1038%2Fsrep26594" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=27199205" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=1%3ACAS%3A528%3ADC%252BC28Xotlehu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=26594&author=A.+Cippitelliauthor=J.+Schochauthor=G.+Debevecauthor=G.+Brunoriauthor=N.+T.+Zaveriauthor=L.+Toll&title=A+key+role+for+the+N%2FOFQ-NOP+receptor+system+in+modulating+nicotine+taking+in+a+model+of+nicotine+and+alcohol+co-administration&doi=10.1038%2Fsrep26594"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">A key role for the N/OFQ-NOP receptor system in modulating nicotine taking in a model of nicotine and alcohol co-administration</span></div><div class="casAuthors">Cippitelli, Andrea; Schoch, Jennifer; Debevec, Ginamarie; Brunori, Gloria; Zaveri, Nurulain T.; Toll, Lawrence</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">26594</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Alc. and nicotine are often co-abused.  Although the N/OFQ-NOP receptor system is considered a potential target for development of drug abuse pharmacotherapies, esp. for alcoholism, little is known about the role of this system in nicotine dependence.  Furthermore, the effect of prior history of nicotine dependence on subsequent nicotine and alc. taking is understudied.  Using an operant co-administration paradigm, in which rats concurrently self-administer nicotine and alc., we found that nicotine dependent rats increased nicotine self-administration over time as compared to non-dependent animals, while patterns of alc. lever pressing did not change between groups.  Pretreatment with the potent NOP receptor agonist AT-202 (0.3-3 mg/kg) increased nicotine lever pressing of both dependent and non-dependent groups, whereas the selective antagonist SB612111 (1-10 mg/kg) elicited a clear redn. of nicotine responses, in both dependent and non-dependent rats.  In parallel, AT-202 only produced minor changes on alc. responses and SB612111 reduced alc. taking at a dose that also reduced locomotor behavior.  Results indicate that a history of nicotine dependence affects subsequent nicotine- but not alc.-maintained responding, and that NOP receptor antagonism, rather than agonism, blocks nicotine self-administration, which strongly suggests a crit. role for the endogenous N/OFQ in the modulation of nicotine reinforcement processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKAbj5-lmbNbVg90H21EOLACvtfcHk0lh7_8x0ln7Mow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xotlehu70%253D&md5=f2057e8558b105839c5fc738b6a91f72</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1038%2Fsrep26594&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep26594%26sid%3Dliteratum%253Aachs%26aulast%3DCippitelli%26aufirst%3DA.%26aulast%3DSchoch%26aufirst%3DJ.%26aulast%3DDebevec%26aufirst%3DG.%26aulast%3DBrunori%26aufirst%3DG.%26aulast%3DZaveri%26aufirst%3DN.%2BT.%26aulast%3DToll%26aufirst%3DL.%26atitle%3DA%2520key%2520role%2520for%2520the%2520N%252FOFQ-NOP%2520receptor%2520system%2520in%2520modulating%2520nicotine%2520taking%2520in%2520a%2520model%2520of%2520nicotine%2520and%2520alcohol%2520co-administration%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D26594%26doi%3D10.1038%2Fsrep26594" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Hilbe, J. M.</span><span> </span><span class="NLM_article-title">Statistica 7</span> <span class="citation_source-journal">Am. Stat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">91</span><span class="NLM_x">–</span> <span class="NLM_lpage">94</span><span class="refDoi"> DOI: 10.1198/000313007X172998</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=10.1198%2F000313007X172998" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2007&pages=91-94&author=J.+M.+Hilbe&title=Statistica+7&doi=10.1198%2F000313007X172998"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1198%2F000313007X172998&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1198%252F000313007X172998%26sid%3Dliteratum%253Aachs%26aulast%3DHilbe%26aufirst%3DJ.%2BM.%26atitle%3DStatistica%25207%26jtitle%3DAm.%2520Stat.%26date%3D2007%26volume%3D61%26spage%3D91%26epage%3D94%26doi%3D10.1198%2F000313007X172998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 6 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ziru  Yu</span>, <span class="hlFld-ContribAuthor ">Dewen  Kong</span>, <span class="hlFld-ContribAuthor ">Yu  Liang</span>, <span class="hlFld-ContribAuthor ">Xiaoyue  Zhao</span>, <span class="hlFld-ContribAuthor ">Guanhua  Du</span>. </span><span class="cited-content_cbyCitation_article-title">Protective effects of VMY-2-95 on corticosterone-induced injuries in mice and cellular models. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmaceutica Sinica B</span><span> <strong>2021,</strong> <em>11 </em>
                                    (7)
                                     , 1903-1913. <a href="https://doi.org/10.1016/j.apsb.2021.03.002" title="DOI URL">https://doi.org/10.1016/j.apsb.2021.03.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.apsb.2021.03.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.apsb.2021.03.002%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmaceutica%2520Sinica%2520B%26atitle%3DProtective%252Beffects%252Bof%252BVMY-2-95%252Bon%252Bcorticosterone-induced%252Binjuries%252Bin%252Bmice%252Band%252Bcellular%252Bmodels%26aulast%3DYu%26aufirst%3DZiru%26date%3D2021%26volume%3D11%26issue%3D7%26spage%3D1903%26epage%3D1913" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mahardian  Rahmadi</span>, <span class="hlFld-ContribAuthor ">Dian  Suasana</span>, <span class="hlFld-ContribAuthor ">Silvy Restuning  Lailis</span>, <span class="hlFld-ContribAuthor ">Dinda Monika Nusantara  Ratri</span>, <span class="hlFld-ContribAuthor ">Chrismawan  Ardianto</span>. </span><span class="cited-content_cbyCitation_article-title">The effects of quercetin on nicotine-induced reward effects in mice. </span><span class="cited-content_cbyCitation_journal-name">Journal of Basic and Clinical Physiology and Pharmacology</span><span> <strong>2021,</strong> <em>32 </em>
                                    (4)
                                     , 327-333. <a href="https://doi.org/10.1515/jbcpp-2020-0418" title="DOI URL">https://doi.org/10.1515/jbcpp-2020-0418</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1515/jbcpp-2020-0418&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1515%2Fjbcpp-2020-0418%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Basic%2520and%2520Clinical%2520Physiology%2520and%2520Pharmacology%26atitle%3DThe%252Beffects%252Bof%252Bquercetin%252Bon%252Bnicotine-induced%252Breward%252Beffects%252Bin%252Bmice%26aulast%3DRahmadi%26aufirst%3DMahardian%26date%3D2021%26date%3D2021%26volume%3D32%26issue%3D4%26spage%3D327%26epage%3D333" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Roberto G. S.  Berlinck</span>, <span class="hlFld-ContribAuthor ">Darlon I.  Bernardi</span>, <span class="hlFld-ContribAuthor ">Taicia  Fill</span>, <span class="hlFld-ContribAuthor ">Alessandra A. G.  Fernandes</span>, <span class="hlFld-ContribAuthor ">Igor D.  Jurberg</span>. </span><span class="cited-content_cbyCitation_article-title">The chemistry and biology of guanidine secondary metabolites. </span><span class="cited-content_cbyCitation_journal-name">Natural Product Reports</span><span> <strong>2021,</strong> <em>66 </em><a href="https://doi.org/10.1039/D0NP00051E" title="DOI URL">https://doi.org/10.1039/D0NP00051E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0NP00051E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0NP00051E%26sid%3Dliteratum%253Aachs%26jtitle%3DNatural%2520Product%2520Reports%26atitle%3DThe%252Bchemistry%252Band%252Bbiology%252Bof%252Bguanidine%252Bsecondary%252Bmetabolites%26aulast%3DBerlinck%26aufirst%3DRoberto%2BG.%2BS.%26date%3D2021%26date%3D2021%26volume%3D66" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">C.N.  Miller</span>, <span class="hlFld-ContribAuthor ">H.M.  Kamens</span>. </span><span class="cited-content_cbyCitation_article-title">The role of nicotinic acetylcholine receptors in alcohol-related behaviors. </span><span class="cited-content_cbyCitation_journal-name">Brain Research Bulletin</span><span> <strong>2020,</strong> <em>163 </em>, 135-142. <a href="https://doi.org/10.1016/j.brainresbull.2020.07.017" title="DOI URL">https://doi.org/10.1016/j.brainresbull.2020.07.017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.brainresbull.2020.07.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.brainresbull.2020.07.017%26sid%3Dliteratum%253Aachs%26jtitle%3DBrain%2520Research%2520Bulletin%26atitle%3DThe%252Brole%252Bof%252Bnicotinic%252Bacetylcholine%252Breceptors%252Bin%252Balcohol-related%252Bbehaviors%26aulast%3DMiller%26aufirst%3DC.N.%26date%3D2020%26volume%3D163%26spage%3D135%26epage%3D142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sarah J.  Cross</span>, <span class="hlFld-ContribAuthor ">Daisy D.  Reynaga</span>, <span class="hlFld-ContribAuthor ">Michelle  Cano</span>, <span class="hlFld-ContribAuthor ">James D.  Belluzzi</span>, <span class="hlFld-ContribAuthor ">Nurulain T.  Zaveri</span>, <span class="hlFld-ContribAuthor ">Frances M.  Leslie</span>. </span><span class="cited-content_cbyCitation_article-title">Differences in mechanisms underlying reinstatement of cigarette smoke extract- and nicotine-seeking behavior in rats. </span><span class="cited-content_cbyCitation_journal-name">Neuropharmacology</span><span> <strong>2020,</strong> <em>162 </em>, 107846. <a href="https://doi.org/10.1016/j.neuropharm.2019.107846" title="DOI URL">https://doi.org/10.1016/j.neuropharm.2019.107846</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neuropharm.2019.107846&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neuropharm.2019.107846%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropharmacology%26atitle%3DDifferences%252Bin%252Bmechanisms%252Bunderlying%252Breinstatement%252Bof%252Bcigarette%252Bsmoke%252Bextract-%252Band%252Bnicotine-seeking%252Bbehavior%252Bin%252Brats%26aulast%3DCross%26aufirst%3DSarah%2BJ.%26date%3D2020%26volume%3D162%26spage%3D107846" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrea  Cippitelli</span>, <span class="hlFld-ContribAuthor ">Gloria  Brunori</span>, <span class="hlFld-ContribAuthor ">Jennifer  Schoch</span>, <span class="hlFld-ContribAuthor ">Christopher J.  Armishaw</span>, <span class="hlFld-ContribAuthor ">Jinhua  Wu</span>, <span class="hlFld-ContribAuthor ">Nurulain T.  Zaveri</span>, <span class="hlFld-ContribAuthor ">Marc A.  Giulianotti</span>, <span class="hlFld-ContribAuthor ">Gregory S.  Welmaker</span>, <span class="hlFld-ContribAuthor ">Lawrence  Toll</span>. </span><span class="cited-content_cbyCitation_article-title">Differential regulation of alcohol taking and seeking by antagonism at α4β2 and α3β4 nAChRs. </span><span class="cited-content_cbyCitation_journal-name">Psychopharmacology</span><span> <strong>2018,</strong> <em>235 </em>
                                    (6)
                                     , 1745-1757. <a href="https://doi.org/10.1007/s00213-018-4883-y" title="DOI URL">https://doi.org/10.1007/s00213-018-4883-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00213-018-4883-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00213-018-4883-y%26sid%3Dliteratum%253Aachs%26jtitle%3DPsychopharmacology%26atitle%3DDifferential%252Bregulation%252Bof%252Balcohol%252Btaking%252Band%252Bseeking%252Bby%252Bantagonism%252Bat%252B%2525CE%2525B14%2525CE%2525B22%252Band%252B%2525CE%2525B13%2525CE%2525B24%252BnAChRs%26aulast%3DCippitelli%26aufirst%3DAndrea%26date%3D2018%26date%3D2018%26volume%3D235%26issue%3D6%26spage%3D1745%26epage%3D1757" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01250/20171221/images/medium/jm-2017-01250w_0011.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01250/20171221/images/large/jm-2017-01250w_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01250&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01250/20171221/images/medium/jm-2017-01250w_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01250/20171221/images/large/jm-2017-01250w_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Bis-cyclic guanidine scaffold contains compounds with moderate affinity for α4β2 nAChR.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01250/20171221/images/large/jm-2017-01250w_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01250&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01250/20171221/images/medium/jm-2017-01250w_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01250/20171221/images/large/jm-2017-01250w_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. SAR of different analogs with core A utilizing the different R group functionalities shown. The compounds were tested for ability to inhibit [<sup>3</sup>H]epibatidine binding at a single concentration (10 μM) at both α4β2 and α3β4 nAChR. Each dot represents a compound tested. The dots are color coded by α3β4 affinity [using a color gradient: red (0%, no binding) to green (100%, binding affinity)] and sized by α4β2 affinity (larger is higher affinity). A larger green dot binds to both targets at 10 μM, a large red dot indicates binding only to α4β2 at 10 μM, and a small green dot indicates binding only to α3β4 at 10 μM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01250/20171221/images/large/jm-2017-01250w_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01250&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01250/20171221/images/medium/jm-2017-01250w_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01250/20171221/images/large/jm-2017-01250w_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Activity of <b>5</b> and <b>13</b> on α4β2 nAChR and α3β4 nAChR in HEK cells. (A) Both <b>5</b> and <b>13</b> alone have no agonistic activity on α4β2 nAChR. (B) <b>5</b> and <b>13</b> potently inhibit epibatidine-induced α4β2 nAChR activation in a dose-dependent manner. (C) Both <b>5</b> and <b>13</b> alone only stimulate α3β4 nAChR at high dose. (D) <b>5</b> and <b>13</b> partially block epibatidine-induced α3β4 nAChR activation only at high dose. All experiments are performed in triplicate and repeated at least twice. Data are presented as mean ± SEM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01250/20171221/images/large/jm-2017-01250w_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01250&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01250/20171221/images/medium/jm-2017-01250w_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01250/20171221/images/large/jm-2017-01250w_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Effect of <b>5</b> on operant nicotine self-administration under a FR-3 reinforcement schedule. (A) Subcutaneous administration of <b>5</b> failed to alter the cumulative number of nicotine lever presses across a 120 min session. (B) <b>5</b> successfully decreased nicotine self-administration across the first 30 min (0.3 and 1 mg/kg) while leaving lever pressing unaltered across the remaining portion of the session. Results are described as mean (±SEM) cumulative number and 30 min fractions of nicotine infusions, respectively: (∗∗) <i>p</i> < 0.01, (∗∗∗) <i>p</i> < 0.001 difference from vehicle (<b>5,</b> 0 mg/kg). For detailed statistics, see “<a class="ref internalNav" href="#sec2" aria-label="Results">Results</a>”.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01250/20171221/images/large/jm-2017-01250w_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01250&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01250/20171221/images/medium/jm-2017-01250w_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01250/20171221/images/large/jm-2017-01250w_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effect of <b>5</b> on relapse-like behavior. <b>5</b> blocked nicotine priming-induced as well as cue-induced reinstatement of nicotine seeking. (A) There was significant reinstatement induction by subcutaneous administration of a nicotine priming dose of 0.15 mg/kg. Pretreatment with <b>5</b> (0.3 and 1 mg/kg) returned lever pressing to the extinction (EXT) levels. (B) Reinstatement of lever pressing was also obtained upon presentation of stimuli (cue light, orange odor) previously associated with nicotine. Pretreatment with <b>5</b> (1 mg/kg) abolished reinstatement. Values represent the mean (±SEM) number of total responses on the nicotine-associated lever in 60 min for both reinstatement paradigms: (#) <i>p</i> < 0.05, (##) <i>p</i> < 0.01 difference from EXT; (∗) <i>p</i> < 0.05 difference from vehicle (<b>5</b>, 0 mg/kg). For detailed statistics, see “<a class="ref internalNav" href="#sec2" aria-label="Results">Results</a>”.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01250/20171221/images/large/jm-2017-01250w_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01250&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01250/20171221/images/medium/jm-2017-01250w_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01250/20171221/images/large/jm-2017-01250w_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Assessment of body temperature. <b>5</b> failed to block nicotine-induced hypothermia and did not induce per se hypothermia. Baseline rectal temperature was measured just prior to injection of 5 (1.0 mg/kg, sc) or vehicle (0.9% saline). Ten minutes later, nicotine (0.5 mg/kg, sc) or vehicle (0.9% saline) was injected, and temperature was measured again after 15, 30, 60, and 120 min. Values represent the mean (±SEM) body temperature (°C): (###) <i>p</i> < 0.001 difference from <i>T</i> = 0 for the nicotine group; (∗∗∗) <i>p</i> < 0.001 difference from <b>5</b>/VEH and VEH/VEH at <i>T</i> = 15 and <i>T</i> = 30. For detailed statistics, see “<a class="ref internalNav" href="#sec2" aria-label="Results">Results</a>”.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01250/20171221/images/large/jm-2017-01250w_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01250&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01250/20171221/images/medium/jm-2017-01250w_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01250/20171221/images/large/jm-2017-01250w_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Detection of <b>5</b> in rat blood and brain using LC–MS–MS. <b>5</b> contents were determined in rat blood and brain 0, 10, 30, and 60 min following sc injection at the dose of 2 mg/kg. Values represent the ratio between the peak area of the analyte (AN) and the peak area of the internal standard (IS). Average (±SEM) for each time point is plotted. For detailed statistics, see “<a class="ref internalNav" href="#sec2" aria-label="Results">Results</a>”.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01250/20171221/images/large/jm-2017-01250w_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01250&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01250/20171221/images/medium/jm-2017-01250w_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01250/20171221/images/large/jm-2017-01250w_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Synthetic Scheme Used for the Synthesis of Core A Type Compounds<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01250/20171221/images/large/jm-2017-01250w_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01250&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Standard Boc coupling protocol utilizing repetitive (a1) 5% DIEA/95% DCM; (a2) Boc-AA, DIC, HOBt, DMF; <b>1</b>. (b1) 55% TFA/45% DCM; (b2) 5% DIEA/95% DCM; COOH, DIC, HOBt, DMF; <b>2</b>. (c) 40× BH<sub>3</sub>/THF (65 °C, 72 h); piperidine (65 °C, 18 h); <b>3</b>. (d) 5× BrCN/0.1 M DCM (shaking12 h); <b>4</b>. (e) HF/anisole, (0 °C, 7 hr); <b>5</b>.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i32">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34013" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34013" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 53 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span> </span><span class="NLM_article-title">The health consequences of smoking—50 years of progress: A report of the surgeon general</span>. <span class="NLM_publisher-name">U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion: Office on Smoking and Health, U.S. Government Printing Office</span>: <span class="NLM_publisher-loc">Washington, DC</span>,<span class="NLM_x"> </span><span class="NLM_year">2014</span><span class="NLM_x">, </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=The+health+consequences+of+smoking%E2%80%9450+years+of+progress%3A+A+report+of+the+surgeon+general.+U.S.+Department+of+Health+and+Human+Services%2C+Centers+for+Disease+Control+and+Prevention%2C+National+Center+for+Chronic+Disease+Prevention+and+Health+Promotion%3A+Office+on+Smoking+and+Health%2C+U.S.+Government+Printing+Office%3A+Washington%2C+DC%2C+2014%2C+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26atitle%3DThe%2520health%2520consequences%2520of%2520smoking%25E2%2580%259450%2520years%2520of%2520progress%253A%2520A%2520report%2520of%2520the%2520surgeon%2520general%26pub%3DU.S.%2520Department%2520of%2520Health%2520and%2520Human%2520Services%252C%2520Centers%2520for%2520Disease%2520Control%2520and%2520Prevention%252C%2520National%2520Center%2520for%2520Chronic%2520Disease%2520Prevention%2520and%2520Health%2520Promotion%253A%2520Office%2520on%2520Smoking%2520and%2520Health%252C%2520U.S.%2520Government%2520Printing%2520Office%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Xu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bishop, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simpson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pechacek, T.</span><span> </span><span class="NLM_article-title">Annual healthcare spending attributable to cigarette smoking: An update</span> <span class="citation_source-journal">Am. J. Prev. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">326</span><span class="NLM_x">–</span> <span class="NLM_lpage">333</span><span class="refDoi"> DOI: 10.1016/j.amepre.2014.10.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=10.1016%2Fj.amepre.2014.10.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=25498551" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=1%3ACAS%3A280%3ADC%252BC2MzntlSnsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2015&pages=326-333&author=X.+Xuauthor=E.+Bishopauthor=S.+Kennedyauthor=S.+Simpsonauthor=T.+Pechacek&title=Annual+healthcare+spending+attributable+to+cigarette+smoking%3A+An+update&doi=10.1016%2Fj.amepre.2014.10.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Annual healthcare spending attributable to cigarette smoking: an update</span></div><div class="casAuthors">Xu Xin; Bishop Ellen E; Kennedy Sara M; Simpson Sean A; Pechacek Terry F</div><div class="citationInfo"><span class="NLM_cas:title">American journal of preventive medicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">326-33</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Fifty years after the first Surgeon General's report, tobacco use remains the nation's leading preventable cause of death and disease, despite declines in adult cigarette smoking prevalence.  Smoking-attributable healthcare spending is an important part of overall smoking-attributable costs in the U.S.  PURPOSE:  To update annual smoking-attributable healthcare spending in the U.S. and provide smoking-attributable healthcare spending estimates by payer (e.g., Medicare, Medicaid, private insurance) or type of medical services.  METHODS:  Analyses used data from the 2006-2010 Medical Expenditure Panel Survey linked to the 2004-2009 National Health Interview Survey.  Estimates from two-part models were combined to predict the share of annual healthcare spending that could be attributable to cigarette smoking.  The analysis was conducted in 2013.  RESULTS:  By 2010, 8.7% (95% CI=6.8%, 11.2%) of annual healthcare spending in the U.S. could be attributed to cigarette smoking, amounting to as much as $170 billion per year.  More than 60% of the attributable spending was paid by public programs, including Medicare, other federally sponsored programs, or Medicaid.  CONCLUSIONS:  These findings indicate that comprehensive tobacco control programs and policies are still needed to continue progress toward ending the tobacco epidemic in the U.S. 50 years after the release of the first Surgeon General's report on smoking and health.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTTJKUGDwGDoLxanA7vODO6fW6udTcc2eZXCIGGWNeVTbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MzntlSnsg%253D%253D&md5=3d6057b3c13a43d3d0c12658ab335360</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.amepre.2014.10.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.amepre.2014.10.012%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DX.%26aulast%3DBishop%26aufirst%3DE.%26aulast%3DKennedy%26aufirst%3DS.%26aulast%3DSimpson%26aufirst%3DS.%26aulast%3DPechacek%26aufirst%3DT.%26atitle%3DAnnual%2520healthcare%2520spending%2520attributable%2520to%2520cigarette%2520smoking%253A%2520An%2520update%26jtitle%3DAm.%2520J.%2520Prev.%2520Med.%26date%3D2015%26volume%3D48%26spage%3D326%26epage%3D333%26doi%3D10.1016%2Fj.amepre.2014.10.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span> </span><span class="NLM_article-title">WHO report on the global tobacco epidemic</span>. <span class="NLM_publisher-name">World Health Organization</span>: <span class="NLM_publisher-loc">Geneva</span>,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=WHO+report+on+the+global+tobacco+epidemic.+World+Health+Organization%3A+Geneva%2C+2011."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26atitle%3DWHO%2520report%2520on%2520the%2520global%2520tobacco%2520epidemic%26pub%3DWorld%2520Health%2520Organization%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Jorenby, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hays, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rigotti, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azoulay, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watsky, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billing, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reeves, K. R.</span><span> </span><span class="NLM_article-title">Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: A randomized controlled trial</span> <span class="citation_source-journal">JAMA</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">296</span><span class="NLM_x">, </span> <span class="NLM_fpage">56</span><span class="NLM_x">–</span> <span class="NLM_lpage">63</span><span class="refDoi"> DOI: 10.1001/jama.296.1.56</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=10.1001%2Fjama.296.1.56" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=296&publication_year=2006&pages=56-63&author=D.+E.+Jorenbyauthor=J.+T.+Haysauthor=N.+A.+Rigottiauthor=S.+Azoulayauthor=E.+J.+Watskyauthor=K.+E.+Williamsauthor=C.+B.+Billingauthor=J.+Gongauthor=K.+R.+Reeves&title=Efficacy+of+varenicline%2C+an+alpha4beta2+nicotinic+acetylcholine+receptor+partial+agonist%2C+vs+placebo+or+sustained-release+bupropion+for+smoking+cessation%3A+A+randomized+controlled+trial&doi=10.1001%2Fjama.296.1.56"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1001%2Fjama.296.1.56&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Fjama.296.1.56%26sid%3Dliteratum%253Aachs%26aulast%3DJorenby%26aufirst%3DD.%2BE.%26aulast%3DHays%26aufirst%3DJ.%2BT.%26aulast%3DRigotti%26aufirst%3DN.%2BA.%26aulast%3DAzoulay%26aufirst%3DS.%26aulast%3DWatsky%26aufirst%3DE.%2BJ.%26aulast%3DWilliams%26aufirst%3DK.%2BE.%26aulast%3DBilling%26aufirst%3DC.%2BB.%26aulast%3DGong%26aufirst%3DJ.%26aulast%3DReeves%26aufirst%3DK.%2BR.%26atitle%3DEfficacy%2520of%2520varenicline%252C%2520an%2520alpha4beta2%2520nicotinic%2520acetylcholine%2520receptor%2520partial%2520agonist%252C%2520vs%2520placebo%2520or%2520sustained-release%2520bupropion%2520for%2520smoking%2520cessation%253A%2520A%2520randomized%2520controlled%2520trial%26jtitle%3DJAMA%26date%3D2006%26volume%3D296%26spage%3D56%26epage%3D63%26doi%3D10.1001%2Fjama.296.1.56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Reus, V. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, B. J.</span><span> </span><span class="NLM_article-title">Multimodal techniques for smoking cessation: A review of their efficacy and utilisation and clinical practice guidelines</span> <span class="citation_source-journal">Int. J. Clin. Pract.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">1753</span><span class="NLM_x">–</span> <span class="NLM_lpage">1768</span><span class="refDoi"> DOI: 10.1111/j.1742-1241.2008.01885.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=10.1111%2Fj.1742-1241.2008.01885.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=18795968" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=1%3ACAS%3A280%3ADC%252BD1M%252FntVGhtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2008&pages=1753-1768&author=V.+I.+Reusauthor=B.+J.+Smith&title=Multimodal+techniques+for+smoking+cessation%3A+A+review+of+their+efficacy+and+utilisation+and+clinical+practice+guidelines&doi=10.1111%2Fj.1742-1241.2008.01885.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Multimodal techniques for smoking cessation: a review of their efficacy and utilisation and clinical practice guidelines</span></div><div class="casAuthors">Reus V I; Smith B J</div><div class="citationInfo"><span class="NLM_cas:title">International journal of clinical practice</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1753-68</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">AIMS:  Nicotine addiction is a complex, chronic condition with physiological and psychological/behavioural aspects that make smoking cessation extremely difficult.  This paper reviews current recommendations for smoking cessation and the efficacy of pharmacotherapy and behavioural modification techniques, used either alone or in combination, for smoking cessation.  RESULTS:  Abstinence rates for pharmacotherapies range from approximately 16% to approximately 30% at 1-year follow-up, with efficacy odds ratios (ORs) compared with placebo of approximately 1.7 for nicotine replacement therapy (NRT), approximately 1.9 for bupropion sustained release and approximately 3.0 for varenicline.  Behaviour modification therapies have achieved quit rates of between 8% and 43% for up to 1 year, with ORs in comparison to no treatment of between approximately 1.2 and approximately 2.2.  No direct comparisons have been made between pharmacotherapy alone and psychological behaviour strategies alone.  However, combining physiological approaches with counselling significantly increases the odds of quitting compared with either technique alone.  CONCLUSIONS:  Applying multimodal techniques for the treatment of nicotine addiction is the recommended approach and has demonstrated the potential to improve rates of permanent abstinence in smokers attempting cessation.  While the numbers of patients receiving help and advice regarding smoking cessation is increasing, the multimodal approach appears to be currently underutilised by clinicians and therefore smoking cessation strategies are not being optimised.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSwDF94IoprsbBItaL1WaVAfW6udTcc2ebZeWH4fDU7S7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M%252FntVGhtg%253D%253D&md5=9427fa7892026767fe8f78b45494e2a8</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1111%2Fj.1742-1241.2008.01885.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1742-1241.2008.01885.x%26sid%3Dliteratum%253Aachs%26aulast%3DReus%26aufirst%3DV.%2BI.%26aulast%3DSmith%26aufirst%3DB.%2BJ.%26atitle%3DMultimodal%2520techniques%2520for%2520smoking%2520cessation%253A%2520A%2520review%2520of%2520their%2520efficacy%2520and%2520utilisation%2520and%2520clinical%2520practice%2520guidelines%26jtitle%3DInt.%2520J.%2520Clin.%2520Pract.%26date%3D2008%26volume%3D62%26spage%3D1753%26epage%3D1768%26doi%3D10.1111%2Fj.1742-1241.2008.01885.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Rigotti, N. A.</span><span> </span><span class="NLM_article-title">Clinical practice. Treatment of tobacco use and dependence</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">346</span><span class="NLM_x">, </span> <span class="NLM_fpage">506</span><span class="NLM_x">–</span> <span class="NLM_lpage">512</span><span class="refDoi"> DOI: 10.1056/NEJMcp012279</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=10.1056%2FNEJMcp012279" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=11844853" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=1%3ACAS%3A280%3ADC%252BD387ht1Oltg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=346&publication_year=2002&pages=506-512&author=N.+A.+Rigotti&title=Clinical+practice.+Treatment+of+tobacco+use+and+dependence&doi=10.1056%2FNEJMcp012279"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical practice. Treatment of tobacco use and dependence</span></div><div class="casAuthors">Rigotti Nancy A</div><div class="citationInfo"><span class="NLM_cas:title">The New England journal of medicine</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">346</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">506-12</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQShDhmCcUbGo2y4bB4mnvYfW6udTcc2ebZeWH4fDU7S7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD387ht1Oltg%253D%253D&md5=a126dfdfcaa18f5b4bcce1b043c1befe</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1056%2FNEJMcp012279&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMcp012279%26sid%3Dliteratum%253Aachs%26aulast%3DRigotti%26aufirst%3DN.%2BA.%26atitle%3DClinical%2520practice.%2520Treatment%2520of%2520tobacco%2520use%2520and%2520dependence%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2002%26volume%3D346%26spage%3D506%26epage%3D512%26doi%3D10.1056%2FNEJMcp012279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Moore, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furberg, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glenmullen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maltsberger, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, S.</span><span> </span><span class="NLM_article-title">Suicidal behavior and depression in smoking cessation treatments</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">e27016</span><span class="refDoi"> DOI: 10.1371/journal.pone.0027016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=10.1371%2Fjournal.pone.0027016" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=e27016&author=T.+J.+Mooreauthor=C.+D.+Furbergauthor=J.+Glenmullenauthor=J.+T.+Maltsbergerauthor=S.+Singh&title=Suicidal+behavior+and+depression+in+smoking+cessation+treatments&doi=10.1371%2Fjournal.pone.0027016"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0027016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0027016%26sid%3Dliteratum%253Aachs%26aulast%3DMoore%26aufirst%3DT.%2BJ.%26aulast%3DFurberg%26aufirst%3DC.%2BD.%26aulast%3DGlenmullen%26aufirst%3DJ.%26aulast%3DMaltsberger%26aufirst%3DJ.%2BT.%26aulast%3DSingh%26aufirst%3DS.%26atitle%3DSuicidal%2520behavior%2520and%2520depression%2520in%2520smoking%2520cessation%2520treatments%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26spage%3De27016%26doi%3D10.1371%2Fjournal.pone.0027016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Picciotto, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rimondini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lena, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marubio, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pich, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuxe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Changeux, J. P.</span><span> </span><span class="NLM_article-title">Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">391</span><span class="NLM_x">, </span> <span class="NLM_fpage">173</span><span class="NLM_x">–</span> <span class="NLM_lpage">177</span><span class="refDoi"> DOI: 10.1038/34413</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=10.1038%2F34413" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=391&publication_year=1998&pages=173-177&author=M.+R.+Picciottoauthor=M.+Zoliauthor=R.+Rimondiniauthor=C.+Lenaauthor=L.+M.+Marubioauthor=E.+M.+Pichauthor=K.+Fuxeauthor=J.+P.+Changeux&title=Acetylcholine+receptors+containing+the+beta2+subunit+are+involved+in+the+reinforcing+properties+of+nicotine&doi=10.1038%2F34413"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2F34413&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F34413%26sid%3Dliteratum%253Aachs%26aulast%3DPicciotto%26aufirst%3DM.%2BR.%26aulast%3DZoli%26aufirst%3DM.%26aulast%3DRimondini%26aufirst%3DR.%26aulast%3DLena%26aufirst%3DC.%26aulast%3DMarubio%26aufirst%3DL.%2BM.%26aulast%3DPich%26aufirst%3DE.%2BM.%26aulast%3DFuxe%26aufirst%3DK.%26aulast%3DChangeux%26aufirst%3DJ.%2BP.%26atitle%3DAcetylcholine%2520receptors%2520containing%2520the%2520beta2%2520subunit%2520are%2520involved%2520in%2520the%2520reinforcing%2520properties%2520of%2520nicotine%26jtitle%3DNature%26date%3D1998%26volume%3D391%26spage%3D173%26epage%3D177%26doi%3D10.1038%2F34413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Stolerman, I. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoaib, M.</span><span> </span><span class="NLM_article-title">The neurobiology of tobacco addiction</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">467</span><span class="NLM_x">–</span> <span class="NLM_lpage">473</span><span class="refDoi"> DOI: 10.1016/0165-6147(91)90638-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=10.1016%2F0165-6147%2891%2990638-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1991&pages=467-473&author=I.+P.+Stolermanauthor=M.+Shoaib&title=The+neurobiology+of+tobacco+addiction&doi=10.1016%2F0165-6147%2891%2990638-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2F0165-6147%2891%2990638-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0165-6147%252891%252990638-9%26sid%3Dliteratum%253Aachs%26aulast%3DStolerman%26aufirst%3DI.%2BP.%26aulast%3DShoaib%26aufirst%3DM.%26atitle%3DThe%2520neurobiology%2520of%2520tobacco%2520addiction%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D1991%26volume%3D12%26spage%3D467%26epage%3D473%26doi%3D10.1016%2F0165-6147%2891%2990638-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Perry, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gold, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntosh, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pezzullo, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kellar, K. J.</span><span> </span><span class="NLM_article-title">Chronic nicotine differentially regulates alpha6- and beta3-containing nicotinic cholinergic receptors in rat brain</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">322</span><span class="NLM_x">, </span> <span class="NLM_fpage">306</span><span class="NLM_x">–</span> <span class="NLM_lpage">315</span><span class="refDoi"> DOI: 10.1124/jpet.107.121228</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=10.1124%2Fjpet.107.121228" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=17446303" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=1%3ACAS%3A528%3ADC%252BD2sXntl2jtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=322&publication_year=2007&pages=306-315&author=D.+C.+Perryauthor=D.+Maoauthor=A.+B.+Goldauthor=J.+M.+McIntoshauthor=J.+C.+Pezzulloauthor=K.+J.+Kellar&title=Chronic+nicotine+differentially+regulates+alpha6-+and+beta3-containing+nicotinic+cholinergic+receptors+in+rat+brain&doi=10.1124%2Fjpet.107.121228"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Chronic nicotine differentially regulates α6- and β3-containing nicotinic cholinergic receptors in rat brain</span></div><div class="casAuthors">Perry, David C.; Mao, Danyan; Gold, Allison B.; McIntosh, J. Michael; Pezzullo, John C.; Kellar, Kenneth J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">322</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">306-315</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The authors investigated the effects of chronic nicotine on α6- and β3-contg. nicotinic acetylcholine receptors (nAChRs) in 2 rat brain regions using 3 methodol. approaches: radioligand binding, immunopptn., and nicotine-stimulated synaptosomal release of dopamine.  Nicotine was administered by osmotic minipumps for 2 wk.  Quant. autoradiog. with [125I]α-conotoxin MII to selectively label α6* nAChRs showed a 28% decrease in binding in the striatum but no change in the superior colliculus.  Immunopptn. of nAChRs labeled by [3H]epibatidine in these 2 regions showed that chronic nicotine increased α4- and β2-contg. nAChRs by 39 to 67%.  In contrast, chronic nicotine caused a 39% decrease in α6-contg. nAChRs in the striatum but no change in the superior colliculus.  No changes in β3-contg. nAChRs were seen in either region after chronic nicotine.  The decreased expression of α6-contg. nAChRs persisted for at least 3 days, recovering to baseline by 7 days after removal of the pumps.  There was a small but significant decrease in total nicotine-stimulated dopamine release in striatal synaptosomes after nicotine exposure.  However, the component of dopamine release that was resistant to α-conotoxin MII blockade was unaffected, whereas dopamine release that was sensitive to blockade by α-conotoxin MII was decreased by 56%.  Apparently, the α6* nAChR is regulated differently from other nAChR subtypes, and the inclusion of a β3 subunit with α6 may serve to inhibit nicotine-induced down-regulation of these receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpf3ZipLqKbBbVg90H21EOLACvtfcHk0lgqu8vM2jty-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXntl2jtLY%253D&md5=4c5bcca04504d53d03749e58f9ddbb76</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1124%2Fjpet.107.121228&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.107.121228%26sid%3Dliteratum%253Aachs%26aulast%3DPerry%26aufirst%3DD.%2BC.%26aulast%3DMao%26aufirst%3DD.%26aulast%3DGold%26aufirst%3DA.%2BB.%26aulast%3DMcIntosh%26aufirst%3DJ.%2BM.%26aulast%3DPezzullo%26aufirst%3DJ.%2BC.%26aulast%3DKellar%26aufirst%3DK.%2BJ.%26atitle%3DChronic%2520nicotine%2520differentially%2520regulates%2520alpha6-%2520and%2520beta3-containing%2520nicotinic%2520cholinergic%2520receptors%2520in%2520rat%2520brain%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2007%26volume%3D322%26spage%3D306%26epage%3D315%26doi%3D10.1124%2Fjpet.107.121228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Perry, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, H. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Musachio, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davila-Garcia, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kellar, K. J.</span><span> </span><span class="NLM_article-title">Measuring nicotinic receptors with characteristics of alpha4beta2, alpha3beta2 and alpha3beta4 subtypes in rat tissues by autoradiography</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">468</span><span class="NLM_x">–</span> <span class="NLM_lpage">481</span><span class="refDoi"> DOI: 10.1046/j.1471-4159.2002.00951.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=10.1046%2Fj.1471-4159.2002.00951.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=12153472" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=1%3ACAS%3A528%3ADC%252BD38Xmt1ejs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2002&pages=468-481&author=D.+C.+Perryauthor=Y.+Xiaoauthor=H.+N.+Nguyenauthor=J.+L.+Musachioauthor=M.+I.+Davila-Garciaauthor=K.+J.+Kellar&title=Measuring+nicotinic+receptors+with+characteristics+of+alpha4beta2%2C+alpha3beta2+and+alpha3beta4+subtypes+in+rat+tissues+by+autoradiography&doi=10.1046%2Fj.1471-4159.2002.00951.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Measuring nicotinic receptors with characteristics of α4β2, α3β2 and α3β4 subtypes in rat tissues by autoradiography</span></div><div class="casAuthors">Perry, David C.; Xiao, Yingxian; Nguyen, Henry N.; Musachio, John L.; Davila-Garcia, Martha I.; Kellar, Kenneth J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">468-481</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">Comparison of [125I]epibatidine and [125I]A-85380 autoradiog. showed evidence for nicotinic receptor heterogeneity.  To identify the receptor subtypes, we performed [125I]epibatidine autoradiog. in the presence of cytisine or A-85380.  By comparing these results with binding data from human embryonic kidney (HEK) 293 cells stably transfected with different combinations of rat nicotinic receptor subunits, we were able to quantify three distinct populations of [125I]epibatidine binding sites with characteristics of α4β2, α3β2 and α3β4 receptors.  Although the predominant subtype in rat brain was α4β2, non-α4β2 binding sites were prominent in many regions.  In the habenulo-peduncular system, cerebellum, substantia gelatinosa, and many medullary nuclei, α3β4-like binding accounted for more than 40% of [125I]epibatidine binding, and nearly all binding in superior cervical ganglion and pineal gland.  Other regions enriched in α3β4-like binding included locus ceruleus, dorsal tegmentum, subiculum and anteroventral thalamic nucleus.  Regions enriched in α3β2-like binding included the habenulo-peduncular system, many visual system structures, certain geniculate nuclei, and dopaminergic regions.  The combination of autoradiog. using a broad spectrum radioligand in the presence of selective competitors, and data from binding to defined receptor subtypes in expression systems, allowed us to quantify the relative populations of these three subtypes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovDTZ1PG0SkbVg90H21EOLACvtfcHk0lijaWcsKlKWDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xmt1ejs7s%253D&md5=d8ab0027dff45775f4f70b27ad3d0911</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.2002.00951.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.2002.00951.x%26sid%3Dliteratum%253Aachs%26aulast%3DPerry%26aufirst%3DD.%2BC.%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DNguyen%26aufirst%3DH.%2BN.%26aulast%3DMusachio%26aufirst%3DJ.%2BL.%26aulast%3DDavila-Garcia%26aufirst%3DM.%2BI.%26aulast%3DKellar%26aufirst%3DK.%2BJ.%26atitle%3DMeasuring%2520nicotinic%2520receptors%2520with%2520characteristics%2520of%2520alpha4beta2%252C%2520alpha3beta2%2520and%2520alpha3beta4%2520subtypes%2520in%2520rat%2520tissues%2520by%2520autoradiography%26jtitle%3DJ.%2520Neurochem.%26date%3D2002%26volume%3D82%26spage%3D468%26epage%3D481%26doi%3D10.1046%2Fj.1471-4159.2002.00951.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Epping-Jordan, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picciotto, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Changeux, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pich, E. M.</span><span> </span><span class="NLM_article-title">Assessment of nicotinic acetylcholine receptor subunit contributions to nicotine self-administration in mutant mice</span> <span class="citation_source-journal">Psychopharmacology (Berl)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">147</span><span class="NLM_x">, </span> <span class="NLM_fpage">25</span><span class="NLM_x">–</span> <span class="NLM_lpage">26</span><span class="refDoi"> DOI: 10.1007/s002130051135</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=10.1007%2Fs002130051135" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=10591862" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=1%3ACAS%3A528%3ADC%252BD3cXpslOjsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=147&publication_year=1999&pages=25-26&author=M.+P.+Epping-Jordanauthor=M.+R.+Picciottoauthor=J.+P.+Changeuxauthor=E.+M.+Pich&title=Assessment+of+nicotinic+acetylcholine+receptor+subunit+contributions+to+nicotine+self-administration+in+mutant+mice&doi=10.1007%2Fs002130051135"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Assessment of nicotinic acetylcholine receptor subunit contributions to nicotine self-administration in mutant mice</span></div><div class="casAuthors">Epping-Jordan, Mark P.; Picciotto, Marina R.; Changeux, Jean-Pierre; Pich, Emilio Merlo</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Berlin)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">147</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">25-26</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">Genetic deletion of neuronal nicotine acetylcholine receptors (nAChrs) combined with mouse i.v. self-administration has provided a powerful approach for understanding the neuropharmacol. substrates of nicotine reinforcement.  Because nAChr mutant mice lack responsiveness to nicotine, a substitution procedure was employed.  Mice were first trained to self-administer cocaine until this behavior was stable.  Nicotine was then substituted for cocaine to det. if nicotine could maintain self-administration in wild type (WT) and mutant (Mut) mice.  A sep. group of WT mice received saline substituted for cocaine to demonstrate extinction of self-administration in a relevant control group.  This procedure allowed the detn. if contribution of β2-contg. nAChrs is specific to nicotine reinforcement or if these receptors play a more general role in operant learning or reinforcement.  A significant role for β2-contg. nAChrs in nicotine self-administration was demonstrated using a nicotine substitution self-administration procedure.  Further, the role of β2-contg. nAChrs appears to be specific to nicotine reinforcement because β2 Mut mice acquired a cocaine-reinforced discriminated operant response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeMGT1n2GIi7Vg90H21EOLACvtfcHk0lijaWcsKlKWDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXpslOjsg%253D%253D&md5=d5c58b33da2c363ed2e1ff4c51726140</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1007%2Fs002130051135&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs002130051135%26sid%3Dliteratum%253Aachs%26aulast%3DEpping-Jordan%26aufirst%3DM.%2BP.%26aulast%3DPicciotto%26aufirst%3DM.%2BR.%26aulast%3DChangeux%26aufirst%3DJ.%2BP.%26aulast%3DPich%26aufirst%3DE.%2BM.%26atitle%3DAssessment%2520of%2520nicotinic%2520acetylcholine%2520receptor%2520subunit%2520contributions%2520to%2520nicotine%2520self-administration%2520in%2520mutant%2520mice%26jtitle%3DPsychopharmacology%2520%2528Berl%2529%26date%3D1999%26volume%3D147%26spage%3D25%26epage%3D26%26doi%3D10.1007%2Fs002130051135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Tobey, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walentiny, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiley, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damaj, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azar, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koob, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">George, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vann, R. E.</span><span> </span><span class="NLM_article-title">Effects of the specific alpha4beta2 nachr antagonist, 2-fluoro-3-(4-nitrophenyl) deschloroepibatidine, on nicotine reward-related behaviors in rats and mice</span> <span class="citation_source-journal">Psychopharmacology (Berl)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">223</span><span class="NLM_x">, </span> <span class="NLM_fpage">159</span><span class="NLM_x">–</span> <span class="NLM_lpage">168</span><span class="refDoi"> DOI: 10.1007/s00213-012-2703-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=10.1007%2Fs00213-012-2703-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=22526534" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=1%3ACAS%3A280%3ADC%252BC38rnsVygsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=223&publication_year=2012&pages=159-168&author=K.+M.+Tobeyauthor=D.+M.+Walentinyauthor=J.+L.+Wileyauthor=F.+I.+Carrollauthor=M.+I.+Damajauthor=M.+R.+Azarauthor=G.+F.+Koobauthor=O.+Georgeauthor=L.+S.+Harrisauthor=R.+E.+Vann&title=Effects+of+the+specific+alpha4beta2+nachr+antagonist%2C+2-fluoro-3-%284-nitrophenyl%29+deschloroepibatidine%2C+on+nicotine+reward-related+behaviors+in+rats+and+mice&doi=10.1007%2Fs00213-012-2703-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of the specific α4β2 nAChR antagonist, 2-fluoro-3-(4-nitrophenyl) deschloroepibatidine, on nicotine reward-related behaviors in rats and mice</span></div><div class="casAuthors">Tobey K M; Walentiny D M; Wiley J L; Carroll F I; Damaj M I; Azar M R; Koob G F; George O; Harris L S; Vann R E</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">223</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">159-68</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">RATIONALE:  Alleviating addiction to tobacco products could prevent millions of deaths.  Investigating novel compounds selectively targeting α4β2 nAChRs hypothesized to have a key role in the rewarding effects of nicotine may be a useful approach for future treatment.  OBJECTIVES:  The present study was designed to evaluate 2-fluoro-3-(4-nitrophenyl) deschloroepibatidine (4-nitro-PFEB), a potent competitive antagonist of neuronal α4β2 nAChRs, in several animal models related to nicotine reward: drug discrimination, intracranial self-stimulation (ICSS), conditioned place preference, and limited access to self-administration.  METHODS:  Long Evans rats were trained in a two-lever discrimination procedure to discriminate 0.4 mg/kg nicotine (s.c.) from saline.  Male Sprague-Dawley rats were stereotaxically implanted with electrodes and trained to respond for direct electrical stimulation of the medial forebrain bundle.  ICR mice were evaluated using an unbiased place preference paradigm, and finally, male Wistar rats were implanted with intrajugular catheters and tested for nicotine self-administration under limited access (1 h/day).  RESULTS:  4-Nitro-PFEB attenuated the discriminative stimulus effects of nicotine, but alone did not produce nicotine-like discriminative stimulus effects.  Nicotine-induced facilitation of ICSS reward thresholds was reversed by 4-nitro-PFEB, which alone had no effect on thresholds. 4-Nitro-PFEB also blocked the conditioned place preference produced by nicotine, but alone had no effect on conditioned place preference.  Finally, 4-nitro-PFEB dose-dependently decreased nicotine self-administration.  CONCLUSIONS:  These results support the hypothesis that neuronal α4β2 nAChRs play a key role in mediating the rewarding effects of nicotine and further suggest that targeting α4β2 nAChRs may yield a potential candidate for the treatment of nicotine dependence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR1DbbUUbK00yEJCPKhJPuqfW6udTcc2eaVdc5i5IgB27ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38rnsVygsQ%253D%253D&md5=aef646d06eebc0f193974a9758607da1</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1007%2Fs00213-012-2703-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-012-2703-3%26sid%3Dliteratum%253Aachs%26aulast%3DTobey%26aufirst%3DK.%2BM.%26aulast%3DWalentiny%26aufirst%3DD.%2BM.%26aulast%3DWiley%26aufirst%3DJ.%2BL.%26aulast%3DCarroll%26aufirst%3DF.%2BI.%26aulast%3DDamaj%26aufirst%3DM.%2BI.%26aulast%3DAzar%26aufirst%3DM.%2BR.%26aulast%3DKoob%26aufirst%3DG.%2BF.%26aulast%3DGeorge%26aufirst%3DO.%26aulast%3DHarris%26aufirst%3DL.%2BS.%26aulast%3DVann%26aufirst%3DR.%2BE.%26atitle%3DEffects%2520of%2520the%2520specific%2520alpha4beta2%2520nachr%2520antagonist%252C%25202-fluoro-3-%25284-nitrophenyl%2529%2520deschloroepibatidine%252C%2520on%2520nicotine%2520reward-related%2520behaviors%2520in%2520rats%2520and%2520mice%26jtitle%3DPsychopharmacology%2520%2528Berl%2529%26date%3D2012%26volume%3D223%26spage%3D159%26epage%3D168%26doi%3D10.1007%2Fs00213-012-2703-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Watkins, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Epping-Jordan, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koob, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markou, A.</span><span> </span><span class="NLM_article-title">Blockade of nicotine self-administration with nicotinic antagonists in rats</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">743</span><span class="NLM_x">–</span> <span class="NLM_lpage">751</span><span class="refDoi"> DOI: 10.1016/S0091-3057(98)00226-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=10.1016%2FS0091-3057%2898%2900226-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=10208381" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=1%3ACAS%3A528%3ADyaK1MXitVCgsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=1999&pages=743-751&author=S.+S.+Watkinsauthor=M.+P.+Epping-Jordanauthor=G.+F.+Koobauthor=A.+Markou&title=Blockade+of+nicotine+self-administration+with+nicotinic+antagonists+in+rats&doi=10.1016%2FS0091-3057%2898%2900226-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Blockade of nicotine self-administration with nicotinic antagonists in rats</span></div><div class="casAuthors">Watkins, Shelly S.; Epping-Jordan, Mark P.; Koob, George F.; Markou, Athina</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology, Biochemistry and Behavior</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">743-751</span>CODEN:
                <span class="NLM_cas:coden">PBBHAU</span>;
        ISSN:<span class="NLM_cas:issn">0091-3057</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">The reinforcing properties of a variety of drugs abused by humans have been investigated using the technique of i.v. self-administration in the rat.  To examine the effect of nicotine dose on nicotine self-administration.  Wistar rats were allowed to self-administer various doses of nicotine using a within-subjects Latin square design.  An inverted U-shaped dose-response curve was obtained, with the highest rates of responding at the 0.03 mg/kg/inf dose.  With 1-h daily nicotine self-administration sessions, rats did not appear dependent on nicotine 24 h later, as indicated by the absence of somatic signs of withdrawal after s.c. injection of a nicotinic acetylcholine receptor antagonist, mecamylamine (0.57 mg/kg).  In another set of studies, pretreatment with s.c. mecamylamine or dihydro-β-erythroidine, two nicotinic acetylcholine receptor antagonists, resulted in significant dose-dependent redns. in nicotine self-administration, at two nicotine doses (0.03 and 0.06 mg/kg/inf).  These results indicate that nicotine is an effective reinforcer in Wistar rats under the present parameters, and that these reinforcing effects are mediated by activation of nicotinic acetylcholine receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5IH2IsK3dy7Vg90H21EOLACvtfcHk0liqUpJTCm5UTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXitVCgsLw%253D&md5=9210da30662bc26091400fa9a4397303</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2FS0091-3057%2898%2900226-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0091-3057%252898%252900226-3%26sid%3Dliteratum%253Aachs%26aulast%3DWatkins%26aufirst%3DS.%2BS.%26aulast%3DEpping-Jordan%26aufirst%3DM.%2BP.%26aulast%3DKoob%26aufirst%3DG.%2BF.%26aulast%3DMarkou%26aufirst%3DA.%26atitle%3DBlockade%2520of%2520nicotine%2520self-administration%2520with%2520nicotinic%2520antagonists%2520in%2520rats%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D1999%26volume%3D62%26spage%3D743%26epage%3D751%26doi%3D10.1016%2FS0091-3057%2898%2900226-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Fowler, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marks, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenny, P. J.</span><span> </span><span class="NLM_article-title">Habenular α5 nicotinic receptor subunit signalling controls nicotine intake</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">471</span><span class="NLM_x">, </span> <span class="NLM_fpage">597</span><span class="NLM_x">–</span> <span class="NLM_lpage">601</span><span class="refDoi"> DOI: 10.1038/nature09797</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=10.1038%2Fnature09797" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=471&publication_year=2011&pages=597-601&author=C.+D.+Fowlerauthor=Q.+Luauthor=P.+M.+Johnsonauthor=M.+J.+Marksauthor=P.+J.+Kenny&title=Habenular+%CE%B15+nicotinic+receptor+subunit+signalling+controls+nicotine+intake&doi=10.1038%2Fnature09797"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fnature09797&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature09797%26sid%3Dliteratum%253Aachs%26aulast%3DFowler%26aufirst%3DC.%2BD.%26aulast%3DLu%26aufirst%3DQ.%26aulast%3DJohnson%26aufirst%3DP.%2BM.%26aulast%3DMarks%26aufirst%3DM.%2BJ.%26aulast%3DKenny%26aufirst%3DP.%2BJ.%26atitle%3DHabenular%2520%25CE%25B15%2520nicotinic%2520receptor%2520subunit%2520signalling%2520controls%2520nicotine%2520intake%26jtitle%3DNature%26date%3D2011%26volume%3D471%26spage%3D597%26epage%3D601%26doi%3D10.1038%2Fnature09797" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Frahm, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slimak, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrarese, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santos-Torres, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antolin-Fontes, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filkin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pons, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fontaine, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsetlin, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maskos, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ibanez-Tallon, I.</span><span> </span><span class="NLM_article-title">Aversion to nicotine is regulated by the balanced activity of beta4 and alpha5 nicotinic receptor subunits in the medial habenula</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">522</span><span class="NLM_x">–</span> <span class="NLM_lpage">535</span><span class="refDoi"> DOI: 10.1016/j.neuron.2011.04.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=10.1016%2Fj.neuron.2011.04.013" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2011&pages=522-535&author=S.+Frahmauthor=M.+A.+Slimakauthor=L.+Ferrareseauthor=J.+Santos-Torresauthor=B.+Antolin-Fontesauthor=S.+Auerauthor=S.+Filkinauthor=S.+Ponsauthor=J.+F.+Fontaineauthor=V.+Tsetlinauthor=U.+Maskosauthor=I.+Ibanez-Tallon&title=Aversion+to+nicotine+is+regulated+by+the+balanced+activity+of+beta4+and+alpha5+nicotinic+receptor+subunits+in+the+medial+habenula&doi=10.1016%2Fj.neuron.2011.04.013"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2011.04.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2011.04.013%26sid%3Dliteratum%253Aachs%26aulast%3DFrahm%26aufirst%3DS.%26aulast%3DSlimak%26aufirst%3DM.%2BA.%26aulast%3DFerrarese%26aufirst%3DL.%26aulast%3DSantos-Torres%26aufirst%3DJ.%26aulast%3DAntolin-Fontes%26aufirst%3DB.%26aulast%3DAuer%26aufirst%3DS.%26aulast%3DFilkin%26aufirst%3DS.%26aulast%3DPons%26aufirst%3DS.%26aulast%3DFontaine%26aufirst%3DJ.%2BF.%26aulast%3DTsetlin%26aufirst%3DV.%26aulast%3DMaskos%26aufirst%3DU.%26aulast%3DIbanez-Tallon%26aufirst%3DI.%26atitle%3DAversion%2520to%2520nicotine%2520is%2520regulated%2520by%2520the%2520balanced%2520activity%2520of%2520beta4%2520and%2520alpha5%2520nicotinic%2520receptor%2520subunits%2520in%2520the%2520medial%2520habenula%26jtitle%3DNeuron%26date%3D2011%26volume%3D70%26spage%3D522%26epage%3D535%26doi%3D10.1016%2Fj.neuron.2011.04.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Harrington, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vinals, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrera-Solis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flores, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faure, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maldonado, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maskos, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robledo, P.</span><span> </span><span class="NLM_article-title">Role of beta4* nicotinic acetylcholine receptors in the habenulo-interpeduncular pathway in nicotine reinforcement in mice</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">1790</span><span class="NLM_x">–</span> <span class="NLM_lpage">1802</span><span class="refDoi"> DOI: 10.1038/npp.2015.346</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=10.1038%2Fnpp.2015.346" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2016&pages=1790-1802&author=L.+Harringtonauthor=X.+Vinalsauthor=A.+Herrera-Solisauthor=A.+Floresauthor=C.+Morelauthor=S.+Toluauthor=P.+Faureauthor=R.+Maldonadoauthor=U.+Maskosauthor=P.+Robledo&title=Role+of+beta4*+nicotinic+acetylcholine+receptors+in+the+habenulo-interpeduncular+pathway+in+nicotine+reinforcement+in+mice&doi=10.1038%2Fnpp.2015.346"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2015.346&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2015.346%26sid%3Dliteratum%253Aachs%26aulast%3DHarrington%26aufirst%3DL.%26aulast%3DVinals%26aufirst%3DX.%26aulast%3DHerrera-Solis%26aufirst%3DA.%26aulast%3DFlores%26aufirst%3DA.%26aulast%3DMorel%26aufirst%3DC.%26aulast%3DTolu%26aufirst%3DS.%26aulast%3DFaure%26aufirst%3DP.%26aulast%3DMaldonado%26aufirst%3DR.%26aulast%3DMaskos%26aufirst%3DU.%26aulast%3DRobledo%26aufirst%3DP.%26atitle%3DRole%2520of%2520beta4%252A%2520nicotinic%2520acetylcholine%2520receptors%2520in%2520the%2520habenulo-interpeduncular%2520pathway%2520in%2520nicotine%2520reinforcement%2520in%2520mice%26jtitle%3DNeuropsychopharmacology%26date%3D2016%26volume%3D41%26spage%3D1790%26epage%3D1802%26doi%3D10.1038%2Fnpp.2015.346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Morel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fattore, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pons, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hay, Y. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambolez, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Biasi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lathrop, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fratta, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maskos, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faure, P.</span><span> </span><span class="NLM_article-title">Nicotine consumption is regulated by a human polymorphism in dopamine neurons</span> <span class="citation_source-journal">Mol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">930</span><span class="NLM_x">–</span> <span class="NLM_lpage">936</span><span class="refDoi"> DOI: 10.1038/mp.2013.158</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=10.1038%2Fmp.2013.158" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=24296975" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFent7nL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2014&pages=930-936&author=C.+Morelauthor=L.+Fattoreauthor=S.+Ponsauthor=Y.+A.+Hayauthor=F.+Martiauthor=B.+Lambolezauthor=M.+De+Biasiauthor=M.+Lathropauthor=W.+Frattaauthor=U.+Maskosauthor=P.+Faure&title=Nicotine+consumption+is+regulated+by+a+human+polymorphism+in+dopamine+neurons&doi=10.1038%2Fmp.2013.158"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Nicotine consumption is regulated by a human polymorphism in dopamine neurons</span></div><div class="casAuthors">Morel, C.; Fattore, L.; Pons, S.; Hay, Y. A.; Marti, F.; Lambolez, B.; De Biasi, M.; Lathrop, M.; Fratta, W.; Maskos, U.; Faure, P.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Psychiatry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">930-936</span>CODEN:
                <span class="NLM_cas:coden">MOPSFQ</span>;
        ISSN:<span class="NLM_cas:issn">1359-4184</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Smoking is the most important preventable cause of morbidity and mortality worldwide.  Recent genome-wide assocn. studies highlighted a human haplotype on chromosome 15 underlying the risk for tobacco dependence and lung cancer.  Several polymorphisms in the CHRNA3-CHRNA5-CHRNB4 cluster coding for the nicotinic acetylcholine receptor (nAChR) α3, α5 and β4 subunits were implicated.  In mouse models, we define a key role in the control of sensitivity to nicotine for the α5 subunit in dopaminergic (DAergic) neurons of the ventral tegmental area (VTA).  We first investigated the reinforcing effects of nicotine in drug-naive α5-/- mice using an acute i.v. nicotine self-administration task and ex vivo and in vivo electrophysiol. recordings of nicotine-elicited DA cell activation.  We designed lentiviral re-expression vectors to achieve targeted re-expression of wild-type or mutant α5 in the VTA, in general, or in DA neurons exclusively.  Our results establish a crucial role for α5*-nAChRs in DAergic neurons.  These receptors are key regulators that det. the min. nicotine dose necessary for DA cell activation and thus nicotine reinforcement.  Finally, we demonstrate that a single-nucleotide polymorphism, the non-synonymous α5 variant rs16969968, frequent in many human populations, exhibits a partial loss of function of the protein in vivo.  This leads to increased nicotine consumption in the self-administration paradigm.  We thus define a crit. link between a human predisposition marker, its expression in DA neurons and nicotine intake.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0HXYJq7vF07Vg90H21EOLACvtfcHk0lhnLhuZFAU2Qw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFent7nL&md5=24748cfd2d7781cf2eeb5685d015af51</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fmp.2013.158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fmp.2013.158%26sid%3Dliteratum%253Aachs%26aulast%3DMorel%26aufirst%3DC.%26aulast%3DFattore%26aufirst%3DL.%26aulast%3DPons%26aufirst%3DS.%26aulast%3DHay%26aufirst%3DY.%2BA.%26aulast%3DMarti%26aufirst%3DF.%26aulast%3DLambolez%26aufirst%3DB.%26aulast%3DDe%2BBiasi%26aufirst%3DM.%26aulast%3DLathrop%26aufirst%3DM.%26aulast%3DFratta%26aufirst%3DW.%26aulast%3DMaskos%26aufirst%3DU.%26aulast%3DFaure%26aufirst%3DP.%26atitle%3DNicotine%2520consumption%2520is%2520regulated%2520by%2520a%2520human%2520polymorphism%2520in%2520dopamine%2520neurons%26jtitle%3DMol.%2520Psychiatry%26date%3D2014%26volume%3D19%26spage%3D930%26epage%3D936%26doi%3D10.1038%2Fmp.2013.158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Houghten, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinilla, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giulianotti, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Appel, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dooley, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nefzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ostresh, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maggiora, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medina-Franco, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunner, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, J.</span><span> </span><span class="NLM_article-title">Strategies for the use of mixture-based synthetic combinatorial libraries: Scaffold ranking, direct testing in vivo, and enhanced deconvolution by computational methods</span> <span class="citation_source-journal">J. Comb. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">19</span><span class="refDoi"> DOI: 10.1021/cc7001205</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cc7001205" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVWgurfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2008&pages=3-19&author=R.+A.+Houghtenauthor=C.+Pinillaauthor=M.+A.+Giulianottiauthor=J.+R.+Appelauthor=C.+T.+Dooleyauthor=A.+Nefziauthor=J.+M.+Ostreshauthor=Y.+Yuauthor=G.+M.+Maggioraauthor=J.+L.+Medina-Francoauthor=D.+Brunnerauthor=J.+Schneider&title=Strategies+for+the+use+of+mixture-based+synthetic+combinatorial+libraries%3A+Scaffold+ranking%2C+direct+testing+in+vivo%2C+and+enhanced+deconvolution+by+computational+methods&doi=10.1021%2Fcc7001205"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Strategies for the Use of Mixture-Based Synthetic Combinatorial Libraries: Scaffold Ranking, Direct Testing In Vivo, and Enhanced Deconvolution by Computational Methods</span></div><div class="casAuthors">Houghten, Richard A.; Pinilla, Clemencia; Giulianotti, Marc A.; Appel, Jon R.; Dooley, Colette T.; Nefzi, Adel; Ostresh, John M.; Yu, Yongping; Maggiora, Gerald M.; Medina-Franco, Jose L.; Brunner, Daniela; Schneider, Jeff</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Combinatorial Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-19</span>CODEN:
                <span class="NLM_cas:coden">JCCHFF</span>;
        ISSN:<span class="NLM_cas:issn">1520-4766</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHw0Bw1Gl2KLVg90H21EOLACvtfcHk0lglk1z8Mm808Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVWgurfK&md5=9693c04842ee3232043fd2d8a5dabd44</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fcc7001205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcc7001205%26sid%3Dliteratum%253Aachs%26aulast%3DHoughten%26aufirst%3DR.%2BA.%26aulast%3DPinilla%26aufirst%3DC.%26aulast%3DGiulianotti%26aufirst%3DM.%2BA.%26aulast%3DAppel%26aufirst%3DJ.%2BR.%26aulast%3DDooley%26aufirst%3DC.%2BT.%26aulast%3DNefzi%26aufirst%3DA.%26aulast%3DOstresh%26aufirst%3DJ.%2BM.%26aulast%3DYu%26aufirst%3DY.%26aulast%3DMaggiora%26aufirst%3DG.%2BM.%26aulast%3DMedina-Franco%26aufirst%3DJ.%2BL.%26aulast%3DBrunner%26aufirst%3DD.%26aulast%3DSchneider%26aufirst%3DJ.%26atitle%3DStrategies%2520for%2520the%2520use%2520of%2520mixture-based%2520synthetic%2520combinatorial%2520libraries%253A%2520Scaffold%2520ranking%252C%2520direct%2520testing%2520in%2520vivo%252C%2520and%2520enhanced%2520deconvolution%2520by%2520computational%2520methods%26jtitle%3DJ.%2520Comb.%2520Chem.%26date%3D2008%26volume%3D10%26spage%3D3%26epage%3D19%26doi%3D10.1021%2Fcc7001205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Lopez-Vallejo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giulianotti, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houghten, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medina-Franco, J. L.</span><span> </span><span class="NLM_article-title">Expanding the medicinally relevant chemical space with compound libraries</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">718</span><span class="NLM_x">–</span> <span class="NLM_lpage">726</span><span class="refDoi"> DOI: 10.1016/j.drudis.2012.04.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=10.1016%2Fj.drudis.2012.04.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=22515962" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=1%3ACAS%3A528%3ADC%252BC38XmtFektL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2012&pages=718-726&author=F.+Lopez-Vallejoauthor=M.+A.+Giulianottiauthor=R.+A.+Houghtenauthor=J.+L.+Medina-Franco&title=Expanding+the+medicinally+relevant+chemical+space+with+compound+libraries&doi=10.1016%2Fj.drudis.2012.04.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Expanding the medicinally relevant chemical space with compound libraries</span></div><div class="casAuthors">Lopez-Vallejo, Fabian; Giulianotti, Marc A.; Houghten, Richard A.; Medina-Franco, Jose L.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">13-14</span>),
    <span class="NLM_cas:pages">718-726</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Anal. of marketed drugs and com. vendor libraries used in high-throughput screening suggests that the medicinally relevant chem. space may be expanded to unexplored regions.  Novel regions of the chem. space can be conveniently explored with structurally unique mols. with increased complexity and balanced physicochem. properties.  As a case study, we discuss the chemoinformatic profile of natural products in the Traditional Chinese Medicine (TCM) database and a large collection assembled from 30 small-mol. combinatorial libraries with emphasis on assessing mol. complexity.  The herein surveyed combinatorial libraries have been successfully used over the past 20 years to identify novel bioactive compds. across different therapeutic areas.  Combinatorial libraries and natural products are suitable sources to expand the traditional relevant medicinal chem. space.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhT55nczC7sbVg90H21EOLACvtfcHk0lglk1z8Mm808Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmtFektL0%253D&md5=e47776f21c5f0154c37094db030b2b9a</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2012.04.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2012.04.001%26sid%3Dliteratum%253Aachs%26aulast%3DLopez-Vallejo%26aufirst%3DF.%26aulast%3DGiulianotti%26aufirst%3DM.%2BA.%26aulast%3DHoughten%26aufirst%3DR.%2BA.%26aulast%3DMedina-Franco%26aufirst%3DJ.%2BL.%26atitle%3DExpanding%2520the%2520medicinally%2520relevant%2520chemical%2520space%2520with%2520compound%2520libraries%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2012%26volume%3D17%26spage%3D718%26epage%3D726%26doi%3D10.1016%2Fj.drudis.2012.04.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Wu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maida, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santos, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welmaker, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaVoi, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nefzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houghten, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toll, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giulianotti, M. A.</span><span> </span><span class="NLM_article-title">Scaffold ranking and positional scanning utilized in the discovery of nachr-selective compounds suitable for optimization studies</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">10103</span><span class="NLM_x">–</span> <span class="NLM_lpage">10117</span><span class="refDoi"> DOI: 10.1021/jm401543h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401543h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=10103-10117&author=J.+Wuauthor=Y.+Zhangauthor=L.+E.+Maidaauthor=R.+G.+Santosauthor=G.+S.+Welmakerauthor=T.+M.+LaVoiauthor=A.+Nefziauthor=Y.+Yuauthor=R.+A.+Houghtenauthor=L.+Tollauthor=M.+A.+Giulianotti&title=Scaffold+ranking+and+positional+scanning+utilized+in+the+discovery+of+nachr-selective+compounds+suitable+for+optimization+studies&doi=10.1021%2Fjm401543h"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm401543h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401543h%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DMaida%26aufirst%3DL.%2BE.%26aulast%3DSantos%26aufirst%3DR.%2BG.%26aulast%3DWelmaker%26aufirst%3DG.%2BS.%26aulast%3DLaVoi%26aufirst%3DT.%2BM.%26aulast%3DNefzi%26aufirst%3DA.%26aulast%3DYu%26aufirst%3DY.%26aulast%3DHoughten%26aufirst%3DR.%2BA.%26aulast%3DToll%26aufirst%3DL.%26aulast%3DGiulianotti%26aufirst%3DM.%2BA.%26atitle%3DScaffold%2520ranking%2520and%2520positional%2520scanning%2520utilized%2520in%2520the%2520discovery%2520of%2520nachr-selective%2520compounds%2520suitable%2520for%2520optimization%2520studies%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D10103%26epage%3D10117%26doi%3D10.1021%2Fjm401543h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Pajouhesh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenz, G. R.</span><span> </span><span class="NLM_article-title">Medicinal chemical properties of successful central nervous system drugs</span> <span class="citation_source-journal">NeuroRx</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">541</span><span class="NLM_x">–</span> <span class="NLM_lpage">553</span><span class="refDoi"> DOI: 10.1602/neurorx.2.4.541</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=10.1602%2Fneurorx.2.4.541" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=16489364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=1%3ACAS%3A280%3ADC%252BD28%252FpvVKqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2005&pages=541-553&author=H.+Pajouheshauthor=G.+R.+Lenz&title=Medicinal+chemical+properties+of+successful+central+nervous+system+drugs&doi=10.1602%2Fneurorx.2.4.541"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal chemical properties of successful central nervous system drugs</span></div><div class="casAuthors">Pajouhesh Hassan; Lenz George R</div><div class="citationInfo"><span class="NLM_cas:title">NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">541-53</span>
        ISSN:<span class="NLM_cas:issn">1545-5343</span>.
    </div><div class="casAbstract">Fundamental physiochemical features of CNS drugs are related to their ability to penetrate the blood-brain barrier affinity and exhibit CNS activity.  Factors relevant to the success of CNS drugs are reviewed.  CNS drugs show values of molecular weight, lipophilicity, and hydrogen bond donor and acceptor that in general have a smaller range than general therapeutics.  Pharmacokinetic properties can be manipulated by the medicinal chemist to a significant extent.  The solubility, permeability, metabolic stability, protein binding, and human ether-ago-go-related gene inhibition of CNS compounds need to be optimized simultaneously with potency, selectivity, and other biological parameters.  The balance between optimizing the physiochemical and pharmacokinetic properties to make the best compromises in properties is critical for designing new drugs likely to penetrate the blood brain barrier and affect relevant biological systems.  This review is intended as a guide to designing CNS therapeutic agents with better drug-like properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT_ncsy3yuEinl8icjszYl0fW6udTcc2ebFyFKuJFRftbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28%252FpvVKqsg%253D%253D&md5=0815084e2d107b9243b785d0782dfc3a</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1602%2Fneurorx.2.4.541&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1602%252Fneurorx.2.4.541%26sid%3Dliteratum%253Aachs%26aulast%3DPajouhesh%26aufirst%3DH.%26aulast%3DLenz%26aufirst%3DG.%2BR.%26atitle%3DMedicinal%2520chemical%2520properties%2520of%2520successful%2520central%2520nervous%2520system%2520drugs%26jtitle%3DNeuroRx%26date%3D2005%26volume%3D2%26spage%3D541%26epage%3D553%26doi%3D10.1602%2Fneurorx.2.4.541" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Carroll, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ware, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brieaddy, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navarro, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damaj, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, B. R.</span><span> </span><span class="NLM_article-title">Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 2′-fluoro-3′-(substituted phenyl)deschloroepibatidine analogues. Novel nicotinic antagonist</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">4588</span><span class="NLM_x">–</span> <span class="NLM_lpage">4594</span><span class="refDoi"> DOI: 10.1021/jm040078g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm040078g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=4588-4594&author=F.+I.+Carrollauthor=R.+Wareauthor=L.+E.+Brieaddyauthor=H.+A.+Navarroauthor=M.+I.+Damajauthor=B.+R.+Martin&title=Synthesis%2C+nicotinic+acetylcholine+receptor+binding%2C+and+antinociceptive+properties+of+2%E2%80%B2-fluoro-3%E2%80%B2-%28substituted+phenyl%29deschloroepibatidine+analogues.+Novel+nicotinic+antagonist&doi=10.1021%2Fjm040078g"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm040078g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm040078g%26sid%3Dliteratum%253Aachs%26aulast%3DCarroll%26aufirst%3DF.%2BI.%26aulast%3DWare%26aufirst%3DR.%26aulast%3DBrieaddy%26aufirst%3DL.%2BE.%26aulast%3DNavarro%26aufirst%3DH.%2BA.%26aulast%3DDamaj%26aufirst%3DM.%2BI.%26aulast%3DMartin%26aufirst%3DB.%2BR.%26atitle%3DSynthesis%252C%2520nicotinic%2520acetylcholine%2520receptor%2520binding%252C%2520and%2520antinociceptive%2520properties%2520of%25202%25E2%2580%25B2-fluoro-3%25E2%2580%25B2-%2528substituted%2520phenyl%2529deschloroepibatidine%2520analogues.%2520Novel%2520nicotinic%2520antagonist%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D4588%26epage%3D4594%26doi%3D10.1021%2Fjm040078g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Mihalak, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luetje, C. W.</span><span> </span><span class="NLM_article-title">Varenicline is a partial agonist at alpha4beta2 and a full agonist at alpha7 neuronal nicotinic receptors</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">801</span><span class="NLM_x">–</span> <span class="NLM_lpage">805</span><span class="refDoi"> DOI: 10.1124/mol.106.025130</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=10.1124%2Fmol.106.025130" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2006&pages=801-805&author=K.+B.+Mihalakauthor=F.+I.+Carrollauthor=C.+W.+Luetje&title=Varenicline+is+a+partial+agonist+at+alpha4beta2+and+a+full+agonist+at+alpha7+neuronal+nicotinic+receptors&doi=10.1124%2Fmol.106.025130"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1124%2Fmol.106.025130&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.106.025130%26sid%3Dliteratum%253Aachs%26aulast%3DMihalak%26aufirst%3DK.%2BB.%26aulast%3DCarroll%26aufirst%3DF.%2BI.%26aulast%3DLuetje%26aufirst%3DC.%2BW.%26atitle%3DVarenicline%2520is%2520a%2520partial%2520agonist%2520at%2520alpha4beta2%2520and%2520a%2520full%2520agonist%2520at%2520alpha7%2520neuronal%2520nicotinic%2520receptors%26jtitle%3DMol.%2520Pharmacol.%26date%3D2006%26volume%3D70%26spage%3D801%26epage%3D805%26doi%3D10.1124%2Fmol.106.025130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Chatterjee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steensland, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simms, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holgate, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coe, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurst, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaffer, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rollema, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartlett, S. E.</span><span> </span><span class="NLM_article-title">Partial agonists of the alpha3beta4* neuronal nicotinic acetylcholine receptor reduce ethanol consumption and seeking in rats</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">603</span><span class="NLM_x">–</span> <span class="NLM_lpage">615</span><span class="refDoi"> DOI: 10.1038/npp.2010.191</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=10.1038%2Fnpp.2010.191" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2011&pages=603-615&author=S.+Chatterjeeauthor=P.+Steenslandauthor=J.+A.+Simmsauthor=J.+Holgateauthor=J.+W.+Coeauthor=R.+S.+Hurstauthor=C.+L.+Shafferauthor=J.+Loweauthor=H.+Rollemaauthor=S.+E.+Bartlett&title=Partial+agonists+of+the+alpha3beta4*+neuronal+nicotinic+acetylcholine+receptor+reduce+ethanol+consumption+and+seeking+in+rats&doi=10.1038%2Fnpp.2010.191"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2010.191&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2010.191%26sid%3Dliteratum%253Aachs%26aulast%3DChatterjee%26aufirst%3DS.%26aulast%3DSteensland%26aufirst%3DP.%26aulast%3DSimms%26aufirst%3DJ.%2BA.%26aulast%3DHolgate%26aufirst%3DJ.%26aulast%3DCoe%26aufirst%3DJ.%2BW.%26aulast%3DHurst%26aufirst%3DR.%2BS.%26aulast%3DShaffer%26aufirst%3DC.%2BL.%26aulast%3DLowe%26aufirst%3DJ.%26aulast%3DRollema%26aufirst%3DH.%26aulast%3DBartlett%26aufirst%3DS.%2BE.%26atitle%3DPartial%2520agonists%2520of%2520the%2520alpha3beta4%252A%2520neuronal%2520nicotinic%2520acetylcholine%2520receptor%2520reduce%2520ethanol%2520consumption%2520and%2520seeking%2520in%2520rats%26jtitle%3DNeuropsychopharmacology%26date%3D2011%26volume%3D36%26spage%3D603%26epage%3D615%26doi%3D10.1038%2Fnpp.2010.191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Cippitelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaiolini, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercatelli, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoch, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramirez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciccocioppo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khroyan, T. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasuda, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaveri, N. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pascual, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, X. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toll, L.</span><span> </span><span class="NLM_article-title">At-1001: A high-affinity alpha3beta4 nachr ligand with novel nicotine-suppressive pharmacology</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">172</span><span class="NLM_x">, </span> <span class="NLM_fpage">1834</span><span class="NLM_x">–</span> <span class="NLM_lpage">1845</span><span class="refDoi"> DOI: 10.1111/bph.13034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=10.1111%2Fbph.13034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=25440006" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlslemt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=172&publication_year=2015&pages=1834-1845&author=A.+Cippitelliauthor=J.+Wuauthor=K.+A.+Gaioliniauthor=D.+Mercatelliauthor=J.+Schochauthor=M.+Gormanauthor=A.+Ramirezauthor=R.+Ciccocioppoauthor=T.+V.+Khroyanauthor=D.+Yasudaauthor=N.+T.+Zaveriauthor=C.+Pascualauthor=X.+S.+Xieauthor=L.+Toll&title=At-1001%3A+A+high-affinity+alpha3beta4+nachr+ligand+with+novel+nicotine-suppressive+pharmacology&doi=10.1111%2Fbph.13034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">AT-1001: a high-affinity α3β4 nAChR ligand with novel nicotine-suppressive pharmacology</span></div><div class="casAuthors">Cippitelli, Andrea; Wu, Jinhua; Gaiolini, Kelly A.; Mercatelli, Daniela; Schoch, Jennifer; Gorman, Michelle; Ramirez, Alejandra; Ciccocioppo, Roberto; Khroyan, Taline V.; Yasuda, Dennis; Zaveri, Nurulain T.; Pascual, Conrado; Xie, Xinmin; Toll, Lawrence</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">172</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1834-1845</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose : The α3β4 subtype of nicotinic acetylcholine receptors (nAChRs) has been implicated in mediating nicotine reinforcement processes.  AT-1001 has been recently described as a high-affinity and selective α3β4 nAChR antagonist that blocks nicotine self-administration in rats.  The aim of this study was to investigate the mechanism of action underlying the nicotine-suppressive effects of AT-1001.  Exptl. Approach : Effects of AT-1001 were detd. using in vitro assays and rat models of nicotine addiction, and compared with varenicline.  Key Results : AT-1001 and its analog AT-1012 were functionally selective as antagonists for α3β4 over α4β2 nAChRs, but not to the same extent as the binding selectivity, and had partial agonist activity at α3β4 nAChRs.  In contrast, varenicline was a partial agonist at α4β2, a weak agonist at α3β4 and inhibited α4β2 at a much lower concn. than it inhibited α3β4 nAChRs.  AT-1001 and varenicline also had very different in vivo properties.  Firstly, AT-1001 did not exhibit reinforcing properties per se while varenicline was self-administered.  Secondly, systemic treatment with AT-1001 did not induce reinstatement of nicotine seeking but rather attenuated reinstatement induced by varenicline, as well as nicotine.  Finally, unlike varenicline, AT-1001 selectively blocked nicotine self-administration without altering alc. lever pressing as assessed in an operant co-administration paradigm.  Conclusions and Implications : These findings describe a more complex AT-1001 in vitro profile than previously appreciated and provide further support for the potential of AT-1001 and congeners as clin. useful compds. for smoking cessation, with a mechanism of action distinct from currently available medications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIvmIl3YNpC7Vg90H21EOLACvtfcHk0liYdto8kuyS1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlslemt7s%253D&md5=297041f4f7d470f729ff233fca6ea89d</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1111%2Fbph.13034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.13034%26sid%3Dliteratum%253Aachs%26aulast%3DCippitelli%26aufirst%3DA.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DGaiolini%26aufirst%3DK.%2BA.%26aulast%3DMercatelli%26aufirst%3DD.%26aulast%3DSchoch%26aufirst%3DJ.%26aulast%3DGorman%26aufirst%3DM.%26aulast%3DRamirez%26aufirst%3DA.%26aulast%3DCiccocioppo%26aufirst%3DR.%26aulast%3DKhroyan%26aufirst%3DT.%2BV.%26aulast%3DYasuda%26aufirst%3DD.%26aulast%3DZaveri%26aufirst%3DN.%2BT.%26aulast%3DPascual%26aufirst%3DC.%26aulast%3DXie%26aufirst%3DX.%2BS.%26aulast%3DToll%26aufirst%3DL.%26atitle%3DAt-1001%253A%2520A%2520high-affinity%2520alpha3beta4%2520nachr%2520ligand%2520with%2520novel%2520nicotine-suppressive%2520pharmacology%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2015%26volume%3D172%26spage%3D1834%26epage%3D1845%26doi%3D10.1111%2Fbph.13034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Rollema, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chambers, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coe, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glowa, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurst, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebel, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansbach, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mather, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rovetti, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sands, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaeffer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulz, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tingley, F. D.,  3rd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, K. E.</span><span> </span><span class="NLM_article-title">Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">985</span><span class="NLM_x">–</span> <span class="NLM_lpage">994</span><span class="refDoi"> DOI: 10.1016/j.neuropharm.2006.10.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=10.1016%2Fj.neuropharm.2006.10.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=17157884" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhvVyqtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2007&pages=985-994&author=H.+Rollemaauthor=L.+K.+Chambersauthor=J.+W.+Coeauthor=J.+Glowaauthor=R.+S.+Hurstauthor=L.+A.+Lebelauthor=Y.+Luauthor=R.+S.+Mansbachauthor=R.+J.+Matherauthor=C.+C.+Rovettiauthor=S.+B.+Sandsauthor=E.+Schaefferauthor=D.+W.+Schulzauthor=F.+D.+Tingleyauthor=K.+E.+Williams&title=Pharmacological+profile+of+the+alpha4beta2+nicotinic+acetylcholine+receptor+partial+agonist+varenicline%2C+an+effective+smoking+cessation+aid&doi=10.1016%2Fj.neuropharm.2006.10.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological profile of the α4β2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid</span></div><div class="casAuthors">Rollema, H.; Chambers, L. K.; Coe, J. W.; Glowa, J.; Hurst, R. S.; Lebel, L. A.; Lu, Y.; Mansbach, R. S.; Mather, R. J.; Rovetti, C. C.; Sands, S. B.; Schaeffer, E.; Schulz, D. W.; Tingley, F. D.; Williams, K. E.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">985-994</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The preclin. pharmacol. of the α4β2 nicotinic acetylcholine receptor (nAChR) partial agonist varenicline, a novel smoking cessation agent is described.  Varenicline binds with subnanomolar affinity only to α4β2 nAChRs and in vitro functional patch clamp studies in HEK cells expressing nAChRs show that varenicline is a partial agonist with 45% of nicotine's maximal efficacy at α4β2 nAChRs.  In neurochem. models varenicline has significantly lower (40-60%) efficacy than nicotine in stimulating [3H]-dopamine release from rat brain slices in vitro and in increasing dopamine release from rat nucleus accumbens in vivo, while it is more potent than nicotine.  In addn., when combined with nicotine, varenicline effectively attenuates the nicotine-induced dopamine release to the level of the effect of varenicline alone, consistent with partial agonism.  Finally, varenicline reduces nicotine self-administration in rats and supports lower self-administration break points than nicotine.  These data suggest that varenicline can reproduce to some extent the subjective effects of smoking by partially activating α4β2 nAChRs, while preventing full activation of these receptors by nicotine.  Based on these findings, varenicline was advanced into clin. development and recently shown to be an effective and safe aid for smoking cessation treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgBqovXuf1ALVg90H21EOLACvtfcHk0liYdto8kuyS1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhvVyqtbw%253D&md5=11199806966b56bd3f075a4a902fe206</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2006.10.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2006.10.016%26sid%3Dliteratum%253Aachs%26aulast%3DRollema%26aufirst%3DH.%26aulast%3DChambers%26aufirst%3DL.%2BK.%26aulast%3DCoe%26aufirst%3DJ.%2BW.%26aulast%3DGlowa%26aufirst%3DJ.%26aulast%3DHurst%26aufirst%3DR.%2BS.%26aulast%3DLebel%26aufirst%3DL.%2BA.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DMansbach%26aufirst%3DR.%2BS.%26aulast%3DMather%26aufirst%3DR.%2BJ.%26aulast%3DRovetti%26aufirst%3DC.%2BC.%26aulast%3DSands%26aufirst%3DS.%2BB.%26aulast%3DSchaeffer%26aufirst%3DE.%26aulast%3DSchulz%26aufirst%3DD.%2BW.%26aulast%3DTingley%26aufirst%3DF.%2BD.%26aulast%3DWilliams%26aufirst%3DK.%2BE.%26atitle%3DPharmacological%2520profile%2520of%2520the%2520alpha4beta2%2520nicotinic%2520acetylcholine%2520receptor%2520partial%2520agonist%2520varenicline%252C%2520an%2520effective%2520smoking%2520cessation%2520aid%26jtitle%3DNeuropharmacology%26date%3D2007%26volume%3D52%26spage%3D985%26epage%3D994%26doi%3D10.1016%2Fj.neuropharm.2006.10.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Rollema, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coe, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chambers, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurst, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahl, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, K. E.</span><span> </span><span class="NLM_article-title">Rationale, pharmacology and clinical efficacy of partial agonists of alpha4beta2 nach receptors for smoking cessation</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">316</span><span class="NLM_x">–</span> <span class="NLM_lpage">325</span><span class="refDoi"> DOI: 10.1016/j.tips.2007.05.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=10.1016%2Fj.tips.2007.05.003" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2007&pages=316-325&author=H.+Rollemaauthor=J.+W.+Coeauthor=L.+K.+Chambersauthor=R.+S.+Hurstauthor=S.+M.+Stahlauthor=K.+E.+Williams&title=Rationale%2C+pharmacology+and+clinical+efficacy+of+partial+agonists+of+alpha4beta2+nach+receptors+for+smoking+cessation&doi=10.1016%2Fj.tips.2007.05.003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2007.05.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2007.05.003%26sid%3Dliteratum%253Aachs%26aulast%3DRollema%26aufirst%3DH.%26aulast%3DCoe%26aufirst%3DJ.%2BW.%26aulast%3DChambers%26aufirst%3DL.%2BK.%26aulast%3DHurst%26aufirst%3DR.%2BS.%26aulast%3DStahl%26aufirst%3DS.%2BM.%26aulast%3DWilliams%26aufirst%3DK.%2BE.%26atitle%3DRationale%252C%2520pharmacology%2520and%2520clinical%2520efficacy%2520of%2520partial%2520agonists%2520of%2520alpha4beta2%2520nach%2520receptors%2520for%2520smoking%2520cessation%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2007%26volume%3D28%26spage%3D316%26epage%3D325%26doi%3D10.1016%2Fj.tips.2007.05.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Chatterjee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartlett, S. E.</span><span> </span><span class="NLM_article-title">Neuronal nicotinic acetylcholine receptors as pharmacotherapeutic targets for the treatment of alcohol use disorders</span> <span class="citation_source-journal">CNS Neurol. Disord.: Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">60</span><span class="NLM_x">–</span> <span class="NLM_lpage">76</span><span class="refDoi"> DOI: 10.2174/187152710790966597</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=10.2174%2F187152710790966597" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=20201817" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjtFajs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=60-76&author=S.+Chatterjeeauthor=S.+E.+Bartlett&title=Neuronal+nicotinic+acetylcholine+receptors+as+pharmacotherapeutic+targets+for+the+treatment+of+alcohol+use+disorders&doi=10.2174%2F187152710790966597"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Neuronal nicotinic acetylcholine receptors as pharmacotherapeutic targets for the treatment of alcohol use disorders</span></div><div class="casAuthors">Chatterjee, S.; Bartlett, S. E.</div><div class="citationInfo"><span class="NLM_cas:title">CNS & Neurological Disorders: Drug Targets</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">60-76</span>CODEN:
                <span class="NLM_cas:coden">CNDDA3</span>;
        ISSN:<span class="NLM_cas:issn">1871-5273</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Alc. use disorders (AUDs) are complex and developing effective treatments will require the combination of novel medications and cognitive behavioral therapy approaches.  Epidemiol. studies have shown there is a high correlation between alc. consumption and tobacco use, and the prevalence of smoking in alcoholics is as high as 80% compared to about 30% for the general population.  Both preclin. and clin. data provide evidence that nicotine administration increases alc. intake and non-specific nicotinic receptor antagonists reduce alc.-mediated behaviors.  As nicotine interacts specifically with the neuronal nicotinic acetylcholine receptor (nAChR) system, this suggests that nAChRs play an important role in the behavioral effects of alc.  In this review, we discuss the importance of nAChRs for the treatment of AUDs and argue that the use of FDA approved nAChR ligands, such as varenicline and mecamylamine, approved as smoking cessation aids may prove to be valuable treatments for AUDs.  We also address the importance of combining effective medications with behavioral therapy for the treatment of alc. dependent individuals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFWEmF5pdybLVg90H21EOLACvtfcHk0lgKCQWJQqNqhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjtFajs7Y%253D&md5=925276eab7f62759eb225cc0cea31862</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.2174%2F187152710790966597&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187152710790966597%26sid%3Dliteratum%253Aachs%26aulast%3DChatterjee%26aufirst%3DS.%26aulast%3DBartlett%26aufirst%3DS.%2BE.%26atitle%3DNeuronal%2520nicotinic%2520acetylcholine%2520receptors%2520as%2520pharmacotherapeutic%2520targets%2520for%2520the%2520treatment%2520of%2520alcohol%2520use%2520disorders%26jtitle%3DCNS%2520Neurol.%2520Disord.%253A%2520Drug%2520Targets%26date%3D2010%26volume%3D9%26spage%3D60%26epage%3D76%26doi%3D10.2174%2F187152710790966597" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Cippitelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunori, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaiolini, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaveri, N. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toll, L.</span><span> </span><span class="NLM_article-title">Pharmacological stress is required for the anti-alcohol effect of the alpha3beta4* nachr partial agonist at-1001</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">229</span><span class="NLM_x">–</span> <span class="NLM_lpage">236</span><span class="refDoi"> DOI: 10.1016/j.neuropharm.2015.02.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=10.1016%2Fj.neuropharm.2015.02.005" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=2015&pages=229-236&author=A.+Cippitelliauthor=G.+Brunoriauthor=K.+A.+Gaioliniauthor=N.+T.+Zaveriauthor=L.+Toll&title=Pharmacological+stress+is+required+for+the+anti-alcohol+effect+of+the+alpha3beta4*+nachr+partial+agonist+at-1001&doi=10.1016%2Fj.neuropharm.2015.02.005"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2015.02.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2015.02.005%26sid%3Dliteratum%253Aachs%26aulast%3DCippitelli%26aufirst%3DA.%26aulast%3DBrunori%26aufirst%3DG.%26aulast%3DGaiolini%26aufirst%3DK.%2BA.%26aulast%3DZaveri%26aufirst%3DN.%2BT.%26aulast%3DToll%26aufirst%3DL.%26atitle%3DPharmacological%2520stress%2520is%2520required%2520for%2520the%2520anti-alcohol%2520effect%2520of%2520the%2520alpha3beta4%252A%2520nachr%2520partial%2520agonist%2520at-1001%26jtitle%3DNeuropharmacology%26date%3D2015%26volume%3D93%26spage%3D229%26epage%3D236%26doi%3D10.1016%2Fj.neuropharm.2015.02.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Hendrickson, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao-Shea, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tapper, A. R.</span><span> </span><span class="NLM_article-title">Activation of alpha4* nachrs is necessary and sufficient for varenicline-induced reduction of alcohol consumption</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">10169</span><span class="NLM_x">–</span> <span class="NLM_lpage">10176</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.2601-10.2010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=10.1523%2FJNEUROSCI.2601-10.2010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=20668200" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVahsr%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2010&pages=10169-10176&author=L.+M.+Hendricksonauthor=R.+Zhao-Sheaauthor=X.+Pangauthor=P.+D.+Gardnerauthor=A.+R.+Tapper&title=Activation+of+alpha4*+nachrs+is+necessary+and+sufficient+for+varenicline-induced+reduction+of+alcohol+consumption&doi=10.1523%2FJNEUROSCI.2601-10.2010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of α4* nAChRs is necessary and sufficient for varenicline-induced reduction of alcohol consumption</span></div><div class="casAuthors">Hendrickson, Linzy M.; Zhao-Shea, Rubing; Pang, Xueyan; Gardner, Paul D.; Tapper, Andrew R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">30</span>),
    <span class="NLM_cas:pages">10169-10176</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Recently, the smoking cessation therapeutic varenicline, a nicotinic acetylcholine receptor (nAChR) partial agonist, has been shown to reduce alc. consumption.  However, the mechanism and nAChR subtype(s) involved are unknown.  Here we demonstrate that varenicline and alc. exposure, either alone or in combination, selectively activates dopaminergic (DAergic) neurons within the posterior, but not the anterior, ventral tegmental area (VTA).  To gain insight into which nAChR subtypes may be involved in the response to alc., we analyzed nAChR subunit gene expression in posterior VTA DAergic neurons.  Ethanol-activated DAergic neurons expressed higher levels of α4, α6, and β3 subunit genes compared with nonactivated neurons.  To examine the role of nicotinic receptors contg. the α4 subunit (α4* nAChRs) in varenicline-induced redn. of alc. consumption, we examd. the effect of the drug in two complementary mouse models, a knock-out line that does not express the α4 subunit (α4 KO) and another line that expresses α4* nAChRs hypersensitive to agonist (Leu9'Ala).  While varenicline (0.1-0.3 mg/kg, i.p.) reduced 2% and 20% alc. consumption in wild-type (WT) mice, the drug did not significantly reduce consumption in α4 KO animals.  Conversely, low doses of varenicline (0.0125-0.05 mg/kg, i.p.) that had little effect in WT mice dramatically reduced ethanol intake in Leu9'Ala mice.  Infusion of varenicline into the posterior, but not the anterior VTA was sufficient to reduce alc. consumption.  Together, our data indicate that activation of α4* nAChRs is necessary and sufficient for varenicline redn. of alc. consumption.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNXAkKyyVu_7Vg90H21EOLACvtfcHk0lgKCQWJQqNqhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVahsr%252FF&md5=f0021f4460fa3d691a1b7f0fa6820988</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.2601-10.2010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.2601-10.2010%26sid%3Dliteratum%253Aachs%26aulast%3DHendrickson%26aufirst%3DL.%2BM.%26aulast%3DZhao-Shea%26aufirst%3DR.%26aulast%3DPang%26aufirst%3DX.%26aulast%3DGardner%26aufirst%3DP.%2BD.%26aulast%3DTapper%26aufirst%3DA.%2BR.%26atitle%3DActivation%2520of%2520alpha4%252A%2520nachrs%2520is%2520necessary%2520and%2520sufficient%2520for%2520varenicline-induced%2520reduction%2520of%2520alcohol%2520consumption%26jtitle%3DJ.%2520Neurosci.%26date%3D2010%26volume%3D30%26spage%3D10169%26epage%3D10176%26doi%3D10.1523%2FJNEUROSCI.2601-10.2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Ahmed, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ali, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kramers, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harmark, L. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burger, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoeven, W. M.</span><span> </span><span class="NLM_article-title">Neuropsychiatric adverse events of varenicline: A systematic review of published reports</span> <span class="citation_source-journal">J. Clin. Psychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">55</span><span class="NLM_x">–</span> <span class="NLM_lpage">62</span><span class="refDoi"> DOI: 10.1097/JCP.0b013e31827c0117</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=10.1097%2FJCP.0b013e31827c0117" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=23277249" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlt1ylug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2013&pages=55-62&author=A.+I.+Ahmedauthor=A.+N.+Aliauthor=C.+Kramersauthor=L.+V.+Harmarkauthor=D.+M.+Burgerauthor=W.+M.+Verhoeven&title=Neuropsychiatric+adverse+events+of+varenicline%3A+A+systematic+review+of+published+reports&doi=10.1097%2FJCP.0b013e31827c0117"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Neuropsychiatric Adverse Events of Varenicline: A Systematic Review of Published Reports</span></div><div class="casAuthors">Ahmed, Amir I. A.; Ali, Abdullah N. A.; Kramers, Cees; Haermark, Linda V. D.; Burger, David M.; Verhoeven, Willem M. A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Psychopharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">55-62</span>CODEN:
                <span class="NLM_cas:coden">JCPYDR</span>;
        ISSN:<span class="NLM_cas:issn">0271-0749</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">A review.  Introduction: Over the past years, the impact of varenicline in patients with mental illness has been debated as serious neuropsychiatric adverse events (AEs) have been reported with varenicline use.  Aim: To identify and summarize published case reports of neuropsychiatric AEs ascribed to varenicline and to det. potential risk factors for these AEs.  Methods: A literature search of MEDLINE, the Cochrane Library, EMBASE, and PsychInfo database was conducted for case reports concerning the neuropsychiatric AEs of varenicline published in English from 2006 (approval year by the US Food and Drug Administration and the Dutch Medicines Evaluation Board) to Jan. 1, 2012.  Results: We identified 25 published cases.  In most reports, patients had been admitted to psychiatric hospitals with serious neuropsychiatric AEs due to varenicline.  The av. patient age was 46.4 years, and 56% were men; 68% of patients had a psychiatric history.  The onset of symptoms started 2 days to 3 mo after the initiation of varenicline.  One report described completed suicide in a man with no psychiatric history.  In most cases (84%), the neuropsychiatric symptoms resolved after the discontinuation of varenicline.  Anal. of all reports using the Naranjo causality scale, a method for estg. the probability of adverse drug reactions, indicated probable causality in 76% of the cases and definite causality in 12% of cases.  Conclusion: Varenicline is assocd. with an increased risk of serious neuropsychiatric AEs, esp. in patients with a psychiatric illness.  It is strongly recommended that varenicline be administered only to mentally stable patients and under close monitoring.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHh53xQ6LVlLVg90H21EOLACvtfcHk0lgKCQWJQqNqhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlt1ylug%253D%253D&md5=c0a4e21bca894082a4e303d6a09947cd</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1097%2FJCP.0b013e31827c0117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FJCP.0b013e31827c0117%26sid%3Dliteratum%253Aachs%26aulast%3DAhmed%26aufirst%3DA.%2BI.%26aulast%3DAli%26aufirst%3DA.%2BN.%26aulast%3DKramers%26aufirst%3DC.%26aulast%3DHarmark%26aufirst%3DL.%2BV.%26aulast%3DBurger%26aufirst%3DD.%2BM.%26aulast%3DVerhoeven%26aufirst%3DW.%2BM.%26atitle%3DNeuropsychiatric%2520adverse%2520events%2520of%2520varenicline%253A%2520A%2520systematic%2520review%2520of%2520published%2520reports%26jtitle%3DJ.%2520Clin.%2520Psychopharmacol.%26date%3D2013%26volume%3D33%26spage%3D55%26epage%3D62%26doi%3D10.1097%2FJCP.0b013e31827c0117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Baker, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piper, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stein, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolt, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraser, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiore, M. C.</span><span> </span><span class="NLM_article-title">Effects of nicotine patch vs varenicline vs combination nicotine replacement therapy on smoking cessation at 26 weeks: A randomized clinical trial</span> <span class="citation_source-journal">JAMA</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">315</span><span class="NLM_x">, </span> <span class="NLM_fpage">371</span><span class="NLM_x">–</span> <span class="NLM_lpage">379</span><span class="refDoi"> DOI: 10.1001/jama.2015.19284</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=10.1001%2Fjama.2015.19284" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=315&publication_year=2016&pages=371-379&author=T.+B.+Bakerauthor=M.+E.+Piperauthor=J.+H.+Steinauthor=S.+S.+Smithauthor=D.+M.+Boltauthor=D.+L.+Fraserauthor=M.+C.+Fiore&title=Effects+of+nicotine+patch+vs+varenicline+vs+combination+nicotine+replacement+therapy+on+smoking+cessation+at+26+weeks%3A+A+randomized+clinical+trial&doi=10.1001%2Fjama.2015.19284"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1001%2Fjama.2015.19284&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Fjama.2015.19284%26sid%3Dliteratum%253Aachs%26aulast%3DBaker%26aufirst%3DT.%2BB.%26aulast%3DPiper%26aufirst%3DM.%2BE.%26aulast%3DStein%26aufirst%3DJ.%2BH.%26aulast%3DSmith%26aufirst%3DS.%2BS.%26aulast%3DBolt%26aufirst%3DD.%2BM.%26aulast%3DFraser%26aufirst%3DD.%2BL.%26aulast%3DFiore%26aufirst%3DM.%2BC.%26atitle%3DEffects%2520of%2520nicotine%2520patch%2520vs%2520varenicline%2520vs%2520combination%2520nicotine%2520replacement%2520therapy%2520on%2520smoking%2520cessation%2520at%252026%2520weeks%253A%2520A%2520randomized%2520clinical%2520trial%26jtitle%3DJAMA%26date%3D2016%26volume%3D315%26spage%3D371%26epage%3D379%26doi%3D10.1001%2Fjama.2015.19284" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Rasmussen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swedberg, M. D.</span><span> </span><span class="NLM_article-title">Reinforcing effects of nicotinic compounds: Intravenous self-administration in drug-naive mice</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">567</span><span class="NLM_x">–</span> <span class="NLM_lpage">573</span><span class="refDoi"> DOI: 10.1016/S0091-3057(98)00003-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=10.1016%2FS0091-3057%2898%2900003-3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=1998&pages=567-573&author=T.+Rasmussenauthor=M.+D.+Swedberg&title=Reinforcing+effects+of+nicotinic+compounds%3A+Intravenous+self-administration+in+drug-naive+mice&doi=10.1016%2FS0091-3057%2898%2900003-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2FS0091-3057%2898%2900003-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0091-3057%252898%252900003-3%26sid%3Dliteratum%253Aachs%26aulast%3DRasmussen%26aufirst%3DT.%26aulast%3DSwedberg%26aufirst%3DM.%2BD.%26atitle%3DReinforcing%2520effects%2520of%2520nicotinic%2520compounds%253A%2520Intravenous%2520self-administration%2520in%2520drug-naive%2520mice%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D1998%26volume%3D60%26spage%3D567%26epage%3D573%26doi%3D10.1016%2FS0091-3057%2898%2900003-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Cahill, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindson-Hawley, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fanshawe, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lancaster, T.</span><span> </span><span class="NLM_article-title">Nicotine receptor partial agonists for smoking cessation</span> <span class="citation_source-journal">Cochrane Database Syst. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_fpage">CD006103</span><span class="refDoi"> DOI: 10.1002/14651858.CD006103.pub7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=10.1002%2F14651858.CD006103.pub7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&pages=CD006103&author=K.+Cahillauthor=N.+Lindson-Hawleyauthor=K.+H.+Thomasauthor=T.+R.+Fanshaweauthor=T.+Lancaster&title=Nicotine+receptor+partial+agonists+for+smoking+cessation&doi=10.1002%2F14651858.CD006103.pub7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1002%2F14651858.CD006103.pub7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F14651858.CD006103.pub7%26sid%3Dliteratum%253Aachs%26aulast%3DCahill%26aufirst%3DK.%26aulast%3DLindson-Hawley%26aufirst%3DN.%26aulast%3DThomas%26aufirst%3DK.%2BH.%26aulast%3DFanshawe%26aufirst%3DT.%2BR.%26aulast%3DLancaster%26aufirst%3DT.%26atitle%3DNicotine%2520receptor%2520partial%2520agonists%2520for%2520smoking%2520cessation%26jtitle%3DCochrane%2520Database%2520Syst.%2520Rev.%26date%3D2016%26spage%3DCD006103%26doi%3D10.1002%2F14651858.CD006103.pub7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Levin, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rezvani, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slade, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cauley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hampton, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rose, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paige, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDowell, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kellar, K. J.</span><span> </span><span class="NLM_article-title">Sazetidine-a, a selective alpha4beta2 nicotinic receptor desensitizing agent and partial agonist, reduces nicotine self-administration in rats</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">332</span><span class="NLM_x">, </span> <span class="NLM_fpage">933</span><span class="NLM_x">–</span> <span class="NLM_lpage">939</span><span class="refDoi"> DOI: 10.1124/jpet.109.162073</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=10.1124%2Fjpet.109.162073" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=20007754" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=1%3ACAS%3A528%3ADC%252BC3cXivFCjs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=332&publication_year=2010&pages=933-939&author=E.+D.+Levinauthor=A.+H.+Rezvaniauthor=Y.+Xiaoauthor=S.+Sladeauthor=M.+Cauleyauthor=C.+Wellsauthor=D.+Hamptonauthor=A.+Petroauthor=J.+E.+Roseauthor=M.+L.+Brownauthor=M.+A.+Paigeauthor=B.+E.+McDowellauthor=K.+J.+Kellar&title=Sazetidine-a%2C+a+selective+alpha4beta2+nicotinic+receptor+desensitizing+agent+and+partial+agonist%2C+reduces+nicotine+self-administration+in+rats&doi=10.1124%2Fjpet.109.162073"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Sazetidine-A, a selective α4β2 nicotinic receptor desensitizing agent and partial agonist, reduces nicotine self-administration in rats</span></div><div class="casAuthors">Levin, Edward D.; Rezvani, Amir H.; Xiao, Yingxian; Slade, Susan; Cauley, Marty; Wells, Corinne; Hampton, Dawn; Petro, Ann; Rose, Jed E.; Brown, Milton L.; Paige, Mikell A.; McDowell, Brian E.; Kellar, Kenneth J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">332</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">933-939</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Adequate treatment of tobacco addiction remains problematic.  Part of the problem with treatment is a poor understanding of the pharmacol. aspects of nicotine contributing to addiction.  In addn. to activating nicotinic acetylcholine receptors, nicotine also desensitizes them.  It is currently not known how much of each of nicotine's actions contribute to its particular behavioral effects.  Sazetidine-A (saz-A) is a novel nicotinic receptor-desensitizing agent and partial agonist with high selectivity for α4β2 receptors.  The current expts. were conducted to det. whether saz-A would reduce nicotine self-administration in rats and to characterize its ancillary effects.  Adult male Sprague-Dawley rats were allowed to self-administer nicotine.  After initial food pellet training followed by 10 sessions of nicotine self-administration training, the rats were administered saz-A (0.1-3 mg/kg s.c.) or the saline vehicle in a repeated-measures counterbalanced design.  Saz-A at the 3 mg/kg dose significantly decreased nicotine self-administration relative to performance of the same rats after saline injections.  In a second study, long-term administration of this dose of sazetidine-A over the course of 10 sessions significantly reduced nicotine self-administration with no apparent diminution of effect.  Saz-A in this dose range had only modest effects on locomotor activity, without any overall decrease in activity over a 1-h-long session.  Saz-A significantly reduced food self-administration, but this effect was smaller than its effect on nicotine self-administration.  Saz-A, which is a selective α4β2-desensitizing agent and partial agonist, effectively reduces nicotine self-administration.  This type of treatment holds promise for a new therapy to aid smoking cessation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyXvn7dQpysLVg90H21EOLACvtfcHk0lgRFH9KZ53kpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXivFCjs7s%253D&md5=e6b4e73fc3c6373d3dbc6e249bb8a76c</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1124%2Fjpet.109.162073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.109.162073%26sid%3Dliteratum%253Aachs%26aulast%3DLevin%26aufirst%3DE.%2BD.%26aulast%3DRezvani%26aufirst%3DA.%2BH.%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DSlade%26aufirst%3DS.%26aulast%3DCauley%26aufirst%3DM.%26aulast%3DWells%26aufirst%3DC.%26aulast%3DHampton%26aufirst%3DD.%26aulast%3DPetro%26aufirst%3DA.%26aulast%3DRose%26aufirst%3DJ.%2BE.%26aulast%3DBrown%26aufirst%3DM.%2BL.%26aulast%3DPaige%26aufirst%3DM.%2BA.%26aulast%3DMcDowell%26aufirst%3DB.%2BE.%26aulast%3DKellar%26aufirst%3DK.%2BJ.%26atitle%3DSazetidine-a%252C%2520a%2520selective%2520alpha4beta2%2520nicotinic%2520receptor%2520desensitizing%2520agent%2520and%2520partial%2520agonist%252C%2520reduces%2520nicotine%2520self-administration%2520in%2520rats%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2010%26volume%3D332%26spage%3D933%26epage%3D939%26doi%3D10.1124%2Fjpet.109.162073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Rezvani, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slade, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lumeng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paige, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDowell, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rose, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kellar, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levin, E. D.</span><span> </span><span class="NLM_article-title">Effects of sazetidine-a, a selective alpha4beta2 nicotinic acetylcholine receptor desensitizing agent on alcohol and nicotine self-administration in selectively bred alcohol-preferring (p) rats</span> <span class="citation_source-journal">Psychopharmacology (Berl)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">211</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">174</span><span class="refDoi"> DOI: 10.1007/s00213-010-1878-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=10.1007%2Fs00213-010-1878-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=20535453" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=1%3ACAS%3A528%3ADC%252BC3cXntFGlsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=211&publication_year=2010&pages=161-174&author=A.+H.+Rezvaniauthor=S.+Sladeauthor=C.+Wellsauthor=A.+Petroauthor=L.+Lumengauthor=T.+K.+Liauthor=Y.+Xiaoauthor=M.+L.+Brownauthor=M.+A.+Paigeauthor=B.+E.+McDowellauthor=J.+E.+Roseauthor=K.+J.+Kellarauthor=E.+D.+Levin&title=Effects+of+sazetidine-a%2C+a+selective+alpha4beta2+nicotinic+acetylcholine+receptor+desensitizing+agent+on+alcohol+and+nicotine+self-administration+in+selectively+bred+alcohol-preferring+%28p%29+rats&doi=10.1007%2Fs00213-010-1878-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of sazetidine-A, a selective α4β2 nicotinic acetylcholine receptor desensitizing agent on alcohol and nicotine self-administration in selectively bred alcohol-preferring (P) rats</span></div><div class="casAuthors">Rezvani, Amir H.; Slade, Susan; Wells, Cori; Petro, Ann; Lumeng, Lawrence; Li, Ting-Kai; Xiao, Yingxian; Brown, Milton L.; Paige, Mikell A.; McDowell, Brian E.; Rose, Jed E.; Kellar, Kenneth J.; Levin, Edward D.</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Heidelberg, Germany)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">211</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">161-174</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Rationale: Manipulations of nicotinic cholinergic receptors have been shown to influence both alc. and nicotine intake.  Sazetidine-A [6-(5(((S)-azetidine-2-yl)methoxy)pyridine-3-yl)hex-5-yn-1-ol] is a novel compd. that potently and selectively desensitizes α4β2 nicotinic receptors with only modest receptor activation.  Objectives: The goal of the present study was to examine the effects of sazetidine-A on alc. and nicotine self-administration in alc.-preferring (P) rats.  Methods: P rats were given the choice of water or alc.  Once stable baselines were established, the acute (0, 0.1, 0.3, 1, and 3 mg/kg, s.c.) and chronic (3 mg/kg for 10 days) effects of sazetidine-A on alc. intake were assessed.  Naltrexone (2.5 mg/kg) served as a pos. control.  The effect of sazetidine-A (3 mg/kg) and naltrexone (4 mg/kg) on saccharin (0.2%) preference was also assessed.  In addn., the acute effects of sazetidine-A (3 mg/kg) and naltrexone (4 mg/kg) on alc. intake after alc. deprivation were evaluated.  In another expt., the effects of sazetidine-A (0, 1, or 3 mg/kg) on IV nicotine self-administration in P and NP rats were assessed.  Results: Sazetidine-A caused a dose-dependent redn. in alc. intake.  Chronic sazetidine-A also effectively reduced alc. intake until the seventh day of treatment, when partial tolerance appeared to develop.  In the post-deprivation study, sazetidine-A significantly reduced alc. intake and preference.  Sazetidine-A at 3 mg/kg significantly reduced nicotine self-administration in both lines.  Conclusions: Sazetidine-A significantly reduced alc. and nicotine intake in P rats that self-administer higher levels of both drugs.  Sazetidine-A may hold promise for the treatment of alc. and nicotine addiction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZfW61FFrtlbVg90H21EOLACvtfcHk0lgRFH9KZ53kpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXntFGlsb0%253D&md5=18b4836f096b921e6ef22c8538528ecf</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1007%2Fs00213-010-1878-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-010-1878-8%26sid%3Dliteratum%253Aachs%26aulast%3DRezvani%26aufirst%3DA.%2BH.%26aulast%3DSlade%26aufirst%3DS.%26aulast%3DWells%26aufirst%3DC.%26aulast%3DPetro%26aufirst%3DA.%26aulast%3DLumeng%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DT.%2BK.%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DBrown%26aufirst%3DM.%2BL.%26aulast%3DPaige%26aufirst%3DM.%2BA.%26aulast%3DMcDowell%26aufirst%3DB.%2BE.%26aulast%3DRose%26aufirst%3DJ.%2BE.%26aulast%3DKellar%26aufirst%3DK.%2BJ.%26aulast%3DLevin%26aufirst%3DE.%2BD.%26atitle%3DEffects%2520of%2520sazetidine-a%252C%2520a%2520selective%2520alpha4beta2%2520nicotinic%2520acetylcholine%2520receptor%2520desensitizing%2520agent%2520on%2520alcohol%2520and%2520nicotine%2520self-administration%2520in%2520selectively%2520bred%2520alcohol-preferring%2520%2528p%2529%2520rats%26jtitle%3DPsychopharmacology%2520%2528Berl%2529%26date%3D2010%26volume%3D211%26spage%3D161%26epage%3D174%26doi%3D10.1007%2Fs00213-010-1878-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Hopkins, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rupprecht, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blendy, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, H. D.</span><span> </span><span class="NLM_article-title">Galantamine, an acetylcholinesterase inhibitor and positive allosteric modulator of nicotinic acetylcholine receptors, attenuates nicotine taking and seeking in rats</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">2310</span><span class="NLM_x">–</span> <span class="NLM_lpage">2321</span><span class="refDoi"> DOI: 10.1038/npp.2012.83</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=10.1038%2Fnpp.2012.83" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2012&pages=2310-2321&author=T.+J.+Hopkinsauthor=L.+E.+Rupprechtauthor=M.+R.+Hayesauthor=J.+A.+Blendyauthor=H.+D.+Schmidt&title=Galantamine%2C+an+acetylcholinesterase+inhibitor+and+positive+allosteric+modulator+of+nicotinic+acetylcholine+receptors%2C+attenuates+nicotine+taking+and+seeking+in+rats&doi=10.1038%2Fnpp.2012.83"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2012.83&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2012.83%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DT.%2BJ.%26aulast%3DRupprecht%26aufirst%3DL.%2BE.%26aulast%3DHayes%26aufirst%3DM.%2BR.%26aulast%3DBlendy%26aufirst%3DJ.%2BA.%26aulast%3DSchmidt%26aufirst%3DH.%2BD.%26atitle%3DGalantamine%252C%2520an%2520acetylcholinesterase%2520inhibitor%2520and%2520positive%2520allosteric%2520modulator%2520of%2520nicotinic%2520acetylcholine%2520receptors%252C%2520attenuates%2520nicotine%2520taking%2520and%2520seeking%2520in%2520rats%26jtitle%3DNeuropsychopharmacology%26date%3D2012%26volume%3D37%26spage%3D2310%26epage%3D2321%26doi%3D10.1038%2Fnpp.2012.83" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Maurer, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandager-Nielsen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, H. D.</span><span> </span><span class="NLM_article-title">Attenuation of nicotine taking and seeking in rats by the stoichiometry-selective alpha4beta2 nicotinic acetylcholine receptor positive allosteric modulator ns9283</span> <span class="citation_source-journal">Psychopharmacology (Berl)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">234</span><span class="NLM_x">, </span> <span class="NLM_fpage">475</span><span class="NLM_x">–</span> <span class="NLM_lpage">484</span><span class="refDoi"> DOI: 10.1007/s00213-016-4475-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=10.1007%2Fs00213-016-4475-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=27844094" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=1%3ACAS%3A280%3ADC%252BC2snmtV2hsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=234&publication_year=2017&pages=475-484&author=J.+J.+Maurerauthor=K.+Sandager-Nielsenauthor=H.+D.+Schmidt&title=Attenuation+of+nicotine+taking+and+seeking+in+rats+by+the+stoichiometry-selective+alpha4beta2+nicotinic+acetylcholine+receptor+positive+allosteric+modulator+ns9283&doi=10.1007%2Fs00213-016-4475-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Attenuation of nicotine taking and seeking in rats by the stoichiometry-selective alpha4beta2 nicotinic acetylcholine receptor positive allosteric modulator NS9283</span></div><div class="casAuthors">Maurer John J; Schmidt Heath D; Maurer John J; Schmidt Heath D; Sandager-Nielsen Karin</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">234</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">475-484</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">RATIONALE:  The rewarding and reinforcing effects of nicotine are produced, in large part, by activation of neuronal α4β2* nicotinic acetylcholine receptors (nAChRs), pentameric protein complexes comprised of different stoichiometries of α4 and β2 subunits.  However, little is known about the functional role of distinct subtypes of α4β2* nAChRs in nicotine addiction.  OBJECTIVES:  NS9283 represents a new class of stoichiometry-selective positive allosteric modulators (PAMs) that selectively bind to α4β2 nAChRs containing three α4 and two β2 subunits (3(α4)2(β2) nAChRs).  The present experiments were designed to determine the effects of NS9283 on nicotine self-administration and the reinstatement of nicotine-seeking behavior, an animal model of smoking relapse.  Parallel studies of sucrose self-administration and reinstatement were conducted in separate cohorts of rats to determine if the effects of NS9283 generalized to other reinforced behaviors.  RESULTS:  Acute and repeated administration of NS9283 dose-dependently reduced nicotine self-administration and reinstatement in male Sprague Dawley rats.  These effects were reinforcer specific as no effects of NS9283 on sucrose self-administration and reinstatement were noted.  NS9283 also failed to substitute for nicotine in supporting self-administration behavior suggesting that, at the doses tested, NS9283 alone is not reinforcing.  CONCLUSION:  Taken together, these results provide compelling evidence that stoichiometry-selective PAMs of 3(α4)2(β2) nAChRs attenuate nicotine taking and seeking in rats and suggest that targeting 3(α4)2(β2) nAChRs may represent a promising therapeutic strategy for preventing smoking relapse.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ4YxLjT1wglfSAs_PE1QvifW6udTcc2eaWuSFTLrQuvLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2snmtV2hsQ%253D%253D&md5=8b7bffca3bbec7ae4cef4f3345129fd2</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1007%2Fs00213-016-4475-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-016-4475-7%26sid%3Dliteratum%253Aachs%26aulast%3DMaurer%26aufirst%3DJ.%2BJ.%26aulast%3DSandager-Nielsen%26aufirst%3DK.%26aulast%3DSchmidt%26aufirst%3DH.%2BD.%26atitle%3DAttenuation%2520of%2520nicotine%2520taking%2520and%2520seeking%2520in%2520rats%2520by%2520the%2520stoichiometry-selective%2520alpha4beta2%2520nicotinic%2520acetylcholine%2520receptor%2520positive%2520allosteric%2520modulator%2520ns9283%26jtitle%3DPsychopharmacology%2520%2528Berl%2529%26date%3D2017%26volume%3D234%26spage%3D475%26epage%3D484%26doi%3D10.1007%2Fs00213-016-4475-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Rose, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behm, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westman, E. C.</span><span> </span><span class="NLM_article-title">Nicotine-mecamylamine treatment for smoking cessation: The role of pre-cessation therapy</span> <span class="citation_source-journal">Exp. Clin. Psychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">331</span><span class="NLM_x">–</span> <span class="NLM_lpage">343</span><span class="refDoi"> DOI: 10.1037/1064-1297.6.3.331</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=10.1037%2F1064-1297.6.3.331" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=9725117" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=1%3ACAS%3A528%3ADyaK1cXlslGntbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1998&pages=331-343&author=J.+E.+Roseauthor=F.+M.+Behmauthor=E.+C.+Westman&title=Nicotine-mecamylamine+treatment+for+smoking+cessation%3A+The+role+of+pre-cessation+therapy&doi=10.1037%2F1064-1297.6.3.331"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Nicotine-mecamylamine treatment for smoking cessation: the role of pre-cessation therapy</span></div><div class="casAuthors">Rose, Jed E.; Behm, Frederique M.; Westman, Eric C.</div><div class="citationInfo"><span class="NLM_cas:title">Experimental and Clinical Psychopharmacology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">331-343</span>CODEN:
                <span class="NLM_cas:coden">ECLPES</span>;
        ISSN:<span class="NLM_cas:issn">1064-1297</span>.
    
            (<span class="NLM_cas:orgname">American Psychological Association</span>)
        </div><div class="casAbstract">The nicotinic antagonist mecamylamine was evaluated in a randomized smoking cessation trial.  Four groups of participants (n = 20 per group) received nicotine plus mecamylamine, nicotine alone, mecamylamine alone, or no drug for 4 wk before cessation.  After the quit-smoking date, all subjects received nicotine plus mecamylamine treatment for 6 wk.  Nicotine skin patches (21 mg/24 h) and mecamylamine capsules (2.5-5.0 mg twice per day) were used.  Precessation mecamylamine significantly prolonged the duration of continuous smoking abstinence; abstinence rates at the end of treatment were 47.5% with mecamylamine and 27.5% without mecamylamine.  Nicotine + mecamylamine reduced ad lib smoking, smoking satisfaction, and craving more than either drug alone.  Moreover, the orthostatic decrease in blood pressure caused by mecamylamine was offset by nicotine.  Mecamylamine before smoking cessation may be an effective adjunct to nicotine patch therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-pcw1gk9p3rVg90H21EOLACvtfcHk0lgjGkBMAy_xDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXlslGntbc%253D&md5=f4aee36e6969d6aa1bdf182413cbbe4c</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1037%2F1064-1297.6.3.331&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1037%252F1064-1297.6.3.331%26sid%3Dliteratum%253Aachs%26aulast%3DRose%26aufirst%3DJ.%2BE.%26aulast%3DBehm%26aufirst%3DF.%2BM.%26aulast%3DWestman%26aufirst%3DE.%2BC.%26atitle%3DNicotine-mecamylamine%2520treatment%2520for%2520smoking%2520cessation%253A%2520The%2520role%2520of%2520pre-cessation%2520therapy%26jtitle%3DExp.%2520Clin.%2520Psychopharmacol.%26date%3D1998%26volume%3D6%26spage%3D331%26epage%3D343%26doi%3D10.1037%2F1064-1297.6.3.331" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Rose, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behm, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westman, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levin, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stein, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ripka, G. V.</span><span> </span><span class="NLM_article-title">Mecamylamine combined with nicotine skin patch facilitates smoking cessation beyond nicotine patch treatment alone</span> <span class="citation_source-journal">Clin. Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">86</span><span class="NLM_x">–</span> <span class="NLM_lpage">99</span><span class="refDoi"> DOI: 10.1038/clpt.1994.105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=10.1038%2Fclpt.1994.105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=8033499" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=1%3ACAS%3A528%3ADyaK2cXmslWqurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=1994&pages=86-99&author=J.+E.+Roseauthor=F.+M.+Behmauthor=E.+C.+Westmanauthor=E.+D.+Levinauthor=R.+M.+Steinauthor=G.+V.+Ripka&title=Mecamylamine+combined+with+nicotine+skin+patch+facilitates+smoking+cessation+beyond+nicotine+patch+treatment+alone&doi=10.1038%2Fclpt.1994.105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Mecamylamine combined with nicotine skin patch facilitates smoking cessation beyond nicotine patch treatment alone</span></div><div class="casAuthors">Rose, Jed E.; Behm, Frederique M.; Westman, Eric C.; Levin, Edward D.; Stein, Roy M.; Ripka, Gail V.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacology & Therapeutics (St. Louis, MO, United States)</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">86-99</span>CODEN:
                <span class="NLM_cas:coden">CLPTAT</span>;
        ISSN:<span class="NLM_cas:issn">0009-9236</span>.
    </div><div class="casAbstract">To evaluate concurrent administration of mecamylamine (nicotine antagonist) with nicotine skin patch treatment for smoking cessation.  This was a randomized, double-blind, placebo-controlled trial.  Forty-eight healthy smokers who smoked at least one pack per day were studied at an outpatient smoking cessation research clinic.  The subjects ranged in age from 20 to 40 yr.  Intervention with the nicotine skin patch (6 to 8 wk) plus oral mecamylamine (2.5 to 5 mg twice a day for 5 wk) was compared to nicotine patch plus placebo.  Mecamylamine treatment began 2 wk before smoking cessation.  The primary outcome was continuous abstinence through 7 wk after cessation (1 wk after treatment), confirmed by expired air carbon monoxide measurements.  Secondary measures included point abstinence at 7 wk, continuous abstinence at 6- and 12-mo follow-up, and self-reported withdrawal symptoms.  The continuous abstinence rate at 7 wk was three times higher in the mecamylamine condition: 50% vs. 16.7%, p = 0.015.  Point abstinence at 7 wk was 58% for mecamylamine vs. 29% for placebo, p = 0.044.  At follow-up, continuous abstinence remained higher for mecamylamine: 37.5% vs. 12.5% at 6 mo (p = 0.046) and 37.5% vs. 4.2% at 12 mo (p = 0.004).  Mecamylamine also significantly reduced craving for cigarettes, neg. affect, and appetite.  Agonist-antagonist therapy, consisting of the nicotine patch with oral mecamylamine, may substantially improve current smoking cessation treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvivKy5kYZ57Vg90H21EOLACvtfcHk0li6VC1rs6Co4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXmslWqurs%253D&md5=1ffa5c425a97ff79762dc0380cf702b3</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1038%2Fclpt.1994.105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fclpt.1994.105%26sid%3Dliteratum%253Aachs%26aulast%3DRose%26aufirst%3DJ.%2BE.%26aulast%3DBehm%26aufirst%3DF.%2BM.%26aulast%3DWestman%26aufirst%3DE.%2BC.%26aulast%3DLevin%26aufirst%3DE.%2BD.%26aulast%3DStein%26aufirst%3DR.%2BM.%26aulast%3DRipka%26aufirst%3DG.%2BV.%26atitle%3DMecamylamine%2520combined%2520with%2520nicotine%2520skin%2520patch%2520facilitates%2520smoking%2520cessation%2520beyond%2520nicotine%2520patch%2520treatment%2520alone%26jtitle%3DClin.%2520Pharmacol.%2520Ther.%26date%3D1994%26volume%3D56%26spage%3D86%26epage%3D99%26doi%3D10.1038%2Fclpt.1994.105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Fitch, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kellar, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daly, J. W.</span><span> </span><span class="NLM_article-title">Membrane potential fluorescence: A rapid and highly sensitive assay for nicotinic receptor channel function</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">4909</span><span class="NLM_x">–</span> <span class="NLM_lpage">4914</span><span class="refDoi"> DOI: 10.1073/pnas.0630641100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=10.1073%2Fpnas.0630641100" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2003&pages=4909-4914&author=R.+W.+Fitchauthor=Y.+Xiaoauthor=K.+J.+Kellarauthor=J.+W.+Daly&title=Membrane+potential+fluorescence%3A+A+rapid+and+highly+sensitive+assay+for+nicotinic+receptor+channel+function&doi=10.1073%2Fpnas.0630641100"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0630641100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0630641100%26sid%3Dliteratum%253Aachs%26aulast%3DFitch%26aufirst%3DR.%2BW.%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DKellar%26aufirst%3DK.%2BJ.%26aulast%3DDaly%26aufirst%3DJ.%2BW.%26atitle%3DMembrane%2520potential%2520fluorescence%253A%2520A%2520rapid%2520and%2520highly%2520sensitive%2520assay%2520for%2520nicotinic%2520receptor%2520channel%2520function%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2003%26volume%3D100%26spage%3D4909%26epage%3D4914%26doi%3D10.1073%2Fpnas.0630641100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Carroll, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navarro, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brieaddy, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damaj, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, B. R.</span><span> </span><span class="NLM_article-title">Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 2-exo-2-(2′-substituted-3′-phenyl-5′-pyridinyl)-7-azabicyclo[2.2.1]heptanes. Novel nicotinic antagonist</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">4039</span><span class="NLM_x">–</span> <span class="NLM_lpage">4041</span><span class="refDoi"> DOI: 10.1021/jm015561v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm015561v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=4039-4041&author=F.+I.+Carrollauthor=J.+R.+Leeauthor=H.+A.+Navarroauthor=L.+E.+Brieaddyauthor=P.+Abrahamauthor=M.+I.+Damajauthor=B.+R.+Martin&title=Synthesis%2C+nicotinic+acetylcholine+receptor+binding%2C+and+antinociceptive+properties+of+2-exo-2-%282%E2%80%B2-substituted-3%E2%80%B2-phenyl-5%E2%80%B2-pyridinyl%29-7-azabicyclo%5B2.2.1%5Dheptanes.+Novel+nicotinic+antagonist&doi=10.1021%2Fjm015561v"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fjm015561v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm015561v%26sid%3Dliteratum%253Aachs%26aulast%3DCarroll%26aufirst%3DF.%2BI.%26aulast%3DLee%26aufirst%3DJ.%2BR.%26aulast%3DNavarro%26aufirst%3DH.%2BA.%26aulast%3DBrieaddy%26aufirst%3DL.%2BE.%26aulast%3DAbraham%26aufirst%3DP.%26aulast%3DDamaj%26aufirst%3DM.%2BI.%26aulast%3DMartin%26aufirst%3DB.%2BR.%26atitle%3DSynthesis%252C%2520nicotinic%2520acetylcholine%2520receptor%2520binding%252C%2520and%2520antinociceptive%2520properties%2520of%25202-exo-2-%25282%25E2%2580%25B2-substituted-3%25E2%2580%25B2-phenyl-5%25E2%2580%25B2-pyridinyl%2529-7-azabicyclo%255B2.2.1%255Dheptanes.%2520Novel%2520nicotinic%2520antagonist%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D4039%26epage%3D4041%26doi%3D10.1021%2Fjm015561v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Carroll, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navarro, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brieaddy, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damaj, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, B. R.</span><span> </span><span class="NLM_article-title">Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 2-exo-2-(2′-substituted 5′-pyridinyl)-7-azabicyclo[2.2.1]heptanes. Epibatidine analogues</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">2229</span><span class="NLM_x">–</span> <span class="NLM_lpage">2237</span><span class="refDoi"> DOI: 10.1021/jm0100178</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0100178" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=2229-2237&author=F.+I.+Carrollauthor=F.+Liangauthor=H.+A.+Navarroauthor=L.+E.+Brieaddyauthor=P.+Abrahamauthor=M.+I.+Damajauthor=B.+R.+Martin&title=Synthesis%2C+nicotinic+acetylcholine+receptor+binding%2C+and+antinociceptive+properties+of+2-exo-2-%282%E2%80%B2-substituted+5%E2%80%B2-pyridinyl%29-7-azabicyclo%5B2.2.1%5Dheptanes.+Epibatidine+analogues&doi=10.1021%2Fjm0100178"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fjm0100178&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0100178%26sid%3Dliteratum%253Aachs%26aulast%3DCarroll%26aufirst%3DF.%2BI.%26aulast%3DLiang%26aufirst%3DF.%26aulast%3DNavarro%26aufirst%3DH.%2BA.%26aulast%3DBrieaddy%26aufirst%3DL.%2BE.%26aulast%3DAbraham%26aufirst%3DP.%26aulast%3DDamaj%26aufirst%3DM.%2BI.%26aulast%3DMartin%26aufirst%3DB.%2BR.%26atitle%3DSynthesis%252C%2520nicotinic%2520acetylcholine%2520receptor%2520binding%252C%2520and%2520antinociceptive%2520properties%2520of%25202-exo-2-%25282%25E2%2580%25B2-substituted%25205%25E2%2580%25B2-pyridinyl%2529-7-azabicyclo%255B2.2.1%255Dheptanes.%2520Epibatidine%2520analogues%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D2229%26epage%3D2237%26doi%3D10.1021%2Fjm0100178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Ondachi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luetje, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damaj, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mascarella, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navarro, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, F. I.</span><span> </span><span class="NLM_article-title">Synthesis and nicotinic acetylcholine receptor in vitro and in vivo pharmacological properties of 2′-fluoro-3′-(substituted phenyl)deschloroepibatidine analogues of 2′-fluoro-3′-(4-nitrophenyl)deschloroepibatidine</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">6512</span><span class="NLM_x">–</span> <span class="NLM_lpage">6522</span><span class="refDoi"> DOI: 10.1021/jm300575y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300575y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=6512-6522&author=P.+Ondachiauthor=A.+Castroauthor=C.+W.+Luetjeauthor=M.+I.+Damajauthor=S.+W.+Mascarellaauthor=H.+A.+Navarroauthor=F.+I.+Carroll&title=Synthesis+and+nicotinic+acetylcholine+receptor+in+vitro+and+in+vivo+pharmacological+properties+of+2%E2%80%B2-fluoro-3%E2%80%B2-%28substituted+phenyl%29deschloroepibatidine+analogues+of+2%E2%80%B2-fluoro-3%E2%80%B2-%284-nitrophenyl%29deschloroepibatidine&doi=10.1021%2Fjm300575y"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjm300575y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300575y%26sid%3Dliteratum%253Aachs%26aulast%3DOndachi%26aufirst%3DP.%26aulast%3DCastro%26aufirst%3DA.%26aulast%3DLuetje%26aufirst%3DC.%2BW.%26aulast%3DDamaj%26aufirst%3DM.%2BI.%26aulast%3DMascarella%26aufirst%3DS.%2BW.%26aulast%3DNavarro%26aufirst%3DH.%2BA.%26aulast%3DCarroll%26aufirst%3DF.%2BI.%26atitle%3DSynthesis%2520and%2520nicotinic%2520acetylcholine%2520receptor%2520in%2520vitro%2520and%2520in%2520vivo%2520pharmacological%2520properties%2520of%25202%25E2%2580%25B2-fluoro-3%25E2%2580%25B2-%2528substituted%2520phenyl%2529deschloroepibatidine%2520analogues%2520of%25202%25E2%2580%25B2-fluoro-3%25E2%2580%25B2-%25284-nitrophenyl%2529deschloroepibatidine%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D6512%26epage%3D6522%26doi%3D10.1021%2Fjm300575y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Abdrakhmanova, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damaj, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, B. R.</span><span> </span><span class="NLM_article-title">2-fluoro-3-(4-nitro-phenyl)deschloroepibatidine is a novel potent competitive antagonist of human neuronal alpha4beta2 nachrs</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">1945</span><span class="NLM_x">–</span> <span class="NLM_lpage">1952</span><span class="refDoi"> DOI: 10.1124/mol.105.021782</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=10.1124%2Fmol.105.021782" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2006&pages=1945-1952&author=G.+R.+Abdrakhmanovaauthor=M.+I.+Damajauthor=F.+I.+Carrollauthor=B.+R.+Martin&title=2-fluoro-3-%284-nitro-phenyl%29deschloroepibatidine+is+a+novel+potent+competitive+antagonist+of+human+neuronal+alpha4beta2+nachrs&doi=10.1124%2Fmol.105.021782"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1124%2Fmol.105.021782&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.105.021782%26sid%3Dliteratum%253Aachs%26aulast%3DAbdrakhmanova%26aufirst%3DG.%2BR.%26aulast%3DDamaj%26aufirst%3DM.%2BI.%26aulast%3DCarroll%26aufirst%3DF.%2BI.%26aulast%3DMartin%26aufirst%3DB.%2BR.%26atitle%3D2-fluoro-3-%25284-nitro-phenyl%2529deschloroepibatidine%2520is%2520a%2520novel%2520potent%2520competitive%2520antagonist%2520of%2520human%2520neuronal%2520alpha4beta2%2520nachrs%26jtitle%3DMol.%2520Pharmacol.%26date%3D2006%26volume%3D69%26spage%3D1945%26epage%3D1952%26doi%3D10.1124%2Fmol.105.021782" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Carroll, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navarro, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damaj, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, B. R.</span><span> </span><span class="NLM_article-title">Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 3′-(substituted phenyl)epibatidine analogues. Nicotinic partial agonists</span> <span class="citation_source-journal">J. Nat. Prod.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">306</span><span class="NLM_x">–</span> <span class="NLM_lpage">312</span><span class="refDoi"> DOI: 10.1021/np9006124</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np9006124" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2010&pages=306-312&author=F.+I.+Carrollauthor=W.+Maauthor=L.+Dengauthor=H.+A.+Navarroauthor=M.+I.+Damajauthor=B.+R.+Martin&title=Synthesis%2C+nicotinic+acetylcholine+receptor+binding%2C+and+antinociceptive+properties+of+3%E2%80%B2-%28substituted+phenyl%29epibatidine+analogues.+Nicotinic+partial+agonists&doi=10.1021%2Fnp9006124"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fnp9006124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp9006124%26sid%3Dliteratum%253Aachs%26aulast%3DCarroll%26aufirst%3DF.%2BI.%26aulast%3DMa%26aufirst%3DW.%26aulast%3DDeng%26aufirst%3DL.%26aulast%3DNavarro%26aufirst%3DH.%2BA.%26aulast%3DDamaj%26aufirst%3DM.%2BI.%26aulast%3DMartin%26aufirst%3DB.%2BR.%26atitle%3DSynthesis%252C%2520nicotinic%2520acetylcholine%2520receptor%2520binding%252C%2520and%2520antinociceptive%2520properties%2520of%25203%25E2%2580%25B2-%2528substituted%2520phenyl%2529epibatidine%2520analogues.%2520Nicotinic%2520partial%2520agonists%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2010%26volume%3D73%26spage%3D306%26epage%3D312%26doi%3D10.1021%2Fnp9006124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Giulianotti, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vesely, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azhari, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Souza, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaVoi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houghten, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kyle, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leahy, J. W.</span><span> </span><span class="NLM_article-title">Identification of a hit series of antileishmanial compounds through the use of mixture-based libraries</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">802</span><span class="NLM_x">–</span> <span class="NLM_lpage">807</span><span class="refDoi"> DOI: 10.1021/acsmedchemlett.7b00045</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.7b00045" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=802-807&author=M.+A.+Giulianottiauthor=B.+A.+Veselyauthor=A.+Azhariauthor=A.+Souzaauthor=T.+LaVoiauthor=R.+A.+Houghtenauthor=D.+E.+Kyleauthor=J.+W.+Leahy&title=Identification+of+a+hit+series+of+antileishmanial+compounds+through+the+use+of+mixture-based+libraries&doi=10.1021%2Facsmedchemlett.7b00045"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.7b00045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.7b00045%26sid%3Dliteratum%253Aachs%26aulast%3DGiulianotti%26aufirst%3DM.%2BA.%26aulast%3DVesely%26aufirst%3DB.%2BA.%26aulast%3DAzhari%26aufirst%3DA.%26aulast%3DSouza%26aufirst%3DA.%26aulast%3DLaVoi%26aufirst%3DT.%26aulast%3DHoughten%26aufirst%3DR.%2BA.%26aulast%3DKyle%26aufirst%3DD.%2BE.%26aulast%3DLeahy%26aufirst%3DJ.%2BW.%26atitle%3DIdentification%2520of%2520a%2520hit%2520series%2520of%2520antileishmanial%2520compounds%2520through%2520the%2520use%2520of%2520mixture-based%2520libraries%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D8%26spage%3D802%26epage%3D807%26doi%3D10.1021%2Facsmedchemlett.7b00045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Houghten, R. A.</span><span> </span><span class="NLM_article-title">General method for the rapid solid-phase synthesis of large numbers of peptides: Specificity of antigen-antibody interaction at the level of individual amino acids</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">5131</span><span class="NLM_x">–</span> <span class="NLM_lpage">5135</span><span class="refDoi"> DOI: 10.1073/pnas.82.15.5131</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=10.1073%2Fpnas.82.15.5131" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=2410914" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=1%3ACAS%3A528%3ADyaL2MXkvVKis7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=1985&pages=5131-5135&author=R.+A.+Houghten&title=General+method+for+the+rapid+solid-phase+synthesis+of+large+numbers+of+peptides%3A+Specificity+of+antigen-antibody+interaction+at+the+level+of+individual+amino+acids&doi=10.1073%2Fpnas.82.15.5131"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">General method for the rapid solid-phase synthesis of large numbers of peptides:  Specificity of antigen-antibody interaction at the level of individual amino acids</span></div><div class="casAuthors">Houghten, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">5131-5</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">A novel yet simple method is described that facilitates the synthesis of large nos. of peptides to the extent that the synthesis process need no longer be the limiting factor in many studies involving peptides.  By using the methods described, 10-20 mg of 248 different 13-residue peptides representing single amino acid variants of a segment of the hemagglutinin protein HA1 were prepd. and characterized in <4 wk.  Through examn. of the binding of these analogs to monoclonal antibodies raised against residues 75-110 of HA1, it was found that a single amino acid, aspartic acid of position 101, is of unique importance to the interaction.  Two other residues, aspartic acid-104 and alanine-106, were found to play a lesser but significant role in the binding interaction.  Other single positional residue variations appear to be of little or no importance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAPtOdK8uIsbVg90H21EOLACvtfcHk0lj-bGTSUV5-vg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXkvVKis7s%253D&md5=f0f7ad48ed4169a0d072a7790003aea2</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1073%2Fpnas.82.15.5131&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.82.15.5131%26sid%3Dliteratum%253Aachs%26aulast%3DHoughten%26aufirst%3DR.%2BA.%26atitle%3DGeneral%2520method%2520for%2520the%2520rapid%2520solid-phase%2520synthesis%2520of%2520large%2520numbers%2520of%2520peptides%253A%2520Specificity%2520of%2520antigen-antibody%2520interaction%2520at%2520the%2520level%2520of%2520individual%2520amino%2520acids%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1985%26volume%3D82%26spage%3D5131%26epage%3D5135%26doi%3D10.1073%2Fpnas.82.15.5131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Manku, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laplante, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopac, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, D. G.</span><span> </span><span class="NLM_article-title">A mild and general solid-phase method for the synthesis of chiral polyamines. Solution studies on the cleavage of borane-amine intermediates from the reduction of secondary amides</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">874</span><span class="NLM_x">–</span> <span class="NLM_lpage">885</span><span class="refDoi"> DOI: 10.1021/jo005647g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo005647g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhs1yrtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2001&pages=874-885&author=S.+Mankuauthor=C.+Laplanteauthor=D.+Kopacauthor=T.+Chanauthor=D.+G.+Hall&title=A+mild+and+general+solid-phase+method+for+the+synthesis+of+chiral+polyamines.+Solution+studies+on+the+cleavage+of+borane-amine+intermediates+from+the+reduction+of+secondary+amides&doi=10.1021%2Fjo005647g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">A Mild and General Solid-Phase Method for the Synthesis of Chiral Polyamines. Solution Studies on the Cleavage of Borane-Amine Intermediates from the Reduction of Secondary Amides</span></div><div class="casAuthors">Manku, Sukhdev; Laplante, Carmen; Kopac, Dan; Chan, Timothy; Hall, Dennis G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">874-885</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A mild oxidative workup protocol using iodine in an acetic acid-acetate buffer soln. is described for the cleavage of borane-amine adducts arising from the borane-promoted redn. of polyamides supported onto practical trityl-based resins.  Chiral polyamines with diverse side-chain functionalities can be generated as free bases without premature release from the solid support and with essentially no racemization using this method.  A series of model oligomeric secondary diamides contg. various α-amino acid residues (Val, Phe, Tyr, Ser, Cys, Met, Gln, Trp) provided triamine products in high yields and good to excellent purity.  On the other hand, a substrate contg. a tertiary amide formed a rather unusual triaminoborane intermediate that required more stringent workup conditions to liberate the polyamine product.  The redn. of oligomeric tertiary amides was sluggish, but these compds. could nonetheless be obtained in high purity from in situ reductive amination of the corresponding secondary amines.  Control studies, carried out in soln. with a model secondary amide, confirmed the efficiency of the buffered iodine soln. and highlighted several advantages (no heating necessary, no need for strong bases or acids) over existing methods for the cleavage of borane-amine adducts.  A possible mechanism involving all buffer components (iodine, acetic acid, and acetate ion) is proposed in which borane-amine adducts are transformed first to the monoiodoborane-amine and then to the corresponding acetoxyborane-amine adduct of much weaker coordination affinity.  The latter would dissoc. readily and get trapped by the acetic acid to provide the desired secondary amine.  This redn./oxidative workup protocol is useful as a general method for the facile solid-phase synthesis of polyamines for eventual release in soln. and use in various applications.  It is also potentially very useful toward the synthesis and screening of bead-supported libraries of free oligoamines assembled through split-pool methods.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4xZzSfqhUW7Vg90H21EOLACvtfcHk0lj-bGTSUV5-vg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhs1yrtw%253D%253D&md5=2df9d03865b805b3faac00cd493d454e</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fjo005647g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo005647g%26sid%3Dliteratum%253Aachs%26aulast%3DManku%26aufirst%3DS.%26aulast%3DLaplante%26aufirst%3DC.%26aulast%3DKopac%26aufirst%3DD.%26aulast%3DChan%26aufirst%3DT.%26aulast%3DHall%26aufirst%3DD.%2BG.%26atitle%3DA%2520mild%2520and%2520general%2520solid-phase%2520method%2520for%2520the%2520synthesis%2520of%2520chiral%2520polyamines.%2520Solution%2520studies%2520on%2520the%2520cleavage%2520of%2520borane-amine%2520intermediates%2520from%2520the%2520reduction%2520of%2520secondary%2520amides%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2001%26volume%3D66%26spage%3D874%26epage%3D885%26doi%3D10.1021%2Fjo005647g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Ostresh, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoner, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamashin, V. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nefzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houghten, R. A.</span><span> </span><span class="NLM_article-title">Solid-phase synthesis of trisubstituted bicyclic guanidines via cyclization of reduced n-acylated dipeptides</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">8622</span><span class="NLM_x">–</span> <span class="NLM_lpage">8623</span><span class="refDoi"> DOI: 10.1021/jo9810617</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo9810617" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=1%3ACAS%3A528%3ADyaK1cXntFKltLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=1998&pages=8622-8623&author=J.+M.+Ostreshauthor=C.+C.+Schonerauthor=V.+T.+Hamashinauthor=A.+Nefziauthor=J.-P.+Meyerauthor=R.+A.+Houghten&title=Solid-phase+synthesis+of+trisubstituted+bicyclic+guanidines+via+cyclization+of+reduced+n-acylated+dipeptides&doi=10.1021%2Fjo9810617"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Solid-Phase Synthesis of Trisubstituted Bicyclic Guanidines via Cyclization of Reduced N-Acylated Dipeptides</span></div><div class="casAuthors">Ostresh, John M.; Schoner, Christa C.; Hamashin, Vince T.; Nefzi, Adel; Meyer, Jean-Philippe; Houghten, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">8622-8623</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel method for the solid-phase synthesis of trisubstituted bicyclic guanidines I (R1 = CH2Ph, Me, CH2CHMe2, Pr; R2 = CH2Ph, Me, Pr; R3 = CH2CH2Ph, Bu, Et) is presented.  The initial reaction step involves the exhaustive redn. of resin-bound N-acylated dipeptides R3CONHCHR2CONHCHR1CONHR (R = polymer support) using borane-THF, followed by cyclization of the resulting triamine with thiocarbonyldiimidazole to generate resin-bound trisubstituted bicyclic guanidines.  Cleavage from the resin using HF yields the desired trisubstituted bicyclic guanidines in excellent yield and purity.  The approaches described enable efficient high-yield and purity syntheses of either polyamines II or bicyclic guanidines.  These methods were applied to the synthesis of both individual compds. and combinatorial libraries.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpP3oHBqwPh_LVg90H21EOLACvtfcHk0ljoDJlzcDPcBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXntFKltLg%253D&md5=e4bd86d14e5d2ba504b76a46783b7fa8</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fjo9810617&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo9810617%26sid%3Dliteratum%253Aachs%26aulast%3DOstresh%26aufirst%3DJ.%2BM.%26aulast%3DSchoner%26aufirst%3DC.%2BC.%26aulast%3DHamashin%26aufirst%3DV.%2BT.%26aulast%3DNefzi%26aufirst%3DA.%26aulast%3DMeyer%26aufirst%3DJ.-P.%26aulast%3DHoughten%26aufirst%3DR.%2BA.%26atitle%3DSolid-phase%2520synthesis%2520of%2520trisubstituted%2520bicyclic%2520guanidines%2520via%2520cyclization%2520of%2520reduced%2520n-acylated%2520dipeptides%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1998%26volume%3D63%26spage%3D8622%26epage%3D8623%26doi%3D10.1021%2Fjo9810617" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Cippitelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoch, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debevec, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunori, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaveri, N. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toll, L.</span><span> </span><span class="NLM_article-title">A key role for the N/OFQ-NOP receptor system in modulating nicotine taking in a model of nicotine and alcohol co-administration</span> <span class="citation_source-journal">Sci. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">26594</span><span class="refDoi"> DOI: 10.1038/srep26594</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=10.1038%2Fsrep26594" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=27199205" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=1%3ACAS%3A528%3ADC%252BC28Xotlehu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=26594&author=A.+Cippitelliauthor=J.+Schochauthor=G.+Debevecauthor=G.+Brunoriauthor=N.+T.+Zaveriauthor=L.+Toll&title=A+key+role+for+the+N%2FOFQ-NOP+receptor+system+in+modulating+nicotine+taking+in+a+model+of+nicotine+and+alcohol+co-administration&doi=10.1038%2Fsrep26594"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">A key role for the N/OFQ-NOP receptor system in modulating nicotine taking in a model of nicotine and alcohol co-administration</span></div><div class="casAuthors">Cippitelli, Andrea; Schoch, Jennifer; Debevec, Ginamarie; Brunori, Gloria; Zaveri, Nurulain T.; Toll, Lawrence</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">26594</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Alc. and nicotine are often co-abused.  Although the N/OFQ-NOP receptor system is considered a potential target for development of drug abuse pharmacotherapies, esp. for alcoholism, little is known about the role of this system in nicotine dependence.  Furthermore, the effect of prior history of nicotine dependence on subsequent nicotine and alc. taking is understudied.  Using an operant co-administration paradigm, in which rats concurrently self-administer nicotine and alc., we found that nicotine dependent rats increased nicotine self-administration over time as compared to non-dependent animals, while patterns of alc. lever pressing did not change between groups.  Pretreatment with the potent NOP receptor agonist AT-202 (0.3-3 mg/kg) increased nicotine lever pressing of both dependent and non-dependent groups, whereas the selective antagonist SB612111 (1-10 mg/kg) elicited a clear redn. of nicotine responses, in both dependent and non-dependent rats.  In parallel, AT-202 only produced minor changes on alc. responses and SB612111 reduced alc. taking at a dose that also reduced locomotor behavior.  Results indicate that a history of nicotine dependence affects subsequent nicotine- but not alc.-maintained responding, and that NOP receptor antagonism, rather than agonism, blocks nicotine self-administration, which strongly suggests a crit. role for the endogenous N/OFQ in the modulation of nicotine reinforcement processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKAbj5-lmbNbVg90H21EOLACvtfcHk0ljoDJlzcDPcBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xotlehu70%253D&md5=f2057e8558b105839c5fc738b6a91f72</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1038%2Fsrep26594&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep26594%26sid%3Dliteratum%253Aachs%26aulast%3DCippitelli%26aufirst%3DA.%26aulast%3DSchoch%26aufirst%3DJ.%26aulast%3DDebevec%26aufirst%3DG.%26aulast%3DBrunori%26aufirst%3DG.%26aulast%3DZaveri%26aufirst%3DN.%2BT.%26aulast%3DToll%26aufirst%3DL.%26atitle%3DA%2520key%2520role%2520for%2520the%2520N%252FOFQ-NOP%2520receptor%2520system%2520in%2520modulating%2520nicotine%2520taking%2520in%2520a%2520model%2520of%2520nicotine%2520and%2520alcohol%2520co-administration%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D26594%26doi%3D10.1038%2Fsrep26594" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Hilbe, J. M.</span><span> </span><span class="NLM_article-title">Statistica 7</span> <span class="citation_source-journal">Am. Stat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">91</span><span class="NLM_x">–</span> <span class="NLM_lpage">94</span><span class="refDoi"> DOI: 10.1198/000313007X172998</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;key=10.1198%2F000313007X172998" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2007&pages=91-94&author=J.+M.+Hilbe&title=Statistica+7&doi=10.1198%2F000313007X172998"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1198%2F000313007X172998&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1198%252F000313007X172998%26sid%3Dliteratum%253Aachs%26aulast%3DHilbe%26aufirst%3DJ.%2BM.%26atitle%3DStatistica%25207%26jtitle%3DAm.%2520Stat.%26date%3D2007%26volume%3D61%26spage%3D91%26epage%3D94%26doi%3D10.1198%2F000313007X172998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i27"><a href="/doi/suppl/10.1021/acs.jmedchem.7b01250">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_12454"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.7b01250">10.1021/acs.jmedchem.7b01250</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Molecular formula strings and some data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01250/suppl_file/jm7b01250_si_001.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01250/suppl_file/jm7b01250_si_001.csv">jm7b01250_si_001.csv (1.58 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.7b01250&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b01250%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2017.60.issue-24%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.7b01250" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                1MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679ac0b79bff3c7c","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
